
<html lang="en"     class="pb-page"  data-request-id="130a045a-fcc7-48d4-b5d3-a2387962e4f9"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-5;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.7b01856"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs)" /></meta><meta name="dc.Creator" content="Christos  Liolios" /></meta><meta name="dc.Creator" content="Benjamin  Buchmuller" /></meta><meta name="dc.Creator" content="Ulrike  Bauder-Wüst" /></meta><meta name="dc.Creator" content="Martin  Schäfer" /></meta><meta name="dc.Creator" content="Karin  Leotta" /></meta><meta name="dc.Creator" content="Uwe  Haberkorn" /></meta><meta name="dc.Creator" content="Matthias  Eder" /></meta><meta name="dc.Creator" content="Klaus  Kopka" /></meta><meta name="dc.Description" content="The GRPr, highly expressed in prostate PCa and breast cancer BCa, is a promising target for the development of new PET radiotracers. The chelator HBED-CC (N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]..." /></meta><meta name="Description" content="The GRPr, highly expressed in prostate PCa and breast cancer BCa, is a promising target for the development of new PET radiotracers. The chelator HBED-CC (N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 12, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b01856" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01856" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b01856" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b01856" /></link>
        
    
    

<title>Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b01856" /></meta><meta property="og:title" content="Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0008.jpeg" /></meta><meta property="og:description" content="The GRPr, highly expressed in prostate PCa and breast cancer BCa, is a promising target for the development of new PET radiotracers. The chelator HBED-CC (N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid) was coupled to the bombesin peptides: HBED-C-BN(2–14) 1, HBED-CC-PEG2-[d-Tyr6,β-Ala11,Thi13,Nle14]-BN(6–14) 2, HBED-CC-Y-[d-Phe6,Sta13,Leu14]-BN(6–14) (Y = 4-amino-1-carboxymethylpiperidine) 3, and HBED-CC-{PEG2-Y-[d-Phe6,Sta13,Leu14]-BN(6–14)}2 4 (homodimer). Compounds 1–4 presented high binding affinities for GRPr (T47D, 0.56–3.51 nM; PC-3, 2.12–4.68 nM). In PC-3 and T47D cells, agonists [68Ga]1 and [68Ga]2 were mainly internalized while antagonists [68Ga]3 and [68Ga]4 were surface bound. Cell-related radioactivity reached a maximum after 45 min, while tracer levels followed GRPr expression (PC-3 &gt; T47D &gt; LNCaP &gt; MDA-MB-231). [68Ga]4 showed the highest cell-bound radioactivity (PC-3 and T47D). In vivo, tumor (PC-3) targeting for [68Ga]3 and [68Ga]4 increased over time, with dynamic μPET showing clearer tumors images at later time points. [68Ga]3 and [68Ga]4 can be considered suitable PET tracers for imaging PCa and BCa expressing GRPr." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b01856"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b01856">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b01856&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b01856&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b01856&amp;href=/doi/10.1021/acs.jmedchem.7b01856" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2062-2074</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01837" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00036" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Monomeric and Dimeric <sup>68</sup>Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs)</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Christos Liolios</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christos Liolios</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: +49 6221 42 2431. E-mail: <a href="/cdn-cgi/l/email-protection#c7a4e9abaea8abaea8b487a3aca1bde9a3a2"><span class="__cf_email__" data-cfemail="a8cb86c4c1c7c4c1c7dbe8ccc3ced286cccd">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christos++Liolios">Christos Liolios</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1909-6212" title="Orcid link">http://orcid.org/0000-0002-1909-6212</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin Buchmuller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin Buchmuller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Buchmuller">Benjamin Buchmuller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ulrike Bauder-Wüst</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ulrike Bauder-Wüst</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ulrike++Bauder-W%C3%BCst">Ulrike Bauder-Wüst</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Martin Schäfer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin Schäfer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Sch%C3%A4fer">Martin Schäfer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Karin Leotta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Karin Leotta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Karin++Leotta">Karin Leotta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Uwe Haberkorn</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Uwe Haberkorn</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Clinical Cooperation Unit Nuclear Medicine,  German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div><div class="loa-info-affiliations-info">Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Uwe++Haberkorn">Uwe Haberkorn</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Matthias Eder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Matthias Eder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Radiopharmaceutical Chemistry,  German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div><div class="loa-info-affiliations-info">Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK) Freiburg, and Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Matthias++Eder">Matthias Eder</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5110-0744" title="Orcid link">http://orcid.org/0000-0002-5110-0744</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Klaus Kopka</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Klaus Kopka</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Radiopharmaceutical Chemistry,  German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Klaus++Kopka">Klaus Kopka</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01856&amp;href=/doi/10.1021%2Facs.jmedchem.7b01856" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2062–2074</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 12, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>15 December 2017</li><li><span class="item_label"><b>Published</b> online</span>12 February 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 March 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b01856" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01856</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2062%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristos%2BLiolios%252C%2BBenjamin%2BBuchmuller%252C%2BUlrike%2BBauder-W%25C3%25BCst%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D5%26contentID%3Dacs.jmedchem.7b01856%26title%3DMonomeric%2Band%2BDimeric%2B68Ga-Labeled%2BBombesin%2BAnalogues%2Bfor%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BImaging%2Bof%2BTumors%2BExpressing%2BGastrin-Releasing%2BPeptide%2BReceptors%2B%2528GRPrs%2529%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2074%26publicationDate%3DMarch%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b01856"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">889</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b01856" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Monomeric and Dimeric 68Ga-Labeled Bombesin Analogues for Positron Emission Tomography (PET) Imaging of Tumors Expressing Gastrin-Releasing Peptide Receptors (GRPrs)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christos&quot;,&quot;last_name&quot;:&quot;Liolios&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Buchmuller&quot;},{&quot;first_name&quot;:&quot;Ulrike&quot;,&quot;last_name&quot;:&quot;Bauder-Wüst&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Schäfer&quot;},{&quot;first_name&quot;:&quot;Karin&quot;,&quot;last_name&quot;:&quot;Leotta&quot;},{&quot;first_name&quot;:&quot;Uwe&quot;,&quot;last_name&quot;:&quot;Haberkorn&quot;},{&quot;first_name&quot;:&quot;Matthias&quot;,&quot;last_name&quot;:&quot;Eder&quot;},{&quot;first_name&quot;:&quot;Klaus&quot;,&quot;last_name&quot;:&quot;Kopka&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;2062-2074&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b01856&quot;},&quot;abstract&quot;:&quot;The GRPr, highly expressed in prostate PCa and breast cancer BCa, is a promising target for the development of new PET radiotracers. The chelator HBED-CC (N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid) was coupled to the bombesin peptides: HBED-C-BN(2–14) 1, HBED-CC-PEG2-[d-Tyr6,β-Ala11,Thi13,Nle14]-BN(6–14) 2, HBED-CC-Y-[d-Phe6,Sta13,Leu14]-BN(6–14) (Y = 4-amino-1-carboxymethylpiperidine) 3, and HBED-CC-{PEG2-Y-[d-Phe6,Sta13,Leu14]-BN(6–14)}2 4 (homodimer). Compounds 1–4 presented high binding affinities for GRPr (T47D, 0.56–3.51 nM; PC-3, 2.12–4.68 nM). In PC-3 and T47D cells, agonists [68Ga]1 and [68Ga]2 were mainly internalized while antagonists [68Ga]3 and [68Ga]4 were surface bound. Cell-related radioactivity reached a maximum after 45 min, while tracer levels followed GRPr expression (PC-3 &gt; T47D &gt; LNCaP &gt; MDA-MB-231). [68Ga]4 showed the highest cell-bound radioactivity (PC-3 and T47D). In vivo, tumor (PC-3) targeting for [68Ga]3 and [68Ga]4 increased over time, with dyna&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01856&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01856" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01856&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01856" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b01856&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01856" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b01856&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b01856&amp;href=/doi/10.1021/acs.jmedchem.7b01856" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b01856" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b01856" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b01856%26sid%3Dliteratum%253Aachs%26pmid%3D29432691%26genre%3Darticle%26aulast%3DLiolios%26date%3D2018%26atitle%3DMonomeric%2Band%2BDimeric%2B68Ga-Labeled%2BBombesin%2BAnalogues%2Bfor%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BImaging%2Bof%2BTumors%2BExpressing%2BGastrin-Releasing%2BPeptide%2BReceptors%2B%2528GRPrs%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D5%26spage%3D2062%26epage%3D2074%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292153" title="Tumors">Tumors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/jmcmar.2018.61.issue-5/20180308/jmcmar.2018.61.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The GRPr, highly expressed in prostate PCa and breast cancer BCa, is a promising target for the development of new PET radiotracers. The chelator HBED-CC (<i>N</i>,<i>N</i>′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-<i>N</i>,<i>N</i>′-diacetic acid) was coupled to the bombesin peptides: HBED-C-BN(2–14) <b>1</b>, HBED-CC-PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,β-Ala<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]-BN(6–14) <b>2</b>, HBED-CC-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) (Y = 4-amino-1-carboxymethylpiperidine) <b>3</b>, and HBED-CC-{PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14)}<sub>2</sub><b>4</b> (homodimer). Compounds <b>1</b>–<b>4</b> presented high binding affinities for GRPr (T47D, 0.56–3.51 nM; PC-3, 2.12–4.68 nM). In PC-3 and T47D cells, agonists [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2</b> were mainly internalized while antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> were surface bound. Cell-related radioactivity reached a maximum after 45 min, while tracer levels followed GRPr expression (PC-3 > T47D > LNCaP > MDA-MB-231). [<sup>68</sup>Ga]<b>4</b> showed the highest cell-bound radioactivity (PC-3 and T47D). In vivo, tumor (PC-3) targeting for [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> increased over time, with dynamic μPET showing clearer tumors images at later time points. [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> can be considered suitable PET tracers for imaging PCa and BCa expressing GRPr.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The gastrin-releasing peptide receptor (GRPr), also called bombesin receptor 2 (BB<sub>2</sub>), is a promising target for noninvasive PET imaging of various types of cancer. GRPr is a glycosylated seven-transmembrane G-protein-coupled receptor, which is expressed in numerous cancers, such as lung, colon, prostate, and breast.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Especially for prostate cancer, GRPr is overexpressed in comparison to sparse expression in normal prostate tissue.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> GRP binding to this receptor stimulates the growth of prostate cancer cells both in vitro and in vivo. A significant inverse correlation was found between GRPr expression and increased Gleason score.<a onclick="showRef(event, 'ref1 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref4">(1,4)</a> In addition GRPr expression has been found in high density in 72–96% of ductal breast cancer specimens.<a onclick="showRef(event, 'ref5 ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7">(5−7)</a> There are multiple preclinical and a few clinical studies published evaluating GRPr as imaging target/imaging biomarker mainly for prostate cancer and secondary for breast cancer.<a onclick="showRef(event, 'ref1 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref1 ref7 ref8 ref9">(1,7−9)</a></div><div class="NLM_p">Bombesin (BBN), a 14-mer GRPr peptide agonist, was initially found in the skin of the fire-bellied toad Bombina bombina,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and since then several peptide GRPr agonists and antagonists have been synthesized, radiolabeled, and tested preclinically and clinically.<a onclick="showRef(event, 'ref1 ref11'); return false;" href="javascript:void(0);" class="ref ref1 ref11">(1,11)</a> BBN agonists internalize after binding to GRPr which is considered advantageous for ligands carrying therapeutic nuclides, but they have a proliferating effect on cancer cells. On the other hand BBN antagonists do not have a proliferation effect on cancer cells, they are mainly surface bound and they have shown less acute adverse effects (e.g. gastrointestinal).<a onclick="showRef(event, 'ref1 ref12'); return false;" href="javascript:void(0);" class="ref ref1 ref12">(1,12)</a></div><div class="NLM_p">Over the past decade the positron emitter <sup>68</sup>Ga has attracted a lot of interest for PET imaging applications, due to its availability from <sup>68</sup>Ge/<sup>68</sup>Ga generators and due to the idea of <sup>68</sup>Ga-labeling using kit-based preparations comparable with those used in <sup>99m</sup>Tc radiopharmacies with <sup>99</sup>Mo/<sup>99m</sup>Tc generators.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Radiometals with a short half-life such as <sup>68</sup>Ga (<i>T</i><sub>1/2</sub> = 68 min) are ideally combined with chelators that have fast kinetics and can form stable complexes at ambient temperature.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Such an agent is HBED-CC, <i>N</i>,<i>N</i>′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-<i>N</i>,<i>N</i>′-diacetic acid, which can be conveniently labeled with <sup>68</sup>Ga (25 °C, 10–20 min, pH 4–4.5) and has two additional carboxylic groups (propionic acid moieties) that can be used for the conjugations to a pharmacophore/binding vector.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This functionality is also ideal for the synthesis of dimeric compounds, resulting in radiolabeled homodimers (same pharmacophore), heterodimers (different pharmacophores),<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> or dual-labeled tracers, e.g., a radiolabeled pharmacophore and a dye for a combination of PET with optical imaging.</div><div class="NLM_p">The multivalency approach (e.g., homodimers) is considered to increase ligand affinity through multiple binding interactions.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Several binding modes have been proposed as an explanation for this effect; i.e., the ligand simultaneously binds to two receptors on the cell surface or the improved statistical effect, where the ligand binds to one receptor, but its apparent local concentration is increased.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> So far only a few studies on BBN-based homodimers have been reported with varying results.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22">(18−22)</a></div><div class="NLM_p">In the present study we investigated the effects of linking the HBED-CC chelator to different BBN pharmacophores. HBED-CC was linked to two agonists, the naturally occurring peptide H<sub>2</sub>N-BN(2–14) and the modified peptide sequence H<sub>2</sub>N-PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,β-Ala<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BN(6–14), as well as to the antagonist, H<sub>2</sub>N–Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14), (Y = 4-amino-1-carboxymethylpiperidine) resulting in ligands <b>1</b>, <b>2</b>, and <b>3</b>, respectively. The last two BBN pharmacophores connected to a DOTA chelator have been used in clinical studies, i.e., BZH3 and RM2.<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a> In addition, by taking advantage of dual conjugation possibilities of HBED-CC, a homodimer was synthesized, HBED-CC-{PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14)}<sub>2</sub><b>4</b> based on the antagonist’s sequence (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The new peptides were evaluated in vitro for their GRPr affinity, internalization, and time kinetic cell binding in prostate cancer (PC-3, high GRPr expression, LNCaP, low expression) and breast cancer cells (T47D, high GRPr expression, MDA-MB-231, low expression). Internal controls for the in vitro studies included BBN, BZH3, and RM2. [<sup>68</sup>Ga]<b>i</b> (<b>i</b> = <b>1</b>–<b>4</b>) compounds were also tested in vivo in mice bearing PC-3 tumors for their tumor-targeting ability and biodistribution behavior with [<sup>68</sup>Ga]RM2 as internal control.</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of GRPr Agonists and Antagonists Coupled with the Chelator HBED-CC<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) FeCl<sub>3</sub>, 1.2 equiv, 5% DIPEA, MeOH/H<sub>2</sub>O 1/1, v/v; (b) TFP (2,3,5,6-tetrafluorophenol), 10 equiv, 0.19 mmol, 311 mg, DIC, 4 equiv, 0.08 mmol, 118 μL, in DMF (1.0 mL), rt, 1 day; (c) pharmacophore (i–iii) 1.2 equiv 6.6 μmol, (i) 10.7 mg, (ii) 8.5 mg, and (iii) 8.3 mg; (d) pharmacophore (iv), 4 equiv, 13.0 mg, 8.5 μmol, excess DIPEA, in DMF (1.0 mL), rt, 1 day; where (i) H<sub>2</sub>N-BN(2–14); (ii) H<sub>2</sub>N-PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,β-Ala<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BN(6–14); (iii) H<sub>2</sub>N–Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14); (iv) H<sub>2</sub>N-PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) and Y = 4-amino-1-carboxymethylpiperidine; (e) [<sup>68</sup>Ga]GaCl<sub>3</sub>, 40 μL (80–100 MBq), <b>1–4</b> (0.3–1.0 nmol) in 0.1 M HEPES buffer (pH = 7.5, 100 μL), 10 μL of HEPES solution (2.1 M). pH 4.2, 98 °C, 10 min.</p></p></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68455" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68455" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The peptidic parts of the tracers were synthesized on a Rink amide resin according to standard Fmoc peptide synthesis protocols. For the reference compounds RM2 and BZH3 the DOTA chelator was coupled as an amino acid and then the final product was cleaved from the resin and purified with RP-HPLC. For the HBED-CC conjugates <b>1</b>–<b>4</b> initially the phenolic and carboxylate groups of HBED-CC were selectively protected by complexation with Fe<sup>3+</sup> to form [Fe(HBED-CC)]<sup>−</sup> and then the two remaining carboxylate groups were selectively activated with TFP (2,3,5,6-tetrafluorophenol) resulting in the mono- and bis-TFP esters of [Fe(HBED-CC]<sup>−</sup>. At the final step, the mono-TFP ester of [Fe(HBED-CC]<sup>−</sup> was reacted with the corresponding peptidic parts resulting into monomers <b>1</b>–<b>3</b>, while the bis TFP ester of [Fe(HBED-CC]<sup>−</sup> resulted in the formation of dimer <b>4</b>. The synthesis of ligands <b>1</b>–<b>4</b> is summarized in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. The final products were of purity greater than 98%. Overall yield for <b>1</b>–<b>3</b> ranged between 15% and 20%, while for the homodimer <b>4</b> it was 10%. At the final step, iron was removed from the ligands via SEP-PAK cartridge after acidic treatment (1 M HCl) and elution with AcCN/H<sub>2</sub>O (8:2, v/v) to afford iron-free products for labeling with <sup>68</sup>Ga and <sup>nat</sup>Ga (see next section). The analyses results of the pure products and their <sup>nat</sup>Ga complexes with RP-HPLC and MALDI-MS are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Calculated Mass Results with MALDI-MS and Retention Times after Radio-RP-HPLC Analysis of the Ligands (L) and Their [<sup>nat</sup>Ga]L and [<sup>68</sup>Ga]L Complexes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">calculated mass</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">[M + H]<sup>+</sup> or [M]<sup>+</sup></th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">chelator</th><th class="colsep0 rowsep0" align="center">linker−pharmacophore</th><th class="colsep0 rowsep0" align="center" char=".">L</th><th class="colsep0 rowsep0" align="center" char=".">[<sup>nat</sup>Ga]L<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">L</th><th class="colsep0 rowsep0" align="center" char=".">[<sup>nat</sup>Ga]L<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>R</sub> (min) [<sup>68</sup>Ga]L</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">HBED-CC</td><td class="colsep0 rowsep0" align="left">BN(2−14)</td><td class="colsep0 rowsep0" align="char" char=".">2023.3</td><td class="colsep0 rowsep0" align="char" char=".">2091.0</td><td class="colsep0 rowsep0" align="char" char=".">2024.8</td><td class="colsep0 rowsep0" align="char" char=".">2091.0</td><td class="colsep0 rowsep0" align="char" char=".">2.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,β-Ala<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]-BN(6–14)</td><td class="colsep0 rowsep0" align="char" char=".">1799.0</td><td class="colsep0 rowsep0" align="char" char=".">1866.7</td><td class="colsep0 rowsep0" align="char" char=".">1800.8</td><td class="colsep0 rowsep0" align="char" char=".">1867.5</td><td class="colsep0 rowsep0" align="char" char=".">2.42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14)</td><td class="colsep0 rowsep0" align="char" char=".">1768.1</td><td class="colsep0 rowsep0" align="char" char=".">1834.8</td><td class="colsep0 rowsep0" align="char" char=".">1769.5</td><td class="colsep0 rowsep0" align="char" char=".">1836.3</td><td class="colsep0 rowsep0" align="char" char=".">2.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14))<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">3293.9</td><td class="colsep0 rowsep0" align="char" char=".">3359.6<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">3294.2</td><td class="colsep0 rowsep0" align="char" char=".">3359.7</td><td class="colsep0 rowsep0" align="char" char=".">2.39</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Theoretical calculations for [ <sup>nat</sup>GaH<sub>2</sub>L] complex, where L equals ligand.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Experimental values, Y = 4-amino-1-carboxymethylpiperidine.</p></div></div></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Labeling with <sup>68</sup>Ga and <sup>nat</sup>Ga</h3><div class="NLM_p">In all cases, radiolabeling with <sup>68</sup>Ga resulted in one single species as determined by analytical RP-HPLC, while the radiochemical yield was >98% (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The retention times (<i>t</i><sub>R</sub>) of the <sup>68</sup>Ga-labeled compounds (obtained by radio-HPLC analysis) are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> (comparative HPLC results for pure [<sup>nat</sup>Ga]<b>i</b> can be found in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf" class="ext-link">Supporting Information, Figure S2</a>). In general, sequence dependent differences proved more important than size for hydrophilicity. More specifically, [<sup>68</sup>Ga]<b>1</b> (molecular weight, MW = 2091.0), containing the native BBN sequence, was the most hydrophilic (<i>t</i><sub>R</sub> = 2.15 min), followed by the antagonist [<sup>68</sup>Ga]<b>3</b> (<i>t</i><sub>R</sub> = 2.25 min, MW = 1868) and the homodimer [<sup>68</sup>Ga]<b>4</b> (<i>t</i><sub>R</sub> = 2.39 min, MW = 3359.7) and finally [<sup>68</sup>Ga]<b>2</b> (<i>t</i><sub>R</sub> = 2.42 min, MW = 1836.3). All compounds were proven stable at room temperature in saline even after 2 h after labeling. After complexation with <sup>nat</sup>Ga compounds were purified with semipreparative RP HPLC and analyzed with MALDI-MS (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). [<sup>nat</sup>Ga]<b>i</b> (<b>i</b> = <b>1</b>–<b>4</b>) complexes showed the same RP-HPLC retention times as the [<sup>68</sup>Ga]<b>i</b>.</div><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The γ-trace of the comparative RP-radio-HPLC analysis after labeling with <sup>68</sup>Ga is presented with the <i>t</i><sub>R</sub> (min) noted at the top of each peak. Radiochemical purity was above 98% in all cases. RP-HPLC analysis was performed on a Chromolith RP-18e (100 mm × 4.6 mm; Merck, Darmstadt, Germany), using a linear A–B gradient (0% B to 100% B in 5 min), flow of 4 mL/min, A consisting of 0.1% aqueous TFA, and B consisting of 0.1% TFA in CH<sub>3</sub>CN.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Determination of Binding Affinity for PSMA and GRPr</h3><div class="NLM_p">An in vitro competitive cell binding assay for the compounds under study was performed against <sup>125</sup>I[Tyr<sup>4</sup>]-BN in order to determine the binding potency for GRPr, with PC-3 (human prostate cancer) and T47D cells (human breast cancer). As internal references, two peptides known from the literature were also included in the assay, i.e., RM2 and BZH3,<a onclick="showRef(event, 'ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25">(23−25)</a> and natural BBN. The results of the IC<sub>50</sub> values (nM) for both cell lines are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. (Displacement curves of <sup>125</sup>I[Tyr<sup>4</sup>]-BBN for ligands <b>1</b>–<b>4</b> and reference compounds natural BBN, RM2, BZH3 are available in <a href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf" class="ext-link">Figure S1 in Supporting Information</a>.) All ligands presented high binding affinities in the nanomolar range close to the values of the reference compound BBN (0.26 nM, T47D and 0.56 nM, PC-3). The IC<sub>50</sub> values observed for most cases were lower for T47D than for PC-3. Ligand <b>1</b> (0.56 nM, T47D and 2.12 nM, PC-3) presented the lowest IC<sub>50</sub> (highest affinities for GRPr), followed by the antagonist <b>3</b> (1.07 nM, T47D; 2.32 nM, PC-3) and its dimer <b>4</b> (3.03 nM, T47D; 2.45 nM, PC-3). The modified agonist H<sub>2</sub>N-PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>, β-Ala<sup>11</sup>,Thi<sup>13</sup>, Nle<sup>14</sup>]-BN(6–14) presented the higher IC<sub>50</sub> values (lowest affinity for GRPr) (3.51 nM, T47D; 4.68 nM, PC-3).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. IC<sub>50</sub> Values of the Compounds <b>1</b>–<b>4</b> Determined against <sup>125</sup>I-BBN (30 nM) in T47D and PC-3 Cells<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">T47D (nM)</th><th class="colsep0 rowsep0" align="center" char=".">log IC<sub>50</sub> (St.Er.)</th><th class="colsep0 rowsep0" align="center" char=".">PC-3 (nM)</th><th class="colsep0 rowsep0" align="center" char=".">log IC<sub>50</sub> (St.Er.)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">0.56</td><td class="colsep0 rowsep0" align="char" char=".">–0.25 (0.04)</td><td class="colsep0 rowsep0" align="char" char=".">2.12</td><td class="colsep0 rowsep0" align="char" char=".">0.33 (0.03)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">3.51</td><td class="colsep0 rowsep0" align="char" char=".">0.54 (0.05)</td><td class="colsep0 rowsep0" align="char" char=".">4.68</td><td class="colsep0 rowsep0" align="char" char=".">0.67 (0.07)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">1.07</td><td class="colsep0 rowsep0" align="char" char=".">0.03 (0.07)</td><td class="colsep0 rowsep0" align="char" char=".">2.12</td><td class="colsep0 rowsep0" align="char" char=".">0.33 (0.12)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">3.03</td><td class="colsep0 rowsep0" align="char" char=".">0.51 (0.06)</td><td class="colsep0 rowsep0" align="char" char=".">2.45</td><td class="colsep0 rowsep0" align="char" char=".">0.39 (0.06)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>BBN</i></td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char="."><i>–0.59 (0.02)</i></td><td class="colsep0 rowsep0" align="char" char=".">0.65</td><td class="colsep0 rowsep0" align="char" char="."><i>–0.19 (0.03)</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>RM2</i></td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char="."><i>–0.20 (0.04)</i></td><td class="colsep0 rowsep0" align="char" char=".">1.33</td><td class="colsep0 rowsep0" align="char" char="."><i>0.12 (0.05)</i></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>BZH3</i></td><td class="colsep0 rowsep0" align="char" char=".">1.85</td><td class="colsep0 rowsep0" align="char" char="."><i>0.28 (0.04)</i></td><td class="colsep0 rowsep0" align="char" char=".">2.08</td><td class="colsep0 rowsep0" align="char" char="."><i>0.32 (0.03)</i></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup><sup>a</sup></sup><p class="last">As internal references (italics), three known compounds from the literature, i.e., BBN, the antagonist RM2, and the agonist and BZH3, were also used.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Internalization Experiments in PC-3 and T47D Cell Lines</h3><div class="NLM_p">The HBED-CC BBN analogues [<sup>68</sup>Ga]<b>i</b> (<b>i</b> = <b>1</b>, <b>2</b>, and <b>3</b>) were tested in vitro in PC-3 and T47D cells (as internal reference [<sup>68</sup>Ga]RM2 was also included in the assay). The results are summarized in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> and <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>. For the two agonists, [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2</b>, the main fraction of cell-bound (surface plus internalized) radioactivity was internalized in PC-3 cells (66% and 54% of total), while the antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> were mainly surface bound (84% and 73% of total). Analogously, in T47D cells the two agonists [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2</b> showed increased internalized radioactivity (76% and 72%), while antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> increased surface bound (89% and 95%) (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). In both PC-3 and T47D cells the total cell-related radioactivity for the dimer [<sup>68</sup>Ga]<b>4</b> was higher than the monomers and at the same levels as the DOTA analogue [<sup>68</sup>Ga]RM2 (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>).</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0001.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Surface, internalized, and total cell bound ligands [<sup>68</sup>Ga]<b>1</b>, [<sup>68</sup>Ga]<b>2</b>, [<sup>68</sup>Ga]<b>3</b>, and [<sup>68</sup>Ga]<b>4</b> expressed as cpm at 37 °C (45 min incubation time) in PC-3 (a) and T47D (b) cells. The values at the top of the bars represent the percentage of the total cell related activity that was surface bound or internalized. Statistical results are expressed as asterisks at the top of the bars (one way nonparametric ANOVA, <i>P</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Total cell related [<sup>68</sup>Ga]<b>i</b> agonists (<b>i</b> = <b>1</b>, <b>2</b>) and antagonists and (<b>i</b> = <b>3</b>, <b>4</b>) in PC-3 (a) and T47D (b) cells. The results are presented as specifically bound radioactivity (cpm) of <sup>68</sup>Ga-labeled compounds (30 nM in 2 × 10<sup>5</sup> PC-3 or T47D cells/well seeded 24 h before the experiment). As reference [<sup>68</sup>Ga]RM2 was included in the assay. Asterisks at the top of the bars represent the statistically significant differences against [<sup>68</sup>Ga]RM2 (ANOVA, one way nonparametric, <i>P</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Time Kinetic Binding Studies</h3><div class="NLM_p">Time kinetic data (0–90 min) for <sup>68</sup>Ga-labeled agonists and antagonists (30 nM in 1.4 × 10<sup>5</sup> cells) were investigated in GRPr positive cell lines PC-3 (prostate cancer) and T47D (breast cancer) and in negative cell lines LNCaP (prostate cancer) and MDA-MB-231 (breast cancer), while for the highly GRPr expressing PC-3 cell lines blocking experiments were also conducted. Results for antagonists [<sup>68</sup>Ga]<b>3</b> and (PC-3 and PC-3 blocked, T47D, MDA-MB-231, LNCaP) and [<sup>68</sup>Ga]<b>4</b> (PC-3 and PC-3 blocked) are presented in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a, while results for agonists [<sup>68</sup>Ga]<b>2</b> (PC-3 and PC-3 blocked, LNCaP) and [<sup>68</sup>Ga]<b>1</b> (PC-3 and PC-3 blocked) are shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>b. All compounds tested presented similar time kinetics reaching maximal cell-bound activity after approximately 45 min. Antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> reached the plateau slightly faster than agonists [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2</b>, while for all compounds the cell related activity declined after 60 min. In PC-3 cells the homodimeric antagonist [<sup>68</sup>Ga]<b>4</b> presented higher binding than the others, and agonist [<sup>68</sup>Ga]<b>2</b> presented the lowest. For the antagonist [<sup>68</sup>Ga]<b>3</b> the amount of cell bound activity for both negative cell lines LNCaP (prostate cancer) and MDA-MB-231 (breast cancer) was similar and ranged between 0.8% and 1.6% of the given radioactivity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>a). The amount of cell binding for [<sup>68</sup>Ga]<b>i</b> (<b>i</b> = <b>1</b>–<b>4</b>) after blocking PC-3 cells with a 1000× excess of the corresponding pharmacophore ranged between 0.5% and 0.7% of the given radioactivity.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Total cell-bound radioactivity over time of (a) [<sup>68</sup>Ga]<b>4</b> (antagonist) in PC-3 and PC-3 blocked, [<sup>68</sup>Ga]<b>3</b> (antagonist) in PC-3 and PC-3 blocked, T47D, LNCaP, and MDA-MB-231 cells and (b) [<sup>68</sup>Ga]<b>1</b> in PC-3, PC-3 blocked and [<sup>68</sup>Ga]<b>2</b> (agonists) in PC-3, PC-3 blocked and LNCaP cells. Results are expressed as % of the total activity added in 10<sup>5</sup> cells. The GRPr positive cell lines (PC-3, T47D) are presented with solid lines, while the GRPr negative cell lines (LNCaP and MBA-MB-231) and blocking experiments are presented with dashed lines. Blocking experiments were conducted with an addition of 1000-fold excess of the corresponding bombesin pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Biodistribution and Imaging μPET Results</h3><div class="NLM_p">The in vivo biodistribution behavior of the radiolabeled analogues [<sup>68</sup>Ga]<b>i</b> (<b>i</b> = <b>1</b>–<b>4</b>) was examined with organ distribution (30 and 60 min p.i.) and imaging experiments in PC-3 tumor bearing mice. For the two antagonists a comparative organ distribution study (30 and 60 min p.i.) was also conducted against reference antagonistic compound [<sup>68</sup>Ga]RM2. Results (%ID/g ± SD) from the biodistribution experiments (30 and 60 min p.i.) are summarized in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a (for the organ distribution values see also <a href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf" class="ext-link">Table S1, Supporting Information</a>). Tumor-to-background ratios for the antagonists [<sup>68</sup>Ga]<b>i</b> (<b>i</b> = <b>3</b>–<b>4</b>) and reference antagonistic compound [<sup>68</sup>Ga]RM2 have been calculated for 30 and 60 min p.i. and are presented as a bar graph in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b (see also <a href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf" class="ext-link">Table S2, Supporting Information</a>). For the two antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> dynamic μPET imaging studies were also conducted which are being presented in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Comparative biodistribution studies of [<sup>68</sup>Ga]<b>i</b> (<b>i</b> =<b>1</b>−<b>4</b>) and [<sup>68</sup>Ga]RM2 (control) at 30 min (top) and 60 min (bottom) p.i. in Balb nu/nu male mice bearing PC-3 tumors. The results are expressed as percentage of the injected dose per g for each organ or tissue (mean %ID/g ± SD, <i>n</i> = 3−4). Asterisk represent statistically significant differences against [<sup>68</sup>Ga]RM2 (ANOVA, one way nonparametric, <i>P</i> < 0.05). (b) Tumor to normal tissue ratios (mean value ± SD) for the two antagonists under study, [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b>, and the reference compound [<sup>68</sup>Ga]RM2 at 30 min (top) and 60 min p.i.(bottom).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Whole-body μPET images of athymic male nu/nu mice bearing PC-3 tumor xenografts (from left to right, MIP 20–40 min, MIP 120–140 min, and MIP 120–140 min blocked) after iv administration of (a) [<sup>68</sup>Ga]<b>3</b> (100 pmol, 35–45 MBq) and (b) [<sup>68</sup>Ga]<b>4</b> (100 pmol, 35–45 MBq), where T = tumor; K = kidneys, B = bladder, as indicated with arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The biodistribution experiments showed a similar tumor uptake for all compounds tested at 30 min p.i. ranging between 3 and 4 %ID/g, i.e., 3.06% ± 0.28 %ID/g for [<sup>68</sup>Ga]<b>2</b> (agonist) and 4.36% ± 0.90 %ID/g for [<sup>68</sup>Ga]<b>1</b> (agonist containing the native BBN sequence). At 60 min p.i. tumor-localized tracer activity was increased for both antagonists. More specifically for [<sup>68</sup>Ga]<b>3</b> it increased from 4.32 ± 0.25 %ID/g (30 min) to 4.74 ± 1.43 %ID/g (60 min) and for [<sup>68</sup>Ga]<b>4</b> from 3.67 ± 0.27 %ID/g (30 min) to 5.07 ± 1.06 %ID/g (60 min), while for both agonists tumor radioactivity was decreased ([<sup>68</sup>Ga]<b>1</b> was 1.84 ± 0.93 %ID/g and [<sup>68</sup>Ga]<b>2</b> 1.75 ± 0.30 %ID/g, 60 min p.i.). The reference antagonistic compound [<sup>68</sup>Ga]RM2 showed a significantly higher tumor uptake (6.40 ± 1.05 %ID/g) than [<sup>68</sup>Ga]<b>2</b> and [<sup>68</sup>Ga]<b>4</b> at 30 min p.i., but compared to [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>3</b> differences were not significant. At 60 min p.i. tumor uptake for [<sup>68</sup>Ga]RM2 (5.74 ± 1.22 %ID/g) was identical to the other antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> and significantly higher than [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2,</b> both having shown a fast clearance from the tumor.</div><div class="NLM_p">The uptake in pancreas was high for all compounds under study due to the expression of GRPr receptors on pancreatic cells. Pancreatic uptake for compounds [<sup>68</sup>Ga]<b>1</b>, [<sup>68</sup>Ga]<b>2</b>, and [<sup>68</sup>Ga]<b>3</b> was decreased from 30 to 60 min with the exception of [<sup>68</sup>Ga]<b>4</b>, showing a slight increase in the pancreatic radioactivity accumulation (23.83 ± 1.71 %ID/g, 30 min and 35.24 ± 3.29 %ID/g, 60 min). Blocking studies at 30 min p.i. for the antagonistic dimer [<sup>68</sup>Ga]<b>4</b> showed a decrease in both sites of GRPr expression pancreas (4.68 ± 1.67 %ID/g) and tumor (1.17 ± 0.08 %ID/g), providing further proof of its specific binding to GRPr (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf" class="ext-link">Table S1, Supporting Information</a>). The reference compound [<sup>68</sup>Ga]RM2 also showed high pancreatic uptake at 30 min (19.59 ± 3.15 %ID/g) and 60 min (15.23 ± 2.77 %ID/g) p.i., which was less than the dimer [<sup>68</sup>Ga]<b>4</b> but more than the monomer [<sup>68</sup>Ga]<b>3</b>.</div><div class="NLM_p">All compounds were mainly excreted via the kidneys into the urinary bladder. The agonists [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2</b> presented a high kidney uptake at 30 min p.i. (18.75 ± 0.82 and 5.40 ± 1.41 %ID/g, respectively), which was later significantly decreased (4.10 ± 0.55 and 2.02 ± 0.33 %ID/g, 60 min p.i.). The antagonist [<sup>68</sup>Ga]<b>3</b> showed minimal kidney uptake both at 30 min p.i. (3.77 ± 0.67 %ID/g) and at 60 min p.i. (4.23 ± 0.22 %ID/g), likewise [<sup>68</sup>Ga]RM2 (4.00 ± 1.82 %ID/g, 30 min p.i. and 2.09 ± 0.25 %ID/g, 60 min p.i.). Regarding uptake in nontarget organs both [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]RM2 showed a similar pharmacokinetic profile. On the other hand the dimer [<sup>68</sup>Ga]<b>4</b> showed slower elimination rates from the circulation and higher uptake in the kidneys (11.31 ± 4.24 %ID/g, 30 min, 17.67 ± 2.00 %ID/g, 60 min) and liver (6.71 ± 0.22 %ID/g, 30 min and 4.56 ± 0.69 %ID/g, 60 min, respectively).</div><div class="NLM_p">Off-target tissues such as blood, muscle, and the rest of the organs sampled showed minimal uptake and thus low background noise for tumor detection (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). More specifically based on the organ distribution results, the contrast ratios of tumor to normal tissue were calculated for [<sup>68</sup>Ga]<b>i</b> (i = <b>1</b>–<b>4</b>) and [<sup>68</sup>Ga]RM2, respectively and the results are summarized in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b and <a href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf" class="ext-link">Table S2 in Supporting Information</a>. As indicated by the bar graph, the monomeric antagonist [<sup>68</sup>Ga]<b>3</b> and the reference [<sup>68</sup>Ga]RM2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b) were superior to the other compounds, presenting the highest values for most cases at both 30 and 60 min p.i.</div><div class="NLM_p">For the two antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4,</b> dynamic μPET imaging studies (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>) were additionally conducted in order to examine their pharmacokinetic profile at later time points (120 min p.i.). The dynamic μPET imaging and blocking studies of [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b>, (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) showed that both tracers were able to efficiently and specifically visualize the PC-3 tumor. After 1 h p.i., both tracers were washed out from the body though the kidneys and the urinary bladder while remaining in the tumor. Consequently, later time points provided clearer images of PC-3 tumors as shown in the MIPs at 120–140 min p.i. Time–activity curves were generated for selected organs and the tumor (VOIs) (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), and the area under the curve (AUC) was calculated for the first hour. The results of this analysis matched the findings of the biodistribution experiments. Briefly, both tracers presented nearly the same values for tumor AUC (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>) with [<sup>68</sup>Ga]<b>4</b> being slightly better (18.5) than [<sup>68</sup>Ga]<b>3</b> (16.0). Nevertheless, [<sup>68</sup>Ga]<b>3</b> presented a better pharmacokinetic profile by showing lower AUC values for nontarget organs (liver, 19.2) and blood (heart, 25.7) than [<sup>68</sup>Ga]<b>4</b> (liver, 65.2; heart, 24.7).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Time–activity curves expressed as SUVs around the tumor (<b>■</b>), muscle (●), heart (▲), liver (▼) for (a) [<sup>68</sup>Ga]<b>3</b> (100 pmol, 35–45 MBq) and (b) [<sup>68</sup>Ga]<b>4</b> (100 pmol, 35–45 MBq) at 0–60 min p.i. (c) Area under the curve (AUC<sub>0–57min</sub>) for [<sup>68</sup>Ga]<b>3</b> (left) and [<sup>68</sup>Ga]<b>4</b> (right) for selected organs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55711" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55711" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The positron emitter <sup>68</sup>Ga through its availability by elution of <sup>68</sup>Ge/<sup>68</sup>Ga generators<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and usage as radionuclide of choice for a number of clinically relevant radiopharmaceutical precursors such as [<sup>68</sup>Ga]Ga-DOTA-TOC, [<sup>68</sup>Ga]Ga-DOTA-TATE, or [<sup>68</sup>Ga]Ga-PSMA-11 has been established in daily clinical PET imaging during the past decade for highly sensitive and selective noninvasive imaging of distinct tumor entities.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a><sup>68</sup>Ga has a short half-life (<i>T</i><sub>1/2</sub> = 68 min); thus it is ideally combined with tracers which can be rapidly radiolabeled at ambient temperature with high yields<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and which target highly expressed receptors on the surface of cancer cells.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> HBED-CC represents a versatile chelator as it can be easily labeled with <sup>68</sup>Ga at room temperature, while its two additional carboxylic groups not participating at the complexation of the radiometal can be linked to a corresponding pharmacophore of interest.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> Thus, HBED-CC is well suited for the synthesis of dimeric compounds, either homo- or heterodimeric.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a></div><div class="NLM_p">Bombesin receptors and especially subtype bombesin receptor 2 (BB2), also called gastrin-releasing peptide receptor (GRPr), are expressed in various types of cancer (i.e., lung, colon, prostate, breast) and thus considered as promising target for noninvasive PET imaging.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> In previous studies of our group<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> the HBED-CC chelator has been successfully combined with the BBN pharmacophore, [<sup>68</sup>Ga]<b>2</b>, for the investigation of monomers and heterodimers (combining PSMA and BBN), as potential radiotracers for PET imaging of prostate cancer. In this study we further investigated the effects of combing the HBED-CC chelator with different BBN pharmacophores (agonists, antagonists) in an effort to further improve GRPr targeting and biodistribution properties in view of future clinical translation. Since only a few studies regarding BBN homodimers have been reported so far, with varying results,<a onclick="showRef(event, 'ref18 ref20 ref21 ref29'); return false;" href="javascript:void(0);" class="ref ref18 ref20 ref21 ref29">(18,20,21,29)</a> the potential of using the complexing agent HBED-CC for the construction of homodimers was also investigated. As pharmacophores, we tested two BBN agonists, the naturally occurring peptide H<sub>2</sub>N-BN(2–14) (reference), [<sup>68</sup>Ga]<b>1</b>, and the modified peptide sequence H<sub>2</sub>N-PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,β-Ala<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BN(6–14), [<sup>68</sup>Ga]<b>2</b>, and a BBN antagonist, H<sub>2</sub>N–Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14), (Y = 4-amino-1-carboxymethylpiperidine) [<sup>68</sup>Ga]<b>3</b>. The last was also used for the synthesis of the homodimer, [<sup>68</sup>Ga]<b>4</b>. This choice was made because BBN antagonists are expected to have less side effects and nonmitogenic properties.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a></div><div class="NLM_p">All compounds tested in vitro in GRPr expressing cell lines PC-3 and T47D (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) presented IC<sub>50</sub> values in the low nanomolar range, comparable with those of the three reference compounds (BBN, RM2, BZH3). The combination of the HBED-CC with H<sub>2</sub>N-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,Bal<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BN(6–14) <b>2</b> resulted in slightly higher IC<sub>50</sub> values than the reference compound BZH3, possibly due to the interference of HBED-CC with the GRPr binding. The monomeric antagonist <b>3</b> and the agonist containing the native BBN sequence <b>1</b> presented the lowest IC<sub>50</sub> values in both T47D and PC-3. Previously reported studies with similar antagonistic BBN peptides (X-PEG<sub>2</sub>-RM26) conjugated with different chelators have reported IC<sub>50</sub> values (PC-3 cells) in the same range of concentrations, i.e., <sup>nat</sup>Ga complexes of X = NOTA, 2.3 nM; X = NODAGA, 3.0 nM; X = DOTA, 2.9 nM; X= DOTAGA, 10.0 nM; and X = Al<sup>nat</sup>F-NOTA, 4.4 nM.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> Dimer <b>4</b> presented slightly higher IC<sub>50</sub> values than the monomer <b>3</b> regarding T47D but no significant difference in PC-3. This observation could be related to the differences between the two cell lines regarding the expression levels and proximity of receptors on the cell surface (PC-3, 2.5 × 10<sup>5</sup> GRPr/cell; T47D, 36.0 × 10<sup>3</sup>/cell).<a onclick="showRef(event, 'ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35">(33−35)</a> A sparse receptor expression on the cell surface would make multiple binding less possible, in which case the ligand’s binding affinity would be more influenced by the statistical effect.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This means if monovalent binding is assumed, the homodimer has a higher probability of rebinding after dissociation from the receptor.<a onclick="showRef(event, 'ref17 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref19">(17,19)</a></div><div class="NLM_p">Further in vitro testing in PC-3 and T47D cells of antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> showed that cell bound activity was mainly bound on the surface, while for agonists [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2</b> it was internalized (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). These results are in agreement with previous studies on similar BBN antagonists, i.e., RM26<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> and BBN agonists;<a onclick="showRef(event, 'ref7 ref36'); return false;" href="javascript:void(0);" class="ref ref7 ref36">(7,36)</a> i.e., when <sup>111</sup>In-AMBA was tested in T47D cells, it showed higher amounts for the internalized cell fraction (∼60–55%) than the membrane fraction (surface bound, ∼40–45%) for the same range of ligand concentrations (10–1 nM).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Regarding the amount of cell related radioligand nonsignificant differences between the monomeric HBED-CC analogues [<sup>68</sup>Ga]<b>1</b>, [<sup>68</sup>Ga]<b>2</b>, [<sup>68</sup>Ga]<b>3</b> have been observed in both PC-3 and T47D. In contrast, the dimer [<sup>68</sup>Ga]<b>4</b> presented significantly higher total cell binding than the monomers, indicating bivalence had indeed an impact on the binding capacity. However, the overall affinity was slightly reduced which might be attributed to the chemical characteristic and increased size of the dimeric molecule. The tracers [<sup>68</sup>Ga]<b>1</b>, [<sup>68</sup>Ga]<b>2</b>, [<sup>68</sup>Ga]<b>3</b>, and [<sup>68</sup>Ga]<b>4</b> were also compared with the antagonist [<sup>68</sup>Ga]RM2 (reference) with respect to their total cell binding behavior. Statistical analysis of the results in both cell lines, PC-3 and T47D (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>), showed that the dimer [<sup>68</sup>Ga]<b>4</b> was not different from the reference compound, while all other compounds [<sup>68</sup>Ga]<b>1</b>, [<sup>68</sup>Ga]<b>2</b>, and [<sup>68</sup>Ga]<b>3</b> showed less total cell binding.</div><div class="NLM_p">Radiolabeled agonists and antagonists [<sup>68</sup>Ga]<b>i</b> (<b>i</b> = <b>1</b>–<b>4</b>) were investigated for their cell binding kinetics in GRPr positive cell lines, PC-3 (prostate cancer) and T47D (breast cancer), and GRPr negative cell lines, LNCaP (prostate cancer) and MDA-MB-231 (breast cancer), while for the high GRPr expressing PC-3 cells blocking experiments were also conducted (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> presented slightly faster binding kinetics than the agonists, while for all compounds there was a decline in the cell related activity after 60 min, which is in accordance with previous studies on GRPr ligands.<a onclick="showRef(event, 'ref15 ref25'); return false;" href="javascript:void(0);" class="ref ref15 ref25">(15,25)</a> The homodimeric antagonist [<sup>68</sup>Ga]<b>4</b> showed higher binding than the others. The amount of cell related activity for the negative cell lines LNCaP (prostate cancer) and MDA-MB-231 (breast cancer) was similar and ranged between 0.8% and 1.6% of the given radioactivity, which was close to cell binding values for highly expressing GRPr cells, PC-3, during the blocking experiments (0.5–0.7%). This provides further proof for their specific binding on GRPr. The amount of maximum cell-bound [<sup>68</sup>Ga]<b>3</b> followed in order previously reported GRPr expression levels for each cell line PC-3 (2.5 × 10<sup>5</sup> GRPr/cell), LNCaP (5.9 × 10<sup>3</sup> GRPr/cell),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> T47D (3.6 × 10<sup>4</sup> GRPr/cell), MDA-MB-231 (2.27 × 10<sup>3</sup> GRPr/cell).<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a></div><div class="NLM_p">Early studies on BBN dimers on Swiss 3T3 cells suggested that dimeric forms of Lys<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a>-BN have antagonistic properties for GRPr and they were 100- to 1000-fold more potent than the monomers for the inhibition of mitogenesis.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> An enhancement of potency for the BBN dimers has also been reported on melanophores transfected with plasmid encoding GRPr.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Regarding radiolabeled compounds previous studies on two [<sup>64</sup>Cu]Cu-NOTA-Y-BBN(6–14) (Y = -Suc-PEG-Lys/-Gly or -PEG-Gly) dimers have reported nonsignificant differences between the <i>K</i><sub>i</sub> values of monomers (2.51 ± 1.54 nM) and dimers ([<sup>64</sup>Cu]Cu-NOTA-dimer 1, 1.76 ± 1.30; and dimer 2, 2.00 ± 1.59 nM) on PC-3 cells, while the expected higher cellular uptake after dimerization was not observed. On the contrary, the dimers showed lower uptake than the monomer but slower efflux from the cells.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Other studies on BBN dimers, [<sup>99m</sup>Tc]Tc-HYNIC(tricine/TPPTS)-Glu[Aca-BN(7–14)<sub>2</sub>, have reported <i>K</i><sub>i</sub> values being 5 times higher than the monomer (63.40 ± 11.70 nM, PC-3 cells) and a slower but eventually higher cellular accumulation for the dimer [<sup>99m</sup>Tc]Tc-HABN<sub>2</sub> (after 40 min).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> A higher cell uptake was also observed in the case of [<sup>177</sup>Lu]Lu-DOTA-BBN(1–14) and -Ahx-BBN(4–14) dimers in comparison with the monomers.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> According to the authors, this effect was due to bivalent binding or, if monovalent binding was assumed, to an increased probability of rebinding after dissociation. Either way dimerization eventually resulted in higher internalization rates.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">The investigation of the pharmacokinetics of the <sup>68</sup>Ga labeled tracers [<sup>68</sup>Ga]<b>i</b> (<b>i</b> = <b>1</b>–<b>4</b>) showed minimal radioactivity in blood and muscle and the rest of organs sampled, resulting in low background noise for tumor detection (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a). At 30 min p.i. tumor uptake for agonist [<sup>68</sup>Ga]<b>1</b>, antagonist [<sup>68</sup>Ga]<b>3</b> and reference [<sup>68</sup>Ga]RM2 were significantly higher than that of [<sup>68</sup>Ga]<b>2</b> and [<sup>68</sup>Ga]<b>4</b>, while at 60 min p.i. all antagonists including the reference showed significantly higher tumor uptake than the agonists. The reference [<sup>68</sup>Ga]RM2 and [<sup>68</sup>Ga]<b>3</b> did not show significant differences regarding tumor uptake (30 and 60 min p.i.), while for the dimer [<sup>68</sup>Ga]<b>4</b> this was significantly less at 30 min p.i. and the same at 60 min p.i. Among the HBED-CC analogues studied the antagonist [<sup>68</sup>Ga]<b>3</b> has shown the best tumor to normal tissue ratios at both 30 and 60 min p.i. The exchange of the DOTA chelator for HBED-CC did not affect the pharmacokinetics of the tracer as much as the dimerization of the pharmacophore on the HBED-CC chelator. Especially regarding off-target accumulation, the biggest difference between [<sup>68</sup>Ga]RM2 and [<sup>68</sup>Ga]<b>3</b> was in the pancreas, where [<sup>68</sup>Ga]<b>3</b> showed less uptake both at 30 min (<sup>1</sup>/<sub>2</sub>×) and at 60 min (<sup>1</sup>/<sub>3</sub>×) p.i. Additionally, the HBED-CC exchange for DOTA resulted in a slightly slower elimination of [<sup>68</sup>Ga]<b>3</b> from the blood pool; thus reference [<sup>68</sup>Ga]RM2 showed higher tumor/blood values, although at 60 min p.i. [<sup>68</sup>Ga]<b>3</b> has shown higher values for tumor/muscle, tumor/spleen, tumor/brain than [<sup>68</sup>Ga]RM2 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>b). Tracer [<sup>68</sup>Ga]<b>4</b> on the other hand despite showing a higher in vitro uptake had inferior pharmacokinetic properties than the monomer [<sup>68</sup>Ga]<b>3</b>. Possibly because its higher lipophilicity resulted in slower elimination from the circulation and prolonged retention in off-target organs and tissues (i.e., kidneys, liver, and intestines). Previous biodistribution studies on BBN dimers have reported PC-3 tumor uptake of 1.58 ± 0.18 %ID/g (60 min p.i.) for [<sup>99m</sup>Tc]Tc-HABN<sub>2</sub> and for [<sup>64</sup>Cu]Cu-NOTA-dimer <b>2</b> (3.95 ± 0.26 %ID/g, 30 min p.i. and 6.28 ± 2.87 %ID/g, 120 min p.i.). It should also be commented that the differences between the literature values for the tumor uptake at 60 min p.i. for reference [<sup>68</sup>Ga]RM2 (14.11 ± 1.88 %ID/g)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and reported values (5.74 ± 1.22 %ID/g) are most likely due to differences in the labeling procedure (i.e., specific activity, use of cartridge) and the animal models (i.e., tumor size, age of the animals).</div><div class="NLM_p last">The two HBED-CC antagonists [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> were further evaluated at later time points with dynamic imaging μPET studies, in mice bearing PC-3 tumors (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). After 1 h, both tracers were washed out from the body though the kidneys and the urinary bladder, while radioactivity accumulated in the tumor. Thus, later time points provided clearer images of PC-3 tumors. The AUC<sub>tumor</sub> calculated for the first hour after administration showed [<sup>68</sup>Ga]<b>4</b> being slightly better (18.5) than [<sup>68</sup>Ga]<b>3</b> (16.0). Nevertheless, [<sup>68</sup>Ga]<b>3</b> presented a better pharmacokinetic profile by showing lower AUC values for nontarget organs (liver, 19.2) and blood (heart, 25.7) than [<sup>68</sup>Ga]<b>4</b> (liver, 65.2; heart, 24.7). Previous dynamic imaging μPET studies for [<sup>64</sup>Cu]Cu-NOTA-monomer and [<sup>64</sup>Cu]Cu-NOTA-dimer <b>2</b> (mice bearing PC-3 tumors) reported initially a higher tumor uptake for the monomer (until 30 min p.i.) which was then reversed in favor of the dimer.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> The inclusion of charged groups in [<sup>68</sup>Ga]<b>4</b> could possible improve its pharmacokinetic properties toward a faster clearance from the blood pool and nontarget organs, i.e., liver and GRPr expressing pancreas.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i14">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In the present study we synthesized four HBED-CC conjugates of GRPr ligands. The HBED-CC chelator was combined with bombesin analogues for the synthesis of two agonists [<sup>68</sup>Ga]<b>1</b> and [<sup>68</sup>Ga]<b>2</b> (monomers) and two antagonists [<sup>68</sup>Ga]<b>3</b> (monomer) and [<sup>68</sup>Ga]<b>4</b> (homodimer). Overall [<sup>68</sup>Ga]<b>3</b> and its dimer [<sup>68</sup>Ga]<b>4</b> showed the best in vitro and in vivo results. The two antagonists presented low IC<sub>50</sub> values (nanomolar range) and high and fast binding in PC-3 and T47D cells, indicating that they can be considered as good candidates for imaging prostate and breast cancer tumors. In addition the high and specific PC-3 tumor uptake and the good tumor to background ratio at each time point demonstrate their potential as candidates for further PET/CT human studies in the future.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65487" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65487" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Methods</h3><div class="NLM_p">All commercially available chemicals were of analytical grade and were used without further purification. The chemical suppliers were from Sigma-Aldrich (Taufkirchen, Germany) and Merck (Darmstadt, Germany), unless otherwise indicated. Protected amino acids (a.a.) and resins were supplied from Novabiochem (Merck, Darmstadt, Germany) and IRIS Biotech (Marktredwitz, Germany). For all reaction products the chemical purity was greater than 95% as determined by HPLC.</div><div class="NLM_p">The following RP-HPLC systems were used for analysis and purification: Agilent 1100 series, equipped with a multiwavelength detector (MWD) and Latek P402 (Latek Labortechnik-Geraete, Eppelheim, Germany) equipped with a HITACHI variable UV detector (absorbance was measured at 214 and 254 nm) and a γ detector (Bioscan; Washington, USA). Both RP-HPLC systems were equipped with a Chromolith RP-18e (4.6 mm × 100 mm; Merck, Darmstadt, Germany) analytical column. For purifications the following system was used: VWR International, La Prep UV/vis detector P314, pumps P110, equipped with a Nucleodur Sphinx RP, 5 μm VP 250/21 (MACHEREY-NAGEL GmbH & Co. KG, Düren, Germany). Unless stated otherwise the following gradient (A–B) was used for analysis: 0–100% B in 6 min; (A) 0.1% TFA in H<sub>2</sub>O and (B) 0.1% TFA in CH<sub>3</sub>CN; flow of 4 mL/min. For purifications, the following gradient was used: 10–90% B in 20 min, flow of 20 mL/min.</div><div class="NLM_p last">Mass spectrometry was performed with a MALDI-MS Daltonics Microflex system (Bruker Daltonics, Bremen, Germany). Full-scan single mass spectra were obtained by scanning <i>m</i>/<i>z</i> = 200–4000 (2,5-dihydroxybenzoic acid in H<sub>2</sub>O/AcCN 1:1 was used as matrix). For all in vitro and in vivo experiments a NaI (TI) γ counter (Packard Cobra II, GMI, Minnesota, USA) was used for the measurement of radioactive probes.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Chemistry</h3><div class="NLM_p last">All peptides were synthesized on a Rink amide resin (4-methylbenzhydrylamine resin, 200–400 mesh). Amino acid (a.a.) coupling was according to standard Fmoc peptide synthesis protocols (a.a./HBTU/DIPEA, 4.0/3.9/4.0 equiv, 30 min, rt). The same protocol was used for coupling of DOTA-tris(<sup><i>t</i></sup>Bu)ester (CheMatech, Dijon, France) for the reference compound RM2.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> At the final step the peptides were cleaved from the resin with the following mixture TFA/TIPS/H<sub>2</sub>O (95/2.5/2.5, v/v/v), precipitated in ice-cold (0 °C) diethyl ether, and purified with semipreparative HPLC. For the HBED-CC compounds <b>1</b>–<b>4</b> the phenolic and carboxylate groups of HBED-CC (synthesized in house) were selectively protected by complexation with Fe<sup>3+</sup> to form [Fe(HBED-CC)]<sup>−</sup> according to previously published methods.<a onclick="showRef(event, 'ref14 ref37'); return false;" href="javascript:void(0);" class="ref ref14 ref37">(14,37)</a> The two propionic acid functions remaining in [Fe(HBED-CC]<sup>−</sup> (0.01 M solution in DMF, 700 μL) reacted with an excess of TFP (2,3,5,6-tetrafluorophenol) (10 equiv, 0.19 mmol, 311 mg) and DIPC (4 equiv, 0.08 mmol, 118 μL) for 3 days in DMF (0.5 mL, rt). The mono- and bis-TFP ester of [Fe(HBED-CC]<sup>−</sup> compounds were isolated with semipreparative HPLC (overall yield 30%, <i>t</i><sub>R</sub> = 2.9 min; 25%, <i>t</i><sub>R</sub> = 4.8 min, respectively) and identified with mass spectrometry: C<sub>32</sub>H<sub>28</sub>F<sub>4</sub>FeN<sub>2</sub>O<sub>10</sub><sup>(−)</sup>; MW, 732,1; <i>m</i>/<i>z</i> 733.2 [M + H]<sup>+</sup>; C<sub>38</sub>H<sub>28</sub>F<sub>8</sub>FeN<sub>2</sub>O<sub>10</sub><sup>(−)</sup>; MW, 880.5; <i>m</i>/<i>z</i> 881.0 [M + H]<sup>+</sup>. The mono-TFP ester (4.0 mg, 5.5 μmol) then reacted with the purified peptides H<sub>2</sub>N-BN(2–14); H<sub>2</sub>N-PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,β-Ala<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BN(6–14); and H<sub>2</sub>N–Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) (Y = 4-amino-1-carboxymethylpiperidine) (1.2 equiv, 6.6 μmol, 10.7 mg; 8.5 mg and 8.3 mg) resulting in the monomers <b>1</b>–<b>3</b>, respectively (rt, 1 day). For the synthesis of the dimer, <b>4</b>, the peptide H<sub>2</sub>N-PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">D-</span>Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) (4 equiv 13.0 mg, 8.5 μmol) reacted with the bis-TFP ester of [Fe(HBED-CC)]<sup>−</sup> (1.9 mg, 2.1 μmol) and an excess of DIPEA in DMF (1.0 mL) (rt, 1 day) (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The above crude products were purified with preparative HPLC, and their masses were analyzed with MALDI-MS. In the final step iron was removed from the HBED-CC chelators after immobilization of the corresponding chelates on a C-18-SEP-PAK and by flushing with acid treatment (1.0 M HCl) according to previously published methods.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> For calculations of the exact masses ChemBioDraw ultra 13.0 was used.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Labeling with <sup>68</sup>Ga and <sup>nat</sup>Ga</h3><div class="NLM_p last">For radiolabeling, <sup>68</sup>Ga (<i>t</i><sub>1/2</sub> = 68 min, β<sup>+</sup> 88%, E<sub>β+</sub> max 1.9 MeV) eluate was obtained from a <sup>68</sup>Ge/<sup>68</sup>Ga generator based on pyrogallol resin support.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Typically, 1 GBq of <sup>68</sup>Ga was eluted as tetrachlorogallate using 5.5 M HCl. [<sup>68</sup>Ga]GaCl<sub>4</sub><sup>–</sup> was trapped on an anion-exchange resin cartridge (AG1X8, Biorad, Richmond, CA, USA). <sup>68</sup>Ga was subsequently eluted from the cartridge in a final volume of 300 μL of 0.1 M HCl (Merck, Darmstadt, Germany) as [<sup>68</sup>Ga]GaCl<sub>3</sub>. A solution of each radiolabeling precursor (0.3–1.0 nmol) in 0.1 M HEPES buffer, (pH = 7.5, 100 μL) was added to a mixture of 10 μL of HEPES solution (2.1 M) and 40 μL of [<sup>68</sup>Ga]Ga<sup>3+</sup> eluate (80–100 MBq). The pH of the labeling solution was adjusted to 4.2 using 30% NaOH. The reaction mixture was incubated at 98 °C for 10 min. Labeling efficiency was determined via analytical RP-HPLC, solvent gradient A–B: 0–100% B in 6 min, flow of 4 mL/min, (A) 0.1% TFA in H<sub>2</sub>O and (B) 0.1% TFA in CH<sub>3</sub>CN. Radiolabeled ligands were obtained with radiochemical purity (as determined by radio-HPLC) above 98% and used without further purification for in vitro and in vivo experiments. <sup>nat</sup>Ga complexes were formed after the reaction of 10× molar excess of Ga(III) nitrate (Sigma-Aldrich, Germany) in 0.1 N HCl (10 μL) with the compounds under study (1 mM in 0.1 M HEPES buffer, pH 7.5, 40 μL) in a mixture of 10 μL of 2.1 M HEPES solution and 2 μL of 1 N HCl for 2 min at 80 °C.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Cell Culture</h3><div class="NLM_p last">Binding studies and in vivo experiments were performed with the following GRPr positive cell lines, PC-3 cells (bone metastasis of a grade IV prostatic adenocarcinoma, ATCC CRL-1435) and T47D (human breast cancer, ATCC HTB-133). Cells were cultured in DMEM medium supplemented with 10% fetal calf serum and 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine (Invitrogen, Carlsbad, CA, USA). Cells were incubated in a controlled humidified atmosphere containing 5% CO<sub>2</sub> at 37 °C and were subcultured weekly after being detached from the flask surface by trypsin/ethylenediaminetetraacetic acid (EDTA) solution (0.25% trypsin/0.02% EDTA, Invitrogen, Carlsbad, CA, USA). For the cellular assays the cells were harvested using trypsin/EDTA solution and washed with PBS, counted, and seeded on 24- and 96-well plates (internalization and IC<sub>50</sub> studies) or low protein binding Eppendorf tubes (kinetic studies) containing Opti-MEM medium (Gibco, Auckland, New Zealand).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Determination of Binding Affinity for GRPr in PC-3 and T47D Cells</h3><div class="NLM_p last">Binding affinities (IC<sub>50</sub>) were determined by a competitive cell binding assay with the GRPr positive PC-3 and T47D cells, according to known protocols.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> On a 96-well plate (MultiScreen HTS-DV 0.65 μm) the cells (10<sup>5</sup> per well) were incubated with 0.05 nM [<sup>125</sup>I]Tyr<sup>4</sup>-BN (82.8 μCi/mL, 2200 Ci/mmol, PerkinElmer, USA) in the presence of 12 different concentrations of each nonlabeled competitor ranging from 0 to 5000 nM (100 μL/well). After incubation at rt for 45 min with gentle agitation, the binding buffer was removed using a multiscreen vacuum manifold (Millipore, Billerica, MA). Cells were washed with 2 × 100 μL and 1 × 200 μL of ice-cold binding buffer. Cell-bound radioactivity on the filters was measured using a γ counter (Packard Cobra II, GMI, Ramsey, MN, USA). The 50% inhibitory concentrations (IC<sub>50</sub>) and values were calculated by fitting the data using a nonlinear regression algorithm (GraphPad Software, La Jolla, CA, USA). Experiments were performed in triplicate.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Internalization Experiments in PC-3 Cells</h3><div class="NLM_p last">Internalization experiments were performed as previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Briefly, 10<sup>5</sup> PC-3 or T47D cells were seeded in 24-well cell culture plates 24 h before the day of the experiment. The cells were incubated with the radiolabeled compounds (30 nM, in reduced serum, Opti-MEM, Gibco) for 45 min at 37 and 4 °C, respectively. To determine specific cellular uptake, cells were blocked by competition with 1000-fold excess of native BBN or H<sub>2</sub>N-PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) (Y = 4-amino-1-carboxymethylpiperidine) (30 μM). After incubation the supernatant was removed and the cells were washed with ice-cold PBS. To remove surface-bound radioactivity, cells were incubated twice with 0.5 mL of glycine-HCl in PBS (50 mM, pH 2.8) for 5 min. Then cells were washed with 1.0 mL of ice-cold PBS and lysed using 0.5 mL of 0.3 N NaOH (internalized radioactivity). The surface-bound and the internalized fraction were measured in a γ counter (Packard Cobra II, GMI, Ramsey, MN, USA).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Time Kinetic Binding Studies on Cancer Cell Lines</h3><div class="NLM_p last">Specificity of binding over time was analyzed using a modified previously published protocol.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Briefly, solutions of the <sup>68</sup>Ga-labeled compounds (30 nM, 30 MBq/nmol) were added to 1.4 × 10<sup>6</sup> cells (PC-3) suspended in 0.1 mL of Opti-MEM (1% BSA) medium (Gibco, Auckland, New Zealand) and incubated at 37 °C. Samples were briefly vortexed and a 10 μL aliquot (1–1.4 × 10<sup>5</sup> cells) was taken at predetermined time points (15, 30, 45, 60, 90 min). The aliquot was then transferred to a 400 μL microcentrifuge tube (Roth, Germany) containing 350 μL of a 75:25 mixture of silicon oil, density 1.05 (Sigma-Aldrich, Germany), and mineral oil, density 0.872 (Acros, Nidderau, Germany). Separation of cells from the medium was performed by centrifugation at 12 000 rpm for 2 min. After freezing of the tubes using liquid nitrogen, the bottom tips containing the cell pellet were cut off. The cell pellets and the supernatants were separately counted in a γ counter. Nonspecific binding was determined by competitive blocking with a 1000-fold excess of native BBN or H<sub>2</sub>N-PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) (Y = 4-amino-1-carboxymethylpiperidine), 100 mM solution in DMSO, respectively. Cell binding (cell counts) was determined as the percentage of the total counts added to the cell suspension (mean of four replicas ± SD).</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Biodistribution and Imaging μPET Studies</h3><div class="NLM_p">For the experimental tumor models PC-3 cells (5 × 10<sup>6</sup>) were suspended in Opti-MEM medium (Gibco, Auckland, New Zealand) and subcutaneously inoculated (100 μL) into the right trunk of male 7–8 week-old BALB/c nu/nu mice (average weight of 20 ± 2.0 g, Jackson Laboratory, Maine, USA). The tumors were allowed to grow for 3–4 weeks until approximately 1 cm<sup>3</sup> in size (0.100–0.250 g). The <sup>68</sup>Ga-labeled compounds were injected into a tail vein (100 μL, in saline pH 7, 1–2 MBq/mouse; 80 pmol). At predetermined time points after injection (30 and 60 min p.i.), the animals were sacrificed and the organs of interest were dissected, blotted dry, and weighed. The radioactivity was measured using a γ counter and calculated as percentage injected dose per gram (%ID/g). Results were expressed as mean ± SD (3 animals per time point).</div><div class="NLM_p last">The μPET studies were conducted with 5 MBq (approximately 100 pmol) of [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b> injected via a lateral tail vein into PC-3 tumor-bearing mice. Blocking experiments were conducted by coadministering an 1000-fold excess of nonradioactive substance, H<sub>2</sub>N-PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) (Y = 4-amino-1-carboxymethylpiperidine) along with the tracer. The anesthetized animals (1 vol % sevofluran, AbbVie, Ludwigshafen, Germany) were placed in prone position into a small animal PET scanner (Inveon microPET scanner, Siemens, Knoxville TN, USA) to perform a 60 min dynamic microPET scan in list mode, starting 3 s before injection (emission 0–1 h, in list mode), for attenuation correction transmission scan 10 min (two rotating <sup>57</sup>Co sources). After 2 h the animals were measured again (20 min; attenuation correction, 10 min transmission scan). Scans reconstruction software Inveon Acquisition Workplace (IAW) Software, Siemens; protocols, 28 frames 2 × 15 s; 8 × 30 s; 5 × 60 s; 5 × 120 s; 8 × 300 s, and 3 frames 0–20 min; 20–40 min; 40–60 min. Reconstruction settings for 3D-OSEM MAP, 16 subsets, 2 iterations, output interval: 10, MAP iterations:18, output interval: 20, image <i>x</i>–<i>y</i> size 256; image <i>z</i> size 161, size of voxel in mm, <i>y</i> = 0.388; <i>z</i> = 0.796. VOIs around the heart, liver, kidneys, urinary bladder, muscle, and tumor were manually defined and time–activity curves were generated to calculate SUVs (0–1 h, SUV body weight–time graphs). The area under the curve (AUC) was calculated from the SUV–time curves using GraphPad Prism 6. All animal experiments have been conducted according to the German animal welfare law (TierSchG, Approval Number 35-9185.81/G187/15), which implements European Guideline 2010/63/EU, for animal experimentation.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Statistical Aspects</h3><div class="NLM_p last">All experiments were performed at least in triplicate. Quantitative data were expressed as the mean ± SD. If applicable, mean values were compared using Student’s <i>t</i> test or ordinary one-way ANOVA (<i>P</i> values of <0.05). For all statistical calculations GraphPad Prism 6 was used.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25"><a href="/doi/suppl/10.1021/acs.jmedchem.7b01856" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81331" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81331" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b01856" class="ext-link">10.1021/acs.jmedchem.7b01856</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Ligands <b>1</b>−<b>4</b> IC<sub>50</sub> curves, [<sup>nat</sup>Ga]<b>1</b>−<b>4</b> RP-HPLC results, [<sup>68</sup>Ga]<b>1</b>−<b>4</b>, [<sup>nat</sup>Ga]RM2 biodistribution and tumor to normal tissue data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf">jm7b01856_si_001.pdf (482.91 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b01856" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38683" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38683" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christos Liolios</span> - <span class="hlFld-Affiliation affiliation">Division
of Radiopharmaceutical Chemistry, , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1909-6212" title="Orcid link">http://orcid.org/0000-0002-1909-6212</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#91f2bffdf8fefdf8fee2d1f5faf7ebbff5f4"><span class="__cf_email__" data-cfemail="a9ca87c5c0c6c5c0c6dae9cdc2cfd387cdcc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Buchmuller</span> - <span class="hlFld-Affiliation affiliation">Division
of Radiopharmaceutical Chemistry, , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ulrike Bauder-Wüst</span> - <span class="hlFld-Affiliation affiliation">Division
of Radiopharmaceutical Chemistry, , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Schäfer</span> - <span class="hlFld-Affiliation affiliation">Division
of Radiopharmaceutical Chemistry, , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karin Leotta</span> - <span class="hlFld-Affiliation affiliation">Clinical Cooperation Unit Nuclear
Medicine, , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Uwe Haberkorn</span> - <span class="hlFld-Affiliation affiliation">Clinical Cooperation Unit Nuclear
Medicine, 
    German Cancer Consortium (DKTK), 
    , , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthias Eder</span> - <span class="hlFld-Affiliation affiliation">Division
of Radiopharmaceutical Chemistry, 
    German Cancer Consortium (DKTK), 
    , , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Division of Radiopharmaceutical
Development, German Cancer Consortium (DKTK) Freiburg, and Department
of Nuclear Medicine, Faculty of Medicine, Medical Center, University
of Freiburg, Hugstetter Straße
55, 79106 Freiburg, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5110-0744" title="Orcid link">http://orcid.org/0000-0002-5110-0744</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Klaus Kopka</span> - <span class="hlFld-Affiliation affiliation">Division
of Radiopharmaceutical Chemistry, 
    German Cancer Consortium (DKTK), 
    , , and , German
Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ACMP</td><td class="NLM_def"><p class="first last">4-amino-1-carboxymethylpiperidine</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">BBN</td><td class="NLM_def"><p class="first last">bombesin</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">DIPC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-diisopropylcarbodiimide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">HBED-CC</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>′-bis[2-hydroxy-5-(ethylene-β-carboxy)benzyl]ethylenediamine-<i>N</i>,<i>N</i>′-diacetic acid</p></td></tr><tr><td class="NLM_term">GRPR</td><td class="NLM_def"><p class="first last">gastrin releasing peptide receptor</p></td></tr><tr><td class="NLM_term">p.i.</td><td class="NLM_def"><p class="first last">postinjection</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake value</p></td></tr><tr><td class="NLM_term">VOI</td><td class="NLM_def"><p class="first last">volume of interest</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13634" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13634" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 39 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Florio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Bombesin Receptor-Mediated Imaging and Cytotoxicity: Review and Current Status</span>. <i>Curr. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.2174/156720111793663624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2174%2F156720111793663624" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=79-134&issue=1&author=V.+Sanchoauthor=A.+Di+Florioauthor=T.+W.+Moodyauthor=R.+T.+Jensen&title=Bombesin+Receptor-Mediated+Imaging+and+Cytotoxicity%3A+Review+and+Current+Status&doi=10.2174%2F156720111793663624"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F156720111793663624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720111793663624%26sid%3Dliteratum%253Aachs%26aulast%3DSancho%26aufirst%3DV.%26aulast%3DDi%2BFlorio%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin%2520Receptor-Mediated%2520Imaging%2520and%2520Cytotoxicity%253A%2520Review%2520and%2520Current%2520Status%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2011%26volume%3D8%26issue%3D1%26spage%3D79%26epage%3D134%26doi%3D10.2174%2F156720111793663624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parry, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. E.</span></span> <span> </span><span class="NLM_article-title">MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-Releasing Peptide Receptor</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1007/s10549-006-9287-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs10549-006-9287-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=16838112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=175-183&issue=2&author=J.+J.+Parryauthor=R.+Andrewsauthor=B.+E.+Rogers&title=MicroPET+Imaging+of+Breast+Cancer+Using+Radiolabeled+Bombesin+Analogs+Targeting+the+Gastrin-Releasing+Peptide+Receptor&doi=10.1007%2Fs10549-006-9287-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor</span></div><div class="casAuthors">Parry, Jesse J.; Andrews, Rebecca; Rogers, Buck E.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-183</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mammog. is a well-established method for detecting primary breast cancer; however, it has some limitations that may be overcome using nuclear imaging methods.  Current radiopharmaceuticals have limited sensitivity for detecting small primary lesions and it has been suggested that novel radiopharmaceuticals are necessary for detection of primary breast cancer, as well as for detecting metastases and recurrence, or for monitoring therapy.  The gastrin-releasing peptide receptor (GRPR) is a seven-transmembrane G-protein coupled receptor that is overexpressed on primary breast cancer and lymph node metastases.  Bombesin (BN) is a tetradecapeptide that binds with high affinity to GRPR and can be radiolabeled with the positron-emitter, copper-64 (64Cu) for imaging with positron-emission tomog. (PET).  The goal of this study was to evaluate BN analogs that could be radiolabeled with 64Cu for PET imaging of breast cancer.  A series of BN analogs contg. 4, 5, 6, 8, and 12- carbon linkers were evaluated with regard to their binding and internalization into T-47D human breast cancer cells.  The 64Cu-labeled analogs were then evaluated in mice bearing T-47D xenografts by tissue biodistribution and microPET imaging.  These studies showed that all of the analogs had IC50 values <100 nM and were all internalized into T-47D cells.  Biodistribution studies showed that the BN analog with the 8-carbon linker not only had the highest tumor uptake but also had high normal tissue uptake in the liver.  The analogs contg. the 6- or 8-carbon linkers demonstrated good tumor uptake as detd. by microPET imaging.  Overall, this study shows the feasibility of using positron-labeled BN analogs for PET detection of GRPR-expressing breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq--Ps-3rD4l7Vg90H21EOLACvtfcHk0lgk65nOtDwKIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslegtA%253D%253D&md5=95574f8ac5e6fabb8757c152ee70ccd4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs10549-006-9287-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-006-9287-8%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DJ.%2BJ.%26aulast%3DAndrews%26aufirst%3DR.%26aulast%3DRogers%26aufirst%3DB.%2BE.%26atitle%3DMicroPET%2520Imaging%2520of%2520Breast%2520Cancer%2520Using%2520Radiolabeled%2520Bombesin%2520Analogs%2520Targeting%2520the%2520Gastrin-Releasing%2520Peptide%2520Receptor%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D101%26issue%3D2%26spage%3D175%26epage%3D183%26doi%3D10.1007%2Fs10549-006-9287-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rybalov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ananias, H. J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoving, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Poel, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, I. J.</span></span> <span> </span><span class="NLM_article-title">PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">6046</span>– <span class="NLM_lpage">6061</span>, <span class="refDoi"> DOI: 10.3390/ijms15046046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.3390%2Fijms15046046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=24727373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWlur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=6046-6061&issue=4&author=M.+Rybalovauthor=H.+J.+K.+Ananiasauthor=H.+D.+Hovingauthor=H.+G.+van+der+Poelauthor=S.+Rosatiauthor=I.+J.+de+Jong&title=PSMA%2C+EpCAM%2C+VEGF+and+GRPR+as+Imaging+Targets+in+Locally+Recurrent+Prostate+Cancer+after+Radiotherapy&doi=10.3390%2Fijms15046046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">PSMA, EpCAM, VEGF and GRPR as Imaging targets in locally recurrent prostate cancer after radiotherapy</span></div><div class="casAuthors">Rybalov, Maxim; Ananias, Hildo J. K.; Hoving, Hilde D.; van der Poel, Henk G.; Rosati, Stefano; de Jong, Igle J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">6046-6061, 16</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In this retrospective pilot study, the expression of the prostate-specific membrane antigen (PSMA), the epithelial cell adhesion mol. (EpCAM), the vascular endothelial growth factor (VEGF) and the gastrin-releasing peptide receptor (GRPR) in locally recurrent prostate cancer after brachytherapy or external beam radiotherapy (EBRT) was investigated, and their adequacy for targeted imaging was analyzed.  Prostate cancer specimens were collected of 17 patients who underwent salvage prostatectomy because of locally recurrent prostate cancer after brachytherapy or EBRT.  Immunohistochem. was performed.  A pathologist scored the immunoreactivity in prostate cancer and stroma.  Staining for PSMA was seen in 100% (17/17), EpCAM in 82.3% (14/17), VEGF in 82.3% (14/17) and GRPR in 100% (17/17) of prostate cancer specimens.  Staining for PSMA, EpCAM and VEGF was seen in 0% (0/17) and for GRPR in 100% (17/17) of the specimens' stromal compartments.  In 11.8% (2/17) of cases, the GRPR staining intensity of prostate cancer was higher than stroma, while in 88.2% (15/17), the staining was equal.  Based on the absence of stromal staining, PSMA, EpCAM and VEGF show high tumor distinctiveness.  Therefore, PSMA, EpCAM and VEGF can be used as targets for the bioimaging of recurrent prostate cancer after EBRT to exclude metastatic disease and/or to plan local salvage therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjXoO5EfXntrVg90H21EOLACvtfcHk0lgivDDVoY8gIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWlur%252FP&md5=7dd698c124474848d71c2466ad65d4f0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fijms15046046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms15046046%26sid%3Dliteratum%253Aachs%26aulast%3DRybalov%26aufirst%3DM.%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%2BK.%26aulast%3DHoving%26aufirst%3DH.%2BD.%26aulast%3Dvan%2Bder%2BPoel%26aufirst%3DH.%2BG.%26aulast%3DRosati%26aufirst%3DS.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26atitle%3DPSMA%252C%2520EpCAM%252C%2520VEGF%2520and%2520GRPR%2520as%2520Imaging%2520Targets%2520in%2520Locally%2520Recurrent%2520Prostate%2520Cancer%2520after%2520Radiotherapy%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26issue%3D4%26spage%3D6046%26epage%3D6061%26doi%3D10.3390%2Fijms15046046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultze-Seemann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont-Walter, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, W. A.</span></span> <span> </span><span class="NLM_article-title">Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.7150/thno.7324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.7150%2Fthno.7324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=412-419&issue=4&author=G.+Wieserauthor=R.+Mansiauthor=A.+L.+Grosuauthor=W.+Schultze-Seemannauthor=R.+A.+Dumont-Walterauthor=P.+T.+Meyerauthor=H.+R.+Maeckeauthor=J.+C.+Reubiauthor=W.+A.+Weber&title=Positron+Emission+Tomography+%28PET%29+Imaging+of+Prostate+Cancer+with+a+Gastrin+Releasing+Peptide+Receptor+Antagonist+-+from+Mice+to+Men&doi=10.7150%2Fthno.7324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7150%2Fthno.7324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.7324%26sid%3Dliteratum%253Aachs%26aulast%3DWieser%26aufirst%3DG.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DGrosu%26aufirst%3DA.%2BL.%26aulast%3DSchultze-Seemann%26aufirst%3DW.%26aulast%3DDumont-Walter%26aufirst%3DR.%2BA.%26aulast%3DMeyer%26aufirst%3DP.%2BT.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26atitle%3DPositron%2520Emission%2520Tomography%2520%2528PET%2529%2520Imaging%2520of%2520Prostate%2520Cancer%2520with%2520a%2520Gastrin%2520Releasing%2520Peptide%2520Receptor%2520Antagonist%2520-%2520from%2520Mice%2520to%2520Men%26jtitle%3DTheranostics%26date%3D2014%26volume%3D4%26issue%3D4%26spage%3D412%26epage%3D419%26doi%3D10.7150%2Fthno.7324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, R.</span></span> <span> </span><span class="NLM_article-title">Concomitant Vascular GRP-Receptor and VEGF-Receptor Expression in Human Tumors: Molecular Basis for Dual Targeting of Tumoral Vasculature</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1457</span>– <span class="NLM_lpage">1462</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2011.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.peptides.2011.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=21605611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVylt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1457-1462&issue=7&author=J.+C.+Reubiauthor=A.+Fleischmannauthor=B.+Waserauthor=R.+Rehmann&title=Concomitant+Vascular+GRP-Receptor+and+VEGF-Receptor+Expression+in+Human+Tumors%3A+Molecular+Basis+for+Dual+Targeting+of+Tumoral+Vasculature&doi=10.1016%2Fj.peptides.2011.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: Molecular basis for dual targeting of tumoral vasculature</span></div><div class="casAuthors">Reubi, Jean Claude; Fleischmann, Achim; Waser, Beatrice; Rehmann, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1457-1462</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide (GRP) and GRP receptors (GRPR) play a role in tumor angiogenesis.  Recently, GRPR were found to be frequently expressed in the vasculature of a large variety of human cancers.  Here, we characterize these GRPR by comparing the vascular GRPR expression and localization in a selection of human cancers with that of an established biol. marker of neoangiogenesis, the vascular endothelial growth factor (VEGF) receptor.  In vitro quant. receptor autoradiog. was performed in parallel for GRPR and VEGF receptors (VEGFR) in 32 human tumors of various origins, using 125I-Tyr-bombesin and 125I-VEGF165 as radioligands, resp.  Moreover, VEGFR-2 was evaluated immunohistochem.  All tumors expressed GRPR and VEGFR in their vascular system.  VEGFR were expressed in the endothelium in the majority of the vessels.  GRPR were expressed in a subpopulation of vessels, preferably in their muscular coat.  The vessels expressing GRPR were all VEGFR-pos. whereas the VEGFR-expressing vessels were not all GRPR-pos.  GRPR expressing vessels were found immunohistochem. to co-express VEGFR-2.  Remarkably, the d. of vascular GRPR was much higher than that of VEGFR.  The concomitant expression of GRPR with VEGFR appears to be a frequent phenomenon in many human cancers.  The GRPR, localized and expressed in extremely high d. in a subgroup of vessels, may function as target for antiangiogenic tumor therapy or angiodestructive targeted radiotherapy with radiolabeled bombesin analogs alone, or preferably together with VEGFR targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMo62E40UigbVg90H21EOLACvtfcHk0lgivDDVoY8gIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVylt7s%253D&md5=aebb3cb1530f6d7a68a3ea3ee9833241</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2011.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2011.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DFleischmann%26aufirst%3DA.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DRehmann%26aufirst%3DR.%26atitle%3DConcomitant%2520Vascular%2520GRP-Receptor%2520and%2520VEGF-Receptor%2520Expression%2520in%2520Human%2520Tumors%253A%2520Molecular%2520Basis%2520for%2520Dual%2520Targeting%2520of%2520Tumoral%2520Vasculature%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26issue%3D7%26spage%3D1457%26epage%3D1462%26doi%3D10.1016%2Fj.peptides.2011.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Peptide-Based Probes for Cancer Imaging</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1735</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.2967/jnumed.108.053041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.108.053041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=18927341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOhtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=1735-1738&issue=11&author=J.+C.+Reubiauthor=H.+R.+Maecke&title=Peptide-Based+Probes+for+Cancer+Imaging&doi=10.2967%2Fjnumed.108.053041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-based probes for cancer imaging</span></div><div class="casAuthors">Reubi, Jean Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1735-1738</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  Receptors for regulatory peptides are overexpressed in a variety of human cancers.  They represent the mol. basis for in vivo imaging with radiolabeled peptide probes.  Somatostatin-derived tracers, designed to image the sst2-overexpressing neuroendocrine tumors, have enjoyed almost 2 decades of successful development and extensive clin. applications.  More recent developments include second- and third-generation somatostatin analogs, with a broader receptor subtype profile or with antagonistic properties.  Emerging tracers for other peptide receptors, including cholecystokinin/gastrin and GLP-1 analogs for neuroendocrine tumors, bombesin and neuropeptide-Y analogs for prostate or breast cancers, or Arg-Gly-Asp peptides for neoangiogenesis labeling, are also in current development.  Application fields include both SPECT/CT and PET/CT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQl8P0WKboULVg90H21EOLACvtfcHk0lgtuGUauWp1YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOhtLbP&md5=fac1bacd57f62609b1ad2dfee963952f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.053041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.053041%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DPeptide-Based%2520Probes%2520for%2520Cancer%2520Imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26issue%3D11%26spage%3D1735%26epage%3D1738%26doi%3D10.2967%2Fjnumed.108.053041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalm, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieuwerts, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Deurzen, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelewijn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M.</span></span> <span> </span><span class="NLM_article-title"><i>In Vitro</i> and <i>In Vivo</i> Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.153023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.114.153023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=752-757&issue=5&author=S.+U.+Dalmauthor=J.+W.+M.+Martensauthor=A.+M.+Sieuwertsauthor=C.+H.+M.+van+Deurzenauthor=S.+J.+Koelewijnauthor=E.+de+Bloisauthor=T.+Mainaauthor=B.+A.+Nockauthor=L.+Brunelauthor=J.-A.+Fehrentzauthor=J.+Martinezauthor=M.+de+Jongauthor=M.+Melis&title=In+Vitro+and+In+Vivo+Application+of+Radiolabeled+Gastrin-Releasing+Peptide+Receptor+Ligands+in+Breast+Cancer&doi=10.2967%2Fjnumed.114.153023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.153023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.153023%26sid%3Dliteratum%253Aachs%26aulast%3DDalm%26aufirst%3DS.%2BU.%26aulast%3DMartens%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DSieuwerts%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BDeurzen%26aufirst%3DC.%2BH.%2BM.%26aulast%3DKoelewijn%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DFehrentz%26aufirst%3DJ.-A.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMelis%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Application%2520of%2520Radiolabeled%2520Gastrin-Releasing%2520Peptide%2520Receptor%2520Ligands%2520in%2520Breast%2520Cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26issue%3D5%26spage%3D752%26epage%3D757%26doi%3D10.2967%2Fjnumed.114.153023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasanphanich, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retzloff, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanda, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieckman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rold, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sublett, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. J.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Vivo Analysis of [<sup>64</sup>Cu-NO2A-8-Aoc-BBN(7–14)NH<sub>2</sub>]: A Site-Directed Radiopharmaceutical for Positron-Emission Tomography Imaging of T47D Human Breast Cancer Tumors</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.nucmedbio.2008.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=19217529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVyhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=171-181&issue=2&author=A.+F.+Prasanphanichauthor=L.+Retzloffauthor=S.+R.+Laneauthor=P.+K.+Nandaauthor=G.+L.+Sieckmanauthor=T.+L.+Roldauthor=L.+Maauthor=S.+D.+Figueroaauthor=S.+V.+Sublettauthor=T.+J.+Hoffmanauthor=C.+J.+Smith&title=In+Vitro+and+in+Vivo+Analysis+of+%5B64Cu-NO2A-8-Aoc-BBN%287%E2%80%9314%29NH2%5D%3A+A+Site-Directed+Radiopharmaceutical+for+Positron-Emission+Tomography+Imaging+of+T47D+Human+Breast+Cancer+Tumors&doi=10.1016%2Fj.nucmedbio.2008.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo analysis of [64Cu-NO2A-8-Aoc-BBN(7-14)NH2]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors</span></div><div class="casAuthors">Prasanphanich, Adam F.; Retzloff, Lauren; Lane, Stephanie R.; Nanda, Prasant K.; Sieckman, Gary L.; Rold, Tammy L.; Ma, Lixin; Figueroa, Said D.; Sublett, Samantha V.; Hoffman, Timothy J.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Human breast cancer, from which the T-47D cell line was derived, is known to overexpress the gastrin-releasing peptide receptor (GRPR) in some cases.  Bombesin (BBN), an agonist for the GRPR, has been appended with a radionuclide capable of positron-emission tomog. (PET) imaging and therapy.  64Cu-NO2A-8-Aoc-BBN(7-14)NH2 (NO2A=1,4,7-triazacyclononane-1,4-diacetate) has produced high-quality microPET images of GRPR-pos. breast cancer xenografted tumors in mice.  Methods: The imaging probe was synthesized by solid-phase peptide synthesis followed by manual conjugation of the 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) bifunctional chelator and radiolabeling in aq. soln.  The radiolabeled conjugate was subjected to in vitro and in vivo studies to det. its specificity for the GRPR and its pharmacokinetic profile.  A T-47D tumor-bearing mouse was imaged with microPET/CT and microMRI imaging.  Results: The 64Cu-NO2A-8-Aoc-BBN(7-14)NH2 targeting vector was detd. to specifically localize in GRPR-pos. tissue.  Accumulation was obsd. in the tumor in sufficient quantities to allow for identification of tumors in microPET imaging procedures.  For example, uptake and retention in T-47D xenografts at 1, 4 and 24 h were detd. to be 2.27±0.08, 1.35±0.14 and 0.28±0.07 % ID/g, resp.  Conclusions: The 64Cu-NO2A-8-Aoc-BBN(7-14)NH2 produced high-quality microPET images.  The pharmacokinetic profile justifies investigation of this bioconjugate as a potentially useful diagnostic/therapeutic agent.  Addnl., the bioconjugate would serve as a good starting point for modification and optimization of similar agents to maximize tumor uptake and minimize nontarget accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBaUUwx6qabVg90H21EOLACvtfcHk0lgtuGUauWp1YA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVyhtbk%253D&md5=c5e91e70a7ff3caf8156ff3c1b454487</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanphanich%26aufirst%3DA.%2BF.%26aulast%3DRetzloff%26aufirst%3DL.%26aulast%3DLane%26aufirst%3DS.%2BR.%26aulast%3DNanda%26aufirst%3DP.%2BK.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DRold%26aufirst%3DT.%2BL.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFigueroa%26aufirst%3DS.%2BD.%26aulast%3DSublett%26aufirst%3DS.%2BV.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Analysis%2520of%2520%255B64Cu-NO2A-8-Aoc-BBN%25287%25E2%2580%259314%2529NH2%255D%253A%2520A%2520Site-Directed%2520Radiopharmaceutical%2520for%2520Positron-Emission%2520Tomography%2520Imaging%2520of%2520T47D%2520Human%2520Breast%2520Cancer%2520Tumors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2009%26volume%3D36%26issue%3D2%26spage%3D171%26epage%3D181%26doi%3D10.1016%2Fj.nucmedbio.2008.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoykow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomä, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drendel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronsert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P. T.</span></span> <span> </span><span class="NLM_article-title">Gastrin-Releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist <sup>68</sup>Ga-RM2 And PET</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1641</span>– <span class="NLM_lpage">1650</span>, <span class="refDoi"> DOI: 10.7150/thno.14958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.7150%2Fthno.14958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1641-1650&issue=10&author=C.+Stoykowauthor=T.+Erbesauthor=H.+R.+Maeckeauthor=S.+Bullaauthor=M.+Bartholom%C3%A4author=S.+Mayerauthor=V.+Drendelauthor=P.+Bronsertauthor=M.+Wernerauthor=G.+Gitschauthor=W.+A.+Weberauthor=E.+Stickelerauthor=P.+T.+Meyer&title=Gastrin-Releasing+Peptide+Receptor+Imaging+in+Breast+Cancer+Using+the+Receptor+Antagonist+68Ga-RM2+And+PET&doi=10.7150%2Fthno.14958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7150%2Fthno.14958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.14958%26sid%3Dliteratum%253Aachs%26aulast%3DStoykow%26aufirst%3DC.%26aulast%3DErbes%26aufirst%3DT.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DBulla%26aufirst%3DS.%26aulast%3DBartholom%25C3%25A4%26aufirst%3DM.%26aulast%3DMayer%26aufirst%3DS.%26aulast%3DDrendel%26aufirst%3DV.%26aulast%3DBronsert%26aufirst%3DP.%26aulast%3DWerner%26aufirst%3DM.%26aulast%3DGitsch%26aufirst%3DG.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26aulast%3DStickeler%26aufirst%3DE.%26aulast%3DMeyer%26aufirst%3DP.%2BT.%26atitle%3DGastrin-Releasing%2520Peptide%2520Receptor%2520Imaging%2520in%2520Breast%2520Cancer%2520Using%2520the%2520Receptor%2520Antagonist%252068Ga-RM2%2520And%2520PET%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26issue%3D10%26spage%3D1641%26epage%3D1650%26doi%3D10.7150%2Fthno.14958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erspamer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucci, M.</span></span> <span> </span><span class="NLM_article-title">Isolation and Amino Acid Sequences of Alytesin and Bombesin, Two Analogous Active Tetradecapeptides from the Skin of European Discoglossid Frogs</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(72)90162-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2F0003-9861%2872%2990162-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1972&pages=443-446&issue=2&author=A.+Anastasiauthor=V.+Erspamerauthor=M.+Bucci&title=Isolation+and+Amino+Acid+Sequences+of+Alytesin+and+Bombesin%2C+Two+Analogous+Active+Tetradecapeptides+from+the+Skin+of+European+Discoglossid+Frogs&doi=10.1016%2F0003-9861%2872%2990162-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2872%2990162-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252872%252990162-2%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasi%26aufirst%3DA.%26aulast%3DErspamer%26aufirst%3DV.%26aulast%3DBucci%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520Amino%2520Acid%2520Sequences%2520of%2520Alytesin%2520and%2520Bombesin%252C%2520Two%2520Analogous%2520Active%2520Tetradecapeptides%2520from%2520the%2520Skin%2520of%2520European%2520Discoglossid%2520Frogs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1972%26volume%3D148%26issue%3D2%26spage%3D443%26epage%3D446%26doi%3D10.1016%2F0003-9861%2872%2990162-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornelio, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartsmann, G.</span></span> <span> </span><span class="NLM_article-title">Gastrin-Releasing Peptide Receptor as a Molecular Target in Experimental Anticancer Therapy</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1457</span>– <span class="NLM_lpage">1466</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdm058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1093%2Fannonc%2Fmdm058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=17351255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BD2srgvFenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=1457-1466&issue=9&author=D.+B.+Cornelioauthor=R.+Roeslerauthor=G.+Schwartsmann&title=Gastrin-Releasing+Peptide+Receptor+as+a+Molecular+Target+in+Experimental+Anticancer+Therapy&doi=10.1093%2Fannonc%2Fmdm058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy</span></div><div class="casAuthors">Cornelio D B; Roesler R; Schwartsmann G</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1457-66</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">Over the last two decades, several lines of experimental evidence have suggested that the gastrin-releasing peptide (GRP) may act as a growth factor in many types of cancer.  For that reason, gastrin-releasing peptide receptor (GRPR) antagonists have been developed as anticancer candidate compounds, exhibiting impressive antitumoral activity both in vitro and in vivo in various murine and human tumors.  In this article, the GRPR cell surface expression profile in human malignancies is reviewed aiming at the identification of potential tumor types for future clinical trials with GRP analogues and antagonists.  In this review, we summarize the current literature regarding the GRPR status in human malignancies.  Source data were obtained by searching all published material available through Medline, PubMed and relevant articles from 1971 to 2006.  The data available demonstrated a high expression of GRPRs in a large spectrum of human cancers, demonstrating the potential relevance of this intracellular signaling pathway in various human tumor models.  The GRPR may be an interesting target for therapeutic intervention in human malignancies, as carriers for cytotoxins, immunotoxins or radioactive compounds, being also a potential tool for tumor detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVtrv8gW96B0h5eUSa2oe_fW6udTcc2ebA8r0suXcmLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srgvFenuw%253D%253D&md5=01da9a7a9dc23455e2ca1020c7b8b0aa</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdm058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdm058%26sid%3Dliteratum%253Aachs%26aulast%3DCornelio%26aufirst%3DD.%2BB.%26aulast%3DRoesler%26aufirst%3DR.%26aulast%3DSchwartsmann%26aufirst%3DG.%26atitle%3DGastrin-Releasing%2520Peptide%2520Receptor%2520as%2520a%2520Molecular%2520Target%2520in%2520Experimental%2520Anticancer%2520Therapy%26jtitle%3DAnn.%2520Oncol.%26date%3D2007%26volume%3D18%26issue%3D9%26spage%3D1457%26epage%3D1466%26doi%3D10.1093%2Fannonc%2Fmdm058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okarvi, S. M.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.7150/thno.4024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.7150%2Fthno.4024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=481-501&issue=5&author=M.+Faniauthor=H.+R.+Maeckeauthor=S.+M.+Okarvi&title=Radiolabeled+Peptides%3A+Valuable+Tools+for+the+Detection+and+Treatment+of+Cancer&doi=10.7150%2Fthno.4024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7150%2Fthno.4024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.4024%26sid%3Dliteratum%253Aachs%26aulast%3DFani%26aufirst%3DM.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DOkarvi%26aufirst%3DS.%2BM.%26atitle%3DRadiolabeled%2520Peptides%253A%2520Valuable%2520Tools%2520for%2520the%2520Detection%2520and%2520Treatment%2520of%2520Cancer%26jtitle%3DTheranostics%26date%3D2012%26volume%3D2%26issue%3D5%26spage%3D481%26epage%3D501%26doi%3D10.7150%2Fthno.4024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Matching Chelators to Radiometals for Radiopharmaceuticals</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1039/C3CS60304K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1039%2FC3CS60304K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=24173525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGktLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=260-290&issue=1&author=E.+W.+Priceauthor=C.+Orvig&title=Matching+Chelators+to+Radiometals+for+Radiopharmaceuticals&doi=10.1039%2FC3CS60304K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Matching chelators to radiometals for radiopharmaceuticals</span></div><div class="casAuthors">Price, Eric W.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">260-290</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Radiometals comprise many useful radioactive isotopes of various metallic elements.  When properly harnessed, these have valuable emission properties that can be used for diagnostic imaging techniques, such as single photon emission computed tomog. (SPECT, e.g.67Ga, 99mTc, 111In, 177Lu) and positron emission tomog. (PET, e.g.68Ga, 64Cu, 44Sc, 86Y, 89Zr), as well as therapeutic applications (e.g.47Sc, 114mIn, 177Lu, 90Y, 212/213Bi, 212Pb, 225Ac, 186/188Re).  A fundamental crit. component of a radiometal-based radiopharmaceutical is the chelator, the ligand system that binds the radiometal ion in a tight stable coordination complex so that it can be properly directed to a desirable mol. target in vivo.  This article is a guide for selecting the optimal match between chelator and radiometal for use in these systems.  The article briefly introduces a selection of relevant and high impact radiometals, and their potential utility to the fields of radiochem., nuclear medicine, and mol. imaging.  A description of radiometal-based radiopharmaceuticals is provided, and several key design considerations are discussed.  The exptl. methods by which chelators are assessed for their suitability with a variety of radiometal ions is explained, and a large selection of the most common and most promising chelators are evaluated and discussed for their potential use with a variety of radiometals.  Comprehensive tables have been assembled to provide a convenient and accessible overview of the field of radiometal chelating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGxFFPqxTSFrVg90H21EOLACvtfcHk0licZuxgFqXQvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGktLzP&md5=30a847faed78cba5123ffca47bde5aa3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC3CS60304K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60304K%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DE.%2BW.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DMatching%2520Chelators%2520to%2520Radiometals%2520for%2520Radiopharmaceuticals%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26issue%3D1%26spage%3D260%26epage%3D290%26doi%3D10.1039%2FC3CS60304K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wängler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knackmuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGall, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span> <span> </span><span class="NLM_article-title">Tetrafluorophenolate of HBED-CC: A Versatile Conjugation Agent for <sup>68</sup>Ga-Labeled Small Recombinant Antibodies</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1878</span>– <span class="NLM_lpage">1886</span>, <span class="refDoi"> DOI: 10.1007/s00259-008-0816-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-008-0816-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=18509635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=1878-1886&issue=10&author=M.+Ederauthor=B.+W%C3%A4nglerauthor=S.+Knackmussauthor=F.+LeGallauthor=M.+Littleauthor=U.+Haberkornauthor=W.+Mierauthor=M.+Eisenhut&title=Tetrafluorophenolate+of+HBED-CC%3A+A+Versatile+Conjugation+Agent+for+68Ga-Labeled+Small+Recombinant+Antibodies&doi=10.1007%2Fs00259-008-0816-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies</span></div><div class="casAuthors">Eder, Matthias; Waengler, Bjoern; Knackmuss, Stefan; LeGall, Fabrice; Little, Melvyn; Haberkorn, Uwe; Mier, Walter; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1878-1886</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The success of 68Ga-labeled peptides for positron emission tomog. of neuroendocrine tumors is mainly depending on the complex chem. of this radioisotope. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), the chelator of choice has however limitations if its application is expanded to heat-sensitive proteins.  Recombinant antibodies like single chain Fv or diabodies belong to this class of proteins.  They are suited to provide imaging contrast despite the short-lived 68Ga because of their rapid blood clearances and nanomolar affinities.  The heterobifunctional agent N,N'-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid (HBED-CC) was chosen as an alternative ligand because this agent is complexing [68Ga]Ga3+ much faster than DOTA at ambient temps.  A versatile technol. for HBED-CC conjugation of proteins and 68Ga-labeling has been developed.  This included HBED-CC-tetrafluorophenol (TFP) ester synthesis, coupling to the antibody at various pH and complexation reactions performed in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer under different conditions.  The synthesis of the monoreactive 2,3,5,6-tetrafluorophenolate of HBED-CC at a carboxyl group not participating in complex formation used [Fe(HBED-CC)]- for ester formation.  The removal of Fe3+ from purified (HBED-CC)TFP ester was achieved with RP18 cartridge technol.  The conjugation chem. was performed with mAb425 which binds to the epidermal growth factor receptor (EGFR).  This protein was used for optimizing purposes only.  The influence of complexation parameters like temp., pH, reaction time, and HBED-CC/antibody ratio on the biol. activity of this model antibody was investigated.  Furthermore, the outcome of this labeling procedure on the biol. activity of a recombinant diabody (50 kDa) was studied.  It is known that small HBED-CC/antibody ratios are prerequisites for minimal interference of labels with antigen-binding domains.  Here, the coupling of about one HBED-CC per antibody proved to be sufficient for efficient 68Ga labeling, pointing to the successful application of 68Ga for mol. imaging with small recombinant proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaFp4SmuGX2LVg90H21EOLACvtfcHk0ljvTmUJ1tKbhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzK&md5=db2386f042dd670f321bb7020ea7074c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00259-008-0816-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-008-0816-z%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DKnackmuss%26aufirst%3DS.%26aulast%3DLeGall%26aufirst%3DF.%26aulast%3DLittle%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3DTetrafluorophenolate%2520of%2520HBED-CC%253A%2520A%2520Versatile%2520Conjugation%2520Agent%2520for%252068Ga-Labeled%2520Small%2520Recombinant%2520Antibodies%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26issue%3D10%26spage%3D1878%26epage%3D1886%26doi%3D10.1007%2Fs00259-008-0816-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liolios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopka, K.</span></span> <span> </span><span class="NLM_article-title">Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.5b00687</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00687" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVejuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=737-751&issue=3&author=C.+Lioliosauthor=M.+Sch%C3%A4ferauthor=U.+Haberkornauthor=M.+Ederauthor=K.+Kopka&title=Novel+Bispecific+PSMA%2FGRPr+Targeting+Radioligands+with+Optimized+Pharmacokinetics+for+Improved+PET+Imaging+of+Prostate+Cancer&doi=10.1021%2Facs.bioconjchem.5b00687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer</span></div><div class="casAuthors">Liolios, C.; Schaefer, M.; Haberkorn, U.; Eder, M.; Kopka, K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of bispecific radioligands (BRLs) targeting prostate-specific membrane antigen (PSMA) and gastrin releasing peptide receptor (GRPr), both expressed on prostate cancer cells, was developed.  Their design was based on the bombesin (BN) analog, H2N-PEG2-[D-Tyr6,β-Ala11,Thi13,Nle14]BN(6-14), which binds to GRPr with high affinity and specificity, and the peptidomimetic urea-based pseudoirreversible inhibitor of PSMA, Glu-ureido-Lys.  The two pharmacophores were coupled through copper(I)-catalyzed azide-alkyne cycloaddn. to the bis(tetrafluorophenyl) ester of the chelating agent HBED-CC via amino acid linkers made of pos. charged His (H) and neg. charged Glu (E): -(HE)n- (n = 0-3).  The BRLs were labeled with 68Ga, and their preliminary pharmacol. properties were evaluated in vitro (competitive and time kinetic binding assays) on prostate cancer (PC-3, LNCaP) and rat pancreatic (AR42J) cell lines and in vivo by biodistribution and small animal PET imaging studies in both normal and tumor-bearing mice.  The IC50/Ki values detd. for all BRLs essentially matched those of the resp. monomers.  The maximal cellular uptake of the BLRs was obsd. between 20 and 30 min.  The BRLs showed a synergistic ability in vivo by targeting both PSMA (LNCaP) and GRPr (PC-3) pos. tumors, whereas the charged -(HE)n- (n = 1-3) linkers significantly reduced the kidney and spleen uptake.  The bispecific (PSMA and GRPr) targeting ability and optimized pharmacokinetics of the compds. developed in this study could lead to their future application in clin. practice as more sensitive radiotracers for noninvasive imaging of prostate cancer (PCa) by PET/CT and PET/MRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdb-s9rymAp7Vg90H21EOLACvtfcHk0ljvTmUJ1tKbhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVejuw%253D%253D&md5=f6e7805810a50bd7ee9c955ac3df8056</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00687%26sid%3Dliteratum%253Aachs%26aulast%3DLiolios%26aufirst%3DC.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DNovel%2520Bispecific%2520PSMA%252FGRPr%2520Targeting%2520Radioligands%2520with%2520Optimized%2520Pharmacokinetics%2520for%2520Improved%2520PET%2520Imaging%2520of%2520Prostate%2520Cancer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26issue%3D3%26spage%3D737%26epage%3D751%26doi%3D10.1021%2Facs.bioconjchem.5b00687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder-Wüst, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopka, K.</span></span> <span> </span><span class="NLM_article-title">Preclinical Evaluation of a Bispecific Low-Molecular Heterodimer Targeting Both PSMA and GRPR for Improved PET Imaging and Therapy of Prostate Cancer</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1002/pros.22784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1002%2Fpros.22784" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=659-668&issue=6&author=M.+Ederauthor=M.+Sch%C3%A4ferauthor=U.+Bauder-W%C3%BCstauthor=U.+Haberkornauthor=M.+Eisenhutauthor=K.+Kopka&title=Preclinical+Evaluation+of+a+Bispecific+Low-Molecular+Heterodimer+Targeting+Both+PSMA+and+GRPR+for+Improved+PET+Imaging+and+Therapy+of+Prostate+Cancer&doi=10.1002%2Fpros.22784"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fpros.22784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22784%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DBauder-W%25C3%25BCst%26aufirst%3DU.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DPreclinical%2520Evaluation%2520of%2520a%2520Bispecific%2520Low-Molecular%2520Heterodimer%2520Targeting%2520Both%2520PSMA%2520and%2520GRPR%2520for%2520Improved%2520PET%2520Imaging%2520and%2520Therapy%2520of%2520Prostate%2520Cancer%26jtitle%3DProstate%26date%3D2014%26volume%3D74%26issue%3D6%26spage%3D659%26epage%3D668%26doi%3D10.1002%2Fpros.22784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handl, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mash, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillies, R. J.</span></span> <span> </span><span class="NLM_article-title">Hitting Multiple Targets with Multimeric Ligands</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1517/14728222.8.6.565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1517%2F14728222.8.6.565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=15584863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1eisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=565-586&issue=6&author=H.+L.+Handlauthor=J.+Vagnerauthor=H.+Hanauthor=E.+Mashauthor=V.+J.+Hrubyauthor=R.+J.+Gillies&title=Hitting+Multiple+Targets+with+Multimeric+Ligands&doi=10.1517%2F14728222.8.6.565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hitting multiple targets with multimeric ligands</span></div><div class="casAuthors">Handl, Heather L.; Vagner, Josef; Han, Haiyong; Mash, Eugene; Hruby, Victor J.; Gillies, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-586</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Multimeric ligands consist of multiple monomeric ligands attached to a single backbone mol., creating a multimer that can bind to multiple receptors or targets simultaneously.  Numerous examples of multimeric binding exist within nature.  Due to the multiple and simultaneous binding events, multimeric ligands bind with an increased affinity compared to their corresponding monomers.  Multimeric ligands may provide opportunities in the field of drug discovery by providing enhanced selectivity and affinity of binding interactions, thus providing mol.-based targeted therapies.  However, gaps in our knowledge currently exist regarding the quant. measures for important design characteristics, such as flexibility, length and orientation of the inter-ligand linkers, receptor d. and ligand sequence.  In this review, multimeric ligand binding in two sep. phases is examd.  The prerecruitment phase describes the binding of one ligand of a multimer to its corresponding receptor, an event similar to monomeric ligand binding.  This results in transient increases in the local concn. of the other ligands, leading to apparent cooperativity.  The postrecruitment phase only occurs once all receptors have been aligned and bound by their corresponding ligand.  This phase is analogous to DNA-DNA interactions in that the stability of the complex is derived from phys. orientation.  Multiple factors influence the kinetics and thermodn. of multimeric binding, and these are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7NOkX9Q-NcLVg90H21EOLACvtfcHk0ljwq00aQp8YSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1eisg%253D%253D&md5=8aad8ea5debf2373eb5d59f5bab63dc5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14728222.8.6.565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.8.6.565%26sid%3Dliteratum%253Aachs%26aulast%3DHandl%26aufirst%3DH.%2BL.%26aulast%3DVagner%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DMash%26aufirst%3DE.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DGillies%26aufirst%3DR.%2BJ.%26atitle%3DHitting%2520Multiple%2520Targets%2520with%2520Multimeric%2520Ligands%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2004%26volume%3D8%26issue%3D6%26spage%3D565%26epage%3D586%26doi%3D10.1517%2F14728222.8.6.565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrithers, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, M. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of Bivalent Peptide Ligands Targeted to G-Protein-Coupled Receptors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(96)90144-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2FS1074-5521%2896%2990144-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=8807885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADyaK28XkvFWgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=537-542&issue=7&author=M.+D.+Carrithersauthor=M.+R.+Lerner&title=Synthesis+and+Characterization+of+Bivalent+Peptide+Ligands+Targeted+to+G-Protein-Coupled+Receptors&doi=10.1016%2FS1074-5521%2896%2990144-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of bivalent peptide ligands targeted to G-protein-coupled receptors</span></div><div class="casAuthors">Carrithers, Michael D.; Lerner, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-542</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Through the effects of avidity, multivalency can increase the apparent affinity of a ligand for its binding site.  Low mol. wt., high affinity, multivalent ligands theor. could be used to deliver a variety of agents to specific cell subtypes.  In order to target specific G-protein-coupled receptors, a series of monospecific peptide dimers were synthesized that are designed to bind to two adjacent receptor sites.  These dimers, consisting of a ligand region, a short, flexible, uncharged spacer, a longer, polylysine spacer and a single cysteine residue to permit dimerization, and the corresponding monomers were synthesized by solid-phase peptide synthesis.  The ligand domain was either α-MSH an α-MSH receptor antagonist (α-MSH-ANT), or bombesin.  These ligands were characterized in a functional melanocyte dispersion assay.  In wild-type melanophores, the α-MSH dimer stimulated dispersion with an EC50 approx. seven-fold lower than that of the corresponding monomer.  Similarly, in cells transfected with bombesin receptor cDNA, the bombesin dimer was approx. five-fold more potent than the monomer.  The α-MSH-ANT monomer specifically inhibited α-MSH-mediated dispersion with no significant agonist activity, but the dimer acted predominantly as an agonist.  Peptide dimers can be synthesized easily and have enhanced functional activity; monospecific dimers have greater avidity and bispecific dimers are likely to have greater selectivity.  They may therefore have practical potential as specific well-targeting agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1F2Cst_puibVg90H21EOLACvtfcHk0ljwq00aQp8YSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFWgur0%253D&md5=596dd6900a21e7c91d509448f71001c3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2896%2990144-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252896%252990144-1%26sid%3Dliteratum%253Aachs%26aulast%3DCarrithers%26aufirst%3DM.%2BD.%26aulast%3DLerner%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Bivalent%2520Peptide%2520Ligands%2520Targeted%2520to%2520G-Protein-Coupled%2520Receptors%26jtitle%3DChem.%2520Biol.%26date%3D1996%26volume%3D3%26issue%3D7%26spage%3D537%26epage%3D542%26doi%3D10.1016%2FS1074-5521%2896%2990144-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaccard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretzschmar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Novel DOTA-Based Prochelator for Divalent Peptide Vectorization: Synthesis of Dimeric Bombesin Analogues for Multimodality Tumor Imaging and Therapy</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3248</span>– <span class="NLM_lpage">3250</span>, <span class="refDoi"> DOI: 10.1039/b805281f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1039%2Fb805281f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=18622433" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3248-3250&author=K.+Abirajauthor=H.+Jaccardauthor=M.+Kretzschmarauthor=L.+Helmauthor=H.+R.+Maecke&title=Novel+DOTA-Based+Prochelator+for+Divalent+Peptide+Vectorization%3A+Synthesis+of+Dimeric+Bombesin+Analogues+for+Multimodality+Tumor+Imaging+and+Therapy&doi=10.1039%2Fb805281f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2Fb805281f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb805281f%26sid%3Dliteratum%253Aachs%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DJaccard%26aufirst%3DH.%26aulast%3DKretzschmar%26aufirst%3DM.%26aulast%3DHelm%26aufirst%3DL.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DNovel%2520DOTA-Based%2520Prochelator%2520for%2520Divalent%2520Peptide%2520Vectorization%253A%2520Synthesis%2520of%2520Dimeric%2520Bombesin%2520Analogues%2520for%2520Multimodality%2520Tumor%2520Imaging%2520and%2520Therapy%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2008%26volume%3D28%26spage%3D3248%26epage%3D3250%26doi%3D10.1039%2Fb805281f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gawlak, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiener, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braslawsky, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfield, R. S.</span></span> <span> </span><span class="NLM_article-title">Homodimeric Forms of Bombesin Act as Potent Antagonists of Bombesin on Swiss 3T3 Cells</span>. <i>Growth Factors</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.3109/08977199109000280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.3109%2F08977199109000280" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=159-170&issue=2&author=S.+L.+Gawlakauthor=P.+A.+Kienerauthor=G.+R.+Braslawskyauthor=R.+S.+Greenfield&title=Homodimeric+Forms+of+Bombesin+Act+as+Potent+Antagonists+of+Bombesin+on+Swiss+3T3+Cells&doi=10.3109%2F08977199109000280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3109%2F08977199109000280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08977199109000280%26sid%3Dliteratum%253Aachs%26aulast%3DGawlak%26aufirst%3DS.%2BL.%26aulast%3DKiener%26aufirst%3DP.%2BA.%26aulast%3DBraslawsky%26aufirst%3DG.%2BR.%26aulast%3DGreenfield%26aufirst%3DR.%2BS.%26atitle%3DHomodimeric%2520Forms%2520of%2520Bombesin%2520Act%2520as%2520Potent%2520Antagonists%2520of%2520Bombesin%2520on%2520Swiss%25203T3%2520Cells%26jtitle%3DGrowth%2520Factors%26date%3D1991%26volume%3D5%26issue%3D2%26spage%3D159%26epage%3D170%26doi%3D10.3109%2F08977199109000280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumulon-Perreault, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ait-Mohand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guérin, B.</span></span> <span> </span><span class="NLM_article-title">Comparative Study of <sup>64</sup>Cu/NOTA-[D-Tyr<sup>6</sup>,βAla<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BBN(6–14) Monomer and Dimers for Prostate Cancer PET Imaging</span>. <i>EJNMMI Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">8</span>, <span class="refDoi"> DOI: 10.1186/2191-219X-2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1186%2F2191-219X-2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=22333272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaksL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=8&issue=1&author=P.+Fournierauthor=V.+Dumulon-Perreaultauthor=S.+Ait-Mohandauthor=R.+Langloisauthor=F.+B%C3%A9nardauthor=R.+Lecomteauthor=B.+Gu%C3%A9rin&title=Comparative+Study+of+64Cu%2FNOTA-%5BD-Tyr6%2C%CE%B2Ala11%2CThi13%2CNle14%5DBBN%286%E2%80%9314%29+Monomer+and+Dimers+for+Prostate+Cancer+PET+Imaging&doi=10.1186%2F2191-219X-2-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of 64Cu/NOTA-[-Tyr6,βAla11, Thi13, Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging</span></div><div class="casAuthors">Fournier, Patrick; Dumulon-Perreault, Veronique; Ait-Mohand, Samia; Langlois, Rejean; Benard, Francois; Lecomte, Roger; Guerin, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">ERJEAI</span>;
        ISSN:<span class="NLM_cas:issn">2191-219X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Background: Gastrin-releasing peptide receptors [GRPR] are highly over-expressed in multiple cancers and have been studied as a diagnostic target.  Multimeric gastrin-releasing peptides are expected to have enhanced tumor uptake and affinity for GRPR.  In this study, a 64Cu-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid [NOTA]- monomer and two NOTA-dimers of [-Tyr6,βAla11, Thi13, Nle14]bombesin(6-14) ] [BBN(6-14)] were compared.  Methods: Monomeric and dimeric peptides were synthesized on solid phase support and radiolabeled with 64Cu.  NOTA-dimer 1 consists of asym. linked BBN(6-14), while NOTA-dimer 2 has similar spacer between the two BBN(6-14) ligands and the chelator.  In vitro GRPR-binding affinities were detd. with competitive binding assays on PC3 human prostate cancer cells.  In vivo stability and biodistribution of radiolabeled compds. were assessed in Balb/c mice.  Cellular uptake and efflux were measured with radiolabeled NOTA-monomer and NOTAdimer 2 on PC3 cells for up to 4 h.  In vivo biodistribution kinetics were measured in PC3 tumor-bearing Balb/c nude mice by μ-positron emission tomog. [μPET] imaging and confirmed by dissection and counting.  Results: NOTA-monomer, NOTA-dimers 1 and 2 were prepd. with purity of 99%.  The inhibition consts. of the three BBN peptides were comparable and in the low nanomolar range.  All 64Cu-labeled peptides were stable up to 24 h in mouse plasma and 1 h in vivo.  64Cu/NOTA-dimer 2 featuring a longer spacer between the two BBN(6-14) ligands is a more potent GRPR-targeting probe than 64Cu/NOTA-dimer 1.  PC3 tumor uptake profiles are slightly different for 64Cu/NOTA-monomer and 64Cu/NOTA-dimer 2; the monomeric BBN-peptide tracer exhibited higher tumor uptake during the first 0.5 h and a fast renal clearance resulting in higher tumor-to-muscle ratio when compared to 64Cu/NOTA-dimer 2.  The latter exhibited higher tumor-to-blood ratio and was retained longer at the tumor site when compared to 64Cu/NOTA-monomer.  Lower ratios of tumor-to-blood and tumor-to-muscle in blocking expts. showed GRPR-dependant tumor uptake for both tracers.  Conclusion: Both 64Cu/NOTA-monomer and 64Cu/NOTA-dimer 2 are suitable for detecting GRPR-pos. prostate cancer in vivo by PET.  Tumor retention was improved in vivo with 64Cu/NOTA-dimer 2 by applying polyvalency effect and/or statistical rebinding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpphGC1jlwklrVg90H21EOLACvtfcHk0ljwq00aQp8YSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaksL%252FJ&md5=0773e92b6d6cfe89f71b2d2c0e3fc706</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F2191-219X-2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-219X-2-8%26sid%3Dliteratum%253Aachs%26aulast%3DFournier%26aufirst%3DP.%26aulast%3DDumulon-Perreault%26aufirst%3DV.%26aulast%3DAit-Mohand%26aufirst%3DS.%26aulast%3DLanglois%26aufirst%3DR.%26aulast%3DB%25C3%25A9nard%26aufirst%3DF.%26aulast%3DLecomte%26aufirst%3DR.%26aulast%3DGu%25C3%25A9rin%26aufirst%3DB.%26atitle%3DComparative%2520Study%2520of%252064Cu%252FNOTA-%255BD-Tyr6%252C%25CE%25B2Ala11%252CThi13%252CNle14%255DBBN%25286%25E2%2580%259314%2529%2520Monomer%2520and%2520Dimers%2520for%2520Prostate%2520Cancer%2520PET%2520Imaging%26jtitle%3DEJNMMI%2520Res.%26date%3D2012%26volume%3D2%26issue%3D1%26spage%3D8%26doi%3D10.1186%2F2191-219X-2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlucci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ananias, H. J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierckx, R. A. J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helfrich, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsinga, P. H.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a Technetium-99m Labeled Bombesin Homodimer for GRPR Imaging in Prostate Cancer</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1007/s00726-012-1369-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00726-012-1369-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=543-553&issue=2&author=Z.+Yuauthor=G.+Carlucciauthor=H.+J.+K.+Ananiasauthor=R.+A.+J.+O.+Dierckxauthor=S.+Liuauthor=W.+Helfrichauthor=F.+Wangauthor=I.+J.+de+Jongauthor=P.+H.+Elsinga&title=Evaluation+of+a+Technetium-99m+Labeled+Bombesin+Homodimer+for+GRPR+Imaging+in+Prostate+Cancer&doi=10.1007%2Fs00726-012-1369-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00726-012-1369-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-012-1369-9%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DCarlucci%26aufirst%3DG.%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%2BK.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHelfrich%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DF.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26atitle%3DEvaluation%2520of%2520a%2520Technetium-99m%2520Labeled%2520Bombesin%2520Homodimer%2520for%2520GRPR%2520Imaging%2520in%2520Prostate%2520Cancer%26jtitle%3DAmino%2520Acids%26date%3D2013%26volume%3D44%26issue%3D2%26spage%3D543%26epage%3D553%26doi%3D10.1007%2Fs00726-012-1369-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koczan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuettenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmieder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrakopoulou-Strauss, A.</span></span> <span> </span><span class="NLM_article-title">Correlation of the Ga-68-Bombesin Analog Ga-68-BZH3 with Receptors Expression in Gliomas as Measured by Quantitative Dynamic Positron Emission Tomography (dPET) and Gene Arrays</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1007/s11307-011-0508-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs11307-011-0508-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=21744169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BC38zkvVehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=376-383&issue=3&author=L.+G.+Straussauthor=D.+Koczanauthor=M.+Seizauthor=J.+Tuettenbergauthor=K.+Schmiederauthor=L.+Panauthor=C.+Chengauthor=A.+Dimitrakopoulou-Strauss&title=Correlation+of+the+Ga-68-Bombesin+Analog+Ga-68-BZH3+with+Receptors+Expression+in+Gliomas+as+Measured+by+Quantitative+Dynamic+Positron+Emission+Tomography+%28dPET%29+and+Gene+Arrays&doi=10.1007%2Fs11307-011-0508-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arrays</span></div><div class="casAuthors">Strauss Ludwig G; Koczan Dirk; Seiz Marcel; Tuettenberg Jochen; Schmieder Kirsten; Pan Leyun; Cheng Caixia; Dimitrakopoulou-Strauss Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The kinetics of Ga-68-BZH3, a Ga-68-bombesin analog, was compared to molecular biological data obtained from gene arrays in seven patients with a recurrent glioma.  The primary aim of this study was the correlation of receptor expression and tracer kinetics.  PROCEDURES:  Dynamic positron emission tomography studies were performed and the data were analyzed by a volume-of-interest technique using a two-tissue compartment model as well as a non-compartment model.  Gene array data were obtained from gene array analysis of tumor tissue samples.  RESULTS:  The correlation analysis revealed a significant nonlinear correlation of r = 0.89 (p < 0.03) for k1 and BB(2) (gastrin-releasing peptide receptor).  BB(1) and BB(3) were not significantly correlated with k1. vb and k3 were not significantly correlated with the expression data of the receptors on the p < 0.05 level.  CONCLUSIONS:  The parameter k1 is correlated with the expression of BB(2) based on gene array data.  The quantitative analysis of the Ga-68-BZH3 kinetics can be used to predict the receptor expression of BB(2) in gliomas based on k1 of the compartment analysis.  However, this study is limited to the expression data on the mRNA level and further studies are needed to assess the correlation of gene expression on the protein level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHdHQtkCqfRTC850By6mxpfW6udTcc2eb1Drlv8s-pbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zkvVehtw%253D%253D&md5=805fcded5cd13feba23a2021ddb57213</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11307-011-0508-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-011-0508-0%26sid%3Dliteratum%253Aachs%26aulast%3DStrauss%26aufirst%3DL.%2BG.%26aulast%3DKoczan%26aufirst%3DD.%26aulast%3DSeiz%26aufirst%3DM.%26aulast%3DTuettenberg%26aufirst%3DJ.%26aulast%3DSchmieder%26aufirst%3DK.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DDimitrakopoulou-Strauss%26aufirst%3DA.%26atitle%3DCorrelation%2520of%2520the%2520Ga-68-Bombesin%2520Analog%2520Ga-68-BZH3%2520with%2520Receptors%2520Expression%2520in%2520Gliomas%2520as%2520Measured%2520by%2520Quantitative%2520Dynamic%2520Positron%2520Emission%2520Tomography%2520%2528dPET%2529%2520and%2520Gene%2520Arrays%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26issue%3D3%26spage%3D376%26epage%3D383%26doi%3D10.1007%2Fs11307-011-0508-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minamimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loening, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasanawala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambhir, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iagaru, A.</span></span> <span> </span><span class="NLM_article-title">Pilot Comparison of <sup>68</sup>Ga-RM2 PET and <sup>68</sup>Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.168393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.115.168393" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=557-562&issue=4&author=R.+Minamimotoauthor=S.+Hancockauthor=B.+Schneiderauthor=F.+T.+Chinauthor=M.+Jamaliauthor=A.+Loeningauthor=S.+Vasanawalaauthor=S.+S.+Gambhirauthor=A.+Iagaru&title=Pilot+Comparison+of+68Ga-RM2+PET+and+68Ga-PSMA-11+PET+in+Patients+with+Biochemically+Recurrent+Prostate+Cancer&doi=10.2967%2Fjnumed.115.168393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.168393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.168393%26sid%3Dliteratum%253Aachs%26aulast%3DMinamimoto%26aufirst%3DR.%26aulast%3DHancock%26aufirst%3DS.%26aulast%3DSchneider%26aufirst%3DB.%26aulast%3DChin%26aufirst%3DF.%2BT.%26aulast%3DJamali%26aufirst%3DM.%26aulast%3DLoening%26aufirst%3DA.%26aulast%3DVasanawala%26aufirst%3DS.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DIagaru%26aufirst%3DA.%26atitle%3DPilot%2520Comparison%2520of%252068Ga-RM2%2520PET%2520and%252068Ga-PSMA-11%2520PET%2520in%2520Patients%2520with%2520Biochemically%2520Recurrent%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26issue%3D4%26spage%3D557%26epage%3D562%26doi%3D10.2967%2Fjnumed.115.168393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Development of a Potent DOTA-Conjugated Bombesin Antagonist for Targeting GRPr-Positive Tumours</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1007/s00259-010-1596-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-010-1596-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=20717822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2gtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=97-107&issue=1&author=R.+Mansiauthor=X.+Wangauthor=F.+Forrerauthor=B.+Waserauthor=R.+Cescatoauthor=K.+Grahamauthor=S.+Borkowskiauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Development+of+a+Potent+DOTA-Conjugated+Bombesin+Antagonist+for+Targeting+GRPr-Positive+Tumours&doi=10.1007%2Fs00259-010-1596-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours</span></div><div class="casAuthors">Mansi, Rosalba; Wang, Xuejuan; Forrer, Flavio; Waser, Beatrice; Cescato, Renzo; Graham, Keith; Borkowski, Sandra; Reubi, Jean Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Radiolabeled somatostatin-based antagonists show a higher uptake in tumor-bearing mouse models than agonists of similar or even distinctly higher receptor affinity.  Very similar results were obtained with another family of G protein-coupled receptor ligands, the bombesin family.  We describe a new conjugate, RM2, with the chelator DOTA coupled to D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 via the cationic spacer 4-amino-1-carboxymethyl-piperidine for labeling with radiometals such as 111In and 68Ga.  Methods: RM2 was synthesized on a solid support and evaluated in vitro in PC-3 cells.  IC50 and Kd values were detd.  The antagonist potency was evaluated by immunofluorescence-based internalization and Ca2+ mobilization assays.  Biodistribution studies were performed in PC-3 and LNCaP tumor-bearing mice with 111In-RM2 and 68Ga-RM2, resp.  PET/CT studies were performed on PC-3 and LNCaP tumor-bearing nude mice with 68Ga-RM2.  Results: RM2 and 111In-RM2 are high-affinity and selective ligands for the GRP receptor (7.7±3.3 nmol/l for RM2; 9.3±3.3 nmol/l for natIn-RM2).  The potent antagonistic properties were confirmed by an immunofluorescence-based internalization and Ca2+ mobilization assays. 68Ga- and 111In-RM2 showed high and specific uptake in both the tumor and the pancreas.  Uptake in the tumor remained high (15.2±4.8%IA/g at 1 h; 11.7±2.4%IA/g at 4 h), whereas a relatively fast washout from the pancreas and the other abdominal organs was obsd.  Uptake in the pancreas decreased rapidly from 22.6±4.7%IA/g at 1 h to 1.5±0.5%IA/g at 4 h.  Conclusion: RM2 was shown to be a potent GRPr antagonist.  Pharmacokinetics and imaging studies indicate that 111In-RM2 and 68Ga-RM2 are ideal candidates for clin. SPECT and PET studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAsvAlokOzLVg90H21EOLACvtfcHk0lhyIeewNQu4wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2gtLvJ&md5=f3b9a6bfaf46bd8cbf0bfc7db8c2d764</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00259-010-1596-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-010-1596-9%26sid%3Dliteratum%253Aachs%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DForrer%26aufirst%3DF.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DBorkowski%26aufirst%3DS.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DDevelopment%2520of%2520a%2520Potent%2520DOTA-Conjugated%2520Bombesin%2520Antagonist%2520for%2520Targeting%2520GRPr-Positive%2520Tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2011%26volume%3D38%26issue%3D1%26spage%3D97%26epage%3D107%26doi%3D10.1007%2Fs00259-010-1596-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaknun, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Brand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavel, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hörsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dorisio, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dorisiol, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwekkeboom, D. J.</span></span> <span> </span><span class="NLM_article-title">The Joint IAEA, EANM, and SNMMI Practical Guidance on Peptide Receptor Radionuclide Therapy (PRRNT) in Neuroendocrine Tumours</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1007/s00259-012-2330-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-012-2330-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=23389427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1OgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=800-816&issue=5&author=J.+J.+Zaknunauthor=L.+Bodeiauthor=J.+Mueller-Brandauthor=M.+E.+Pavelauthor=R.+P.+Baumauthor=D.+H%C3%B6rschauthor=M.+S.+O%E2%80%99Dorisioauthor=T.+M.+O%E2%80%99Dorisiolauthor=J.+R.+Howeauthor=M.+Cremonesiauthor=D.+J.+Kwekkeboom&title=The+Joint+IAEA%2C+EANM%2C+and+SNMMI+Practical+Guidance+on+Peptide+Receptor+Radionuclide+Therapy+%28PRRNT%29+in+Neuroendocrine+Tumours&doi=10.1007%2Fs00259-012-2330-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours</span></div><div class="casAuthors">Zaknun, John J.; Bodei, L.; Mueller-Brand, J.; Pavel, M. E.; Baum, R. P.; Hoersch, D.; O'Dorisio, M. S.; O'Dorisiol, T. M.; Howe, J. R.; Cremonesi, M.; Kwekkeboom, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">800-816</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy involving the systemic administration of a radiolabeled peptide designed to target with high affinity and specificity receptors overexpressed on tumors.  PRRNT employing the radiotagged somatostatin receptor agonists 90Y-DOTATOC ([90Y-DOTA0,Tyr3]-octreotide) or 177Lu-DOTATATE ([177Lu-DOTA0,Tyr3,Thr8]-octreotide or [177Lu-DOTA0,Tyr3]-octreotate) have been successfully used for the past 15 years to target metastatic or inoperable neuroendocrine tumors expressing the somatostatin receptor subtype 2.  Accumulated evidence from clin. experience indicates that these tumors can be subjected to a high absorbed dose which leads to partial or complete objective responses in up to 30 % of treated patients.  Survival analyses indicate that patients presenting with high tumor receptor expression at study entry and receiving 177Lu-DOTATATE or 90Y-DOTATOC treatment show significantly higher objective responses, leading to longer survival and improved quality of life.  Side effects of PRRNT are typically seen in the kidneys and bone marrow.  These, however, are usually mild provided adequate protective measures are undertaken.  Despite the large body of evidence regarding efficacy and clin. safety, PRRNT is still considered an investigational treatment and its implementation must comply with national legislation, and ethical guidelines concerning human therapeutic investigations.  This guidance was formulated based on recent literature and leading experts' opinions.  It covers the rationale, indications and contraindications for PRRNT, assessment of treatment response and patient follow-up.  This document is aimed at guiding nuclear medicine specialists in selecting likely candidates to receive PRRNT and to deliver the treatment in a safe and effective manner.  This document is largely based on the book published through a joint international effort under the auspices of the Nuclear Medicine Section of the International Atomic Energy Agency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0CTc3ejXDIrVg90H21EOLACvtfcHk0lgoVlG3aRpBbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1OgsrY%253D&md5=49fb597ad447cbb1c9a3f12d5e5644be</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2330-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2330-6%26sid%3Dliteratum%253Aachs%26aulast%3DZaknun%26aufirst%3DJ.%2BJ.%26aulast%3DBodei%26aufirst%3DL.%26aulast%3DMueller-Brand%26aufirst%3DJ.%26aulast%3DPavel%26aufirst%3DM.%2BE.%26aulast%3DBaum%26aufirst%3DR.%2BP.%26aulast%3DH%25C3%25B6rsch%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Dorisio%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Dorisiol%26aufirst%3DT.%2BM.%26aulast%3DHowe%26aufirst%3DJ.%2BR.%26aulast%3DCremonesi%26aufirst%3DM.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Joint%2520IAEA%252C%2520EANM%252C%2520and%2520SNMMI%2520Practical%2520Guidance%2520on%2520Peptide%2520Receptor%2520Radionuclide%2520Therapy%2520%2528PRRNT%2529%2520in%2520Neuroendocrine%2520Tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26issue%3D5%26spage%3D800%26epage%3D816%26doi%3D10.1007%2Fs00259-012-2330-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span> <span> </span><span class="NLM_article-title">PSMA as a Target for Radiolabelled Small Molecules</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">823</span>, <span class="refDoi"> DOI: 10.1007/s00259-013-2374-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-013-2374-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=23463331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BC3svjsFSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=819-823&issue=6&author=M.+Ederauthor=M.+Eisenhutauthor=J.+Babichauthor=U.+Haberkorn&title=PSMA+as+a+Target+for+Radiolabelled+Small+Molecules&doi=10.1007%2Fs00259-013-2374-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">PSMA as a target for radiolabelled small molecules</span></div><div class="casAuthors">Eder Matthias; Eisenhut Michael; Babich John; Haberkorn Uwe</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWV4uZ6DElrHO4gDb7JggCfW6udTcc2ea15mnuHnT2wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svjsFSjsQ%253D%253D&md5=2e1b63f6f70015f72227b98c04a955a4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2374-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2374-2%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DBabich%26aufirst%3DJ.%26aulast%3DHaberkorn%26aufirst%3DU.%26atitle%3DPSMA%2520as%2520a%2520Target%2520for%2520Radiolabelled%2520Small%2520Molecules%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26issue%3D6%26spage%3D819%26epage%3D823%26doi%3D10.1007%2Fs00259-013-2374-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Nahhas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Win, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyszko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubello, D.</span></span> <span> </span><span class="NLM_article-title">What Can Gallium-68 PET Add to Receptor and Molecular Imaging?</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1897</span>– <span class="NLM_lpage">1901</span>, <span class="refDoi"> DOI: 10.1007/s00259-007-0568-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-007-0568-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=17713764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhsFymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=1897-1901&issue=12&author=A.+Al-Nahhasauthor=Z.+Winauthor=T.+Szyszkoauthor=A.+Singhauthor=S.+Khanauthor=D.+Rubello&title=What+Can+Gallium-68+PET+Add+to+Receptor+and+Molecular+Imaging%3F&doi=10.1007%2Fs00259-007-0568-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">What can gallium-68 PET add to receptor and molecular imaging?</span></div><div class="casAuthors">Al-Nahhas Adil; Win Zarni; Szyszko Teresa; Singh Aviral; Khan Sameer; Rubello Domenico</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1897-901</span>
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQNwYR8FsSp6-9TkgmBqTqfW6udTcc2ea15mnuHnT2wbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhsFymsg%253D%253D&md5=bb9c22a2e455cae4f80fd000b0ed16f1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00259-007-0568-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-007-0568-1%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Nahhas%26aufirst%3DA.%26aulast%3DWin%26aufirst%3DZ.%26aulast%3DSzyszko%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DRubello%26aufirst%3DD.%26atitle%3DWhat%2520Can%2520Gallium-68%2520PET%2520Add%2520to%2520Receptor%2520and%2520Molecular%2520Imaging%253F%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2007%26volume%3D34%26issue%3D12%26spage%3D1897%26epage%3D1901%26doi%3D10.1007%2Fs00259-007-0568-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Bombesin Antagonist-Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1978</span>, <span class="refDoi"> DOI: 10.2967/jnumed.111.094375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.111.094375" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1970-1978&issue=12&author=K.+Abirajauthor=R.+Mansiauthor=M.-L.+Tammaauthor=M.+Faniauthor=F.+Forrerauthor=G.+Nicolasauthor=R.+Cescatoauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Bombesin+Antagonist-Based+Radioligands+for+Translational+Nuclear+Imaging+of+Gastrin-Releasing+Peptide+Receptor-Positive+Tumors&doi=10.2967%2Fjnumed.111.094375"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.094375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.094375%26sid%3Dliteratum%253Aachs%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DTamma%26aufirst%3DM.-L.%26aulast%3DFani%26aufirst%3DM.%26aulast%3DForrer%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DG.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DBombesin%2520Antagonist-Based%2520Radioligands%2520for%2520Translational%2520Nuclear%2520Imaging%2520of%2520Gastrin-Releasing%2520Peptide%2520Receptor-Positive%2520Tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26issue%3D12%26spage%3D1970%26epage%3D1978%26doi%3D10.2967%2Fjnumed.111.094375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span> <span> </span><span class="NLM_article-title">Reduction in Receptors for Bombesin and Epidermal Growth Factor in Xenografts of Human Small-Cell Lung Cancer after Treatment with Bombesin Antagonist RC-3095</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">956</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.3.956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1073%2Fpnas.94.3.956" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=956-960&issue=3&author=G.+Halmosauthor=A.+V.+Schally&title=Reduction+in+Receptors+for+Bombesin+and+Epidermal+Growth+Factor+in+Xenografts+of+Human+Small-Cell+Lung+Cancer+after+Treatment+with+Bombesin+Antagonist+RC-3095&doi=10.1073%2Fpnas.94.3.956"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.3.956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.3.956%26sid%3Dliteratum%253Aachs%26aulast%3DHalmos%26aufirst%3DG.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DReduction%2520in%2520Receptors%2520for%2520Bombesin%2520and%2520Epidermal%2520Growth%2520Factor%2520in%2520Xenografts%2520of%2520Human%2520Small-Cell%2520Lung%2520Cancer%2520after%2520Treatment%2520with%2520Bombesin%2520Antagonist%2520RC-3095%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D3%26spage%3D956%26epage%3D960%26doi%3D10.1073%2Fpnas.94.3.956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varasteh, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenström, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velikyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosestedt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindeberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sörensen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlova, A.</span></span> <span> </span><span class="NLM_article-title">The Effect of Macrocyclic Chelators on the Targeting Properties of the <sup>68</sup>Ga-Labeled Gastrin Releasing Peptide Receptor Antagonist PEG<sub>2</sub>-RM26</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.nucmedbio.2014.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=25684649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=446-454&issue=5&author=Z.+Varastehauthor=B.+Mitranauthor=U.+Rosenstr%C3%B6mauthor=I.+Velikyanauthor=M.+Rosestedtauthor=G.+Lindebergauthor=J.+S%C3%B6rensenauthor=M.+Larhedauthor=V.+Tolmachevauthor=A.+Orlova&title=The+Effect+of+Macrocyclic+Chelators+on+the+Targeting+Properties+of+the+68Ga-Labeled+Gastrin+Releasing+Peptide+Receptor+Antagonist+PEG2-RM26&doi=10.1016%2Fj.nucmedbio.2014.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26</span></div><div class="casAuthors">Varasteh, Zohreh; Mitran, Bogdan; Rosenstroem, Ulrika; Velikyan, Irina; Rosestedt, Maria; Lindeberg, Gunnar; Soerensen, Jens; Larhed, Mats; Tolmachev, Vladimir; Orlova, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-454</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Overexpression of gastrin-releasing peptide receptors (GRPR) has been reported in several cancers.  Bombesin (BN) analogs are short peptides with a high affinity for GRPR.  Different BN analogs were evaluated for radionuclide imaging and therapy of GRPR-expressing tumors.  We have previously investigated an antagonistic analog of BN (D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2, RM26) conjugated to NOTA via a PEG2 spacer (NOTA-PEG2-RM26) labeled with 68Ga, 111In and Al18F. 68Ga-labeled NOTA-PEG2-RM26 showed high tumor-to-organ ratios.  The influence of different macrocyclic chelators (NOTA, NODAGA, DOTA and DOTAGA) on the targeting properties of 68Ga-labeled PEG2-RM26 was studied in vitro and in vivo.  All conjugates were labeled with generator-produced 68Ga with high yields and demonstrated high stability and specific binding to GRPR.  The IC50 values of natGa-X-PEG2-RM26 (X = NOTA, DOTA, NODAGA, DOTAGA) were 2.3 ± 0.2, 3.0 ± 0.3, 2.9 ± 0.3 and 10.0 ± 0.6 nM, resp.  The internalization of the conjugates by PC-3 cells was low.  However, the DOTA-conjugated analog demonstrated a higher internalization rate compared to other analogs.  GRPR-specific uptake was found in receptor-pos. normal tissues and PC-3 xenografts for all conjugates.  The biodistribution of the conjugates was influenced by the choice of the chelator moiety.  Although all radiotracers cleared rapidly from the blood, [68Ga]Ga-NOTA-PEG2-RM26 showed significantly lower uptake in lung, muscle and bone compared to the other analogs.  The uptake in tumors (5.40 ± 1.04 %ID/g at 2 h p.i.) and the tumor-to-organ ratios (25 ± 3, 157 ± 23 and 39 ± 4 for blood, muscle and bone, resp.) were significantly higher for the NOTA-conjugate than the other analogs.  Chelators had a clear influence on the biodistribution and targeting properties of 68Ga-labeled antagonistic BN analogs.  Pos. charged [68Ga]Ga-NOTA-PEG2-RM26 provided a low kidney radioactivity uptake, high affinity, high tumor uptake and high image contrast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8-ZMoClJ4j7Vg90H21EOLACvtfcHk0lj327LwAP1KtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSjtLw%253D&md5=ce275834a01ad4241f3402e64ce68ccb</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DVarasteh%26aufirst%3DZ.%26aulast%3DMitran%26aufirst%3DB.%26aulast%3DRosenstr%25C3%25B6m%26aufirst%3DU.%26aulast%3DVelikyan%26aufirst%3DI.%26aulast%3DRosestedt%26aufirst%3DM.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DJ.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DThe%2520Effect%2520of%2520Macrocyclic%2520Chelators%2520on%2520the%2520Targeting%2520Properties%2520of%2520the%252068Ga-Labeled%2520Gastrin%2520Releasing%2520Peptide%2520Receptor%2520Antagonist%2520PEG2-RM26%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2015%26volume%3D42%26issue%3D5%26spage%3D446%26epage%3D454%26doi%3D10.1016%2Fj.nucmedbio.2014.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varasteh, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velikyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindeberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sörensen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlova, A.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Vivo Evaluation of a <sup>18</sup>F-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e81932</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0081932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1371%2Fjournal.pone.0081932" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e81932&issue=12&author=Z.+Varastehauthor=O.+Abergauthor=I.+Velikyanauthor=G.+Lindebergauthor=J.+S%C3%B6rensenauthor=M.+Larhedauthor=G.+Antoniauthor=M.+Sandstr%C3%B6mauthor=V.+Tolmachevauthor=A.+Orlova&title=In+Vitro+and+in+Vivo+Evaluation+of+a+18F-Labeled+High+Affinity+NOTA+Conjugated+Bombesin+Antagonist+as+a+PET+Ligand+for+GRPR-Targeted+Tumor+Imaging&doi=10.1371%2Fjournal.pone.0081932"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0081932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0081932%26sid%3Dliteratum%253Aachs%26aulast%3DVarasteh%26aufirst%3DZ.%26aulast%3DAberg%26aufirst%3DO.%26aulast%3DVelikyan%26aufirst%3DI.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DJ.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520a%252018F-Labeled%2520High%2520Affinity%2520NOTA%2520Conjugated%2520Bombesin%2520Antagonist%2520as%2520a%2520PET%2520Ligand%2520for%2520GRPR-Targeted%2520Tumor%2520Imaging%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3De81932%26doi%3D10.1371%2Fjournal.pone.0081932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maddalena, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantry, L. E.</span></span> <span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2017</span>– <span class="NLM_lpage">2024</span>, <span class="refDoi"> DOI: 10.2967/jnumed.109.064444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.109.064444" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=2017-2024&issue=12&author=M.+E.+Maddalenaauthor=J.+Foxauthor=J.+Chenauthor=W.+Fengauthor=A.+Cagnoliniauthor=K.+E.+Linderauthor=M.+F.+Tweedleauthor=A.+D.+Nunnauthor=L.+E.+Lantry&title=177Lu-AMBA+Biodistribution%2C+Radiotherapeutic+Efficacy%2C+Imaging%2C+and+Autoradiography+in+Prostate+Cancer+Models+with+Low+GRP-R+Expression&doi=10.2967%2Fjnumed.109.064444"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.109.064444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.109.064444%26sid%3Dliteratum%253Aachs%26aulast%3DMaddalena%26aufirst%3DM.%2BE.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DCagnolini%26aufirst%3DA.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26aulast%3DLantry%26aufirst%3DL.%2BE.%26atitle%3D177Lu-AMBA%2520Biodistribution%252C%2520Radiotherapeutic%2520Efficacy%252C%2520Imaging%252C%2520and%2520Autoradiography%2520in%2520Prostate%2520Cancer%2520Models%2520with%2520Low%2520GRP-R%2520Expression%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26issue%3D12%26spage%3D2017%26epage%3D2024%26doi%3D10.2967%2Fjnumed.109.064444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Retzloff, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figureoa, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sublett, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieckman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rold, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of [<sup>99m</sup>Tc-(CO)<sub>3</sub>-X-Y-bombesin(7-14)NH<sub>2</sub>] Conjugates for Targeting Gastrin-Releasing Peptide Receptors Overexpressed on Breast Carcinoma</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=20150613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVymtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=19-30&issue=1&author=L.+B.+Retzloffauthor=L.+Heinzkeauthor=S.+D.+Figureoaauthor=S.+V.+Sublettauthor=L.+Maauthor=G.+L.+Sieckmanauthor=T.+L.+Roldauthor=I.+Santosauthor=T.+J.+Hoffmanauthor=C.+J.+Smith&title=Evaluation+of+%5B99mTc-%28CO%293-X-Y-bombesin%287-14%29NH2%5D+Conjugates+for+Targeting+Gastrin-Releasing+Peptide+Receptors+Overexpressed+on+Breast+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of [99mTc-(CO)3-X-Y-bombesin(7-14)NH2] conjugates for targeting gastrin-releasing peptide receptors overexpressed on breast carcinoma</span></div><div class="casAuthors">Retzloff, Lauren B.; Heinzke, Laura; Figureoa, Said D.; Sublett, Samantha V.; Ma, Lixin; Sieckman, Gary L.; Rold, Tammy L.; Santos, Isabel; Hoffman, Timothy J.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-30</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Gastrin-releasing peptide (GRP) receptors are overexpressed on a variety of human carcinomas, including those of the breast.  These receptors may be targeted with bombesin (BBN), which binds to GRP receptors with high affinity and specificity.  The aim of this study was to develop a 99mTc(I)-BBN analog with favorable pharmacokinetic properties in order to improve the visualization of breast cancer tissue.  Materials and Methods: Solid-phase peptide synthesis was used to produce a series of X-Y-BBN-NH2 conjugates, where X is pyrazolyl (PZ1) or 2,3-diaminopropionic acid (DPR) and Y is a spacer sequence.  Their metalated counterparts were prepd. by reacting [99mTc-(H2O)3(CO)3]+ with the corresponding ligand.  Results: While the PZ1 conjugates exhibited higher GRP receptor binding affinities in vitro, the DPR analogs demonstrated superior target tissue accumulation and pharmacokinetic properties in vivo.  Conclusion: These results demonstrate the ability of the DPR derivs. (Y=glycylserylglycine, triserine) to clearly identify the T47-D tumor tissue in xenografted SCID mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ04fN5ANys7Vg90H21EOLACvtfcHk0ljC1vMDdxt4bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVymtb8%253D&md5=5bc920cde43e8b31afe1e730e402c3f0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRetzloff%26aufirst%3DL.%2BB.%26aulast%3DHeinzke%26aufirst%3DL.%26aulast%3DFigureoa%26aufirst%3DS.%2BD.%26aulast%3DSublett%26aufirst%3DS.%2BV.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DRold%26aufirst%3DT.%2BL.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520%255B99mTc-%2528CO%25293-X-Y-bombesin%25287-14%2529NH2%255D%2520Conjugates%2520for%2520Targeting%2520Gastrin-Releasing%2520Peptide%2520Receptors%2520Overexpressed%2520on%2520Breast%2520Carcinoma%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26issue%3D1%26spage%3D19%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giacchetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauvillé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Crémoux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abita, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuttitta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, F.</span></span> <span> </span><span class="NLM_article-title">Characterization, in Some Human Breast Cancer Cell Lines, of Gastrin-Releasing Peptide-like Receptors Which Are Absent in Normal Breast Epithelial Cells</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910460226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1002%2Fijc.2910460226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=2166713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADyaK3MXhtF2ntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=293-298&issue=2&author=S.+Giacchettiauthor=C.+Gauvill%C3%A9author=P.+de+Cr%C3%A9mouxauthor=L.+Bertinauthor=P.+Berthonauthor=J.+P.+Abitaauthor=F.+Cuttittaauthor=F.+Calvo&title=Characterization%2C+in+Some+Human+Breast+Cancer+Cell+Lines%2C+of+Gastrin-Releasing+Peptide-like+Receptors+Which+Are+Absent+in+Normal+Breast+Epithelial+Cells&doi=10.1002%2Fijc.2910460226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells</span></div><div class="casAuthors">Giacchetti, Sylvie; Gauville, Christiane; De Cremoux, Patricia; Bertin, Laurent; Berthon, Philippe; Abita, Jean Pierre; Cuttitta, Franck; Calvo, Fabien</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-8</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The binding of 125I-Tyr4 bombesin was investigated on plasma membranes of 8 human breast cancer cell lines and 2 long-term cultures of normal human breast epithelial cells.  Scatchard plots were compatible with high-affinity, single-site class of receptors in 3 cell lines (KD of 0.75 × 10-9 and 10-9M, Bmax of 0.75 × 10-13 and 9.7 × 10-13M/mg protein in MDA-MB231 and in T47D cells, resp.) while no binding was obsd. in 5 other cell lines and normal epithelial cells.  The neuropeptide and its structural analogs (natural or synthetic) inhibited the binding of 125I-Tyr4 bombesin in the following order of potency: gastrin-releasing peptide (GRP, EC50 = 1.7 × 10-10M) > BIM 26159 > bombesin, Tyr4 bombesin > BIM 26147 > litorin > neuromedin C.  In contrast, 125I-Tyr4 bombesin binding was not displaced by neuromedin B, somatostatin, bradykinin and insulin.  In agreement with the binding data, SDS-PAGE of the complex 125I-Tyr4 bombesin-receptor covalently linked by ethylene glycol-bissuccinimidyl succinate (EGS) identified after autoradiog. a single band with a mol. wt. of 75,000, which disappeared in the presence of bombesin in excess.  No transcription of either GRP or neuromedin B mRNA could be shown in tumor or normal cells.  Exogenous gastrin-releasing peptide had no effect on growth of the cell lines when a serum-free medium was used, implicating that in breast cancer cell lines this receptor does not mediate growth but has a functional role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXyOvTjAow8bVg90H21EOLACvtfcHk0ljC1vMDdxt4bQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtF2ntLk%253D&md5=e08a59fc54abedd6f0d054f50a1a6134</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910460226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910460226%26sid%3Dliteratum%253Aachs%26aulast%3DGiacchetti%26aufirst%3DS.%26aulast%3DGauvill%25C3%25A9%26aufirst%3DC.%26aulast%3Dde%2BCr%25C3%25A9moux%26aufirst%3DP.%26aulast%3DBertin%26aufirst%3DL.%26aulast%3DBerthon%26aufirst%3DP.%26aulast%3DAbita%26aufirst%3DJ.%2BP.%26aulast%3DCuttitta%26aufirst%3DF.%26aulast%3DCalvo%26aufirst%3DF.%26atitle%3DCharacterization%252C%2520in%2520Some%2520Human%2520Breast%2520Cancer%2520Cell%2520Lines%252C%2520of%2520Gastrin-Releasing%2520Peptide-like%2520Receptors%2520Which%2520Are%2520Absent%2520in%2520Normal%2520Breast%2520Epithelial%2520Cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1990%26volume%3D46%26issue%3D2%26spage%3D293%26epage%3D298%26doi%3D10.1002%2Fijc.2910460226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liolios, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragogeorgi, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zikos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loudos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xanthopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouziotis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paravatou-Petsotas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livaniou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varvarigou, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivolapenko, G. B.</span></span> <span> </span><span class="NLM_article-title">Structural Modifications of <sup>99m</sup>Tc-Labelled Bombesin-like Peptides for Optimizing Pharmacokinetics in Prostate Tumor Targeting</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2012.02.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.ijpharm.2012.02.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=22459664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFWqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2012&pages=1-2&author=C.+C.+Lioliosauthor=E.+A.+Fragogeorgiauthor=C.+Zikosauthor=G.+Loudosauthor=S.+Xanthopoulosauthor=P.+Bouziotisauthor=M.+Paravatou-Petsotasauthor=E.+Livaniouauthor=A.+D.+Varvarigouauthor=G.+B.+Sivolapenko&title=Structural+Modifications+of+99mTc-Labelled+Bombesin-like+Peptides+for+Optimizing+Pharmacokinetics+in+Prostate+Tumor+Targeting&doi=10.1016%2Fj.ijpharm.2012.02.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural modifications of 99mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting</span></div><div class="casAuthors">Liolios, Christos C.; Fragogeorgi, Eirini A.; Zikos, Christos; Loudos, George; Xanthopoulos, Stavros; Bouziotis, Penelope; Paravatou-Petsotas, Maria; Livaniou, Evangelia; Varvarigou, Alexandra D.; Sivolapenko, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The main goal of the present study was to investigate the importance of the addn. of a pos. charged aa in the naturally occurring Bombesin (BN) peptide for its utilization as radiodiagnostic agent, taking into consideration the biodistribution profile, the pharmacokinetic characteristics and the tumor targeting ability.  Two BN-derivs. of the general structure [M-chelator]-(spacer)-BN(2-14)-NH2, where M: 99mTc or 185/187Re, chelator: Gly-Gly-Cys-, spacer: -(arginine)3-, M-BN-A; spacer: -(ornithine)3-, M-BN-O; have been prepd. and evaluated as tumor imaging agents.  The peptides under study presented high radiolabelling efficiency (>98%), significant stability in human plasma (>60% intact radiolabeled peptide after 1 h incubation) and comparable receptor binding affinity with the std. [125I-Tyr4]-BN.  Their internalization rates in the prostate cancer PC-3 cells differed, although the amt. of internalized peptide was the same.  The biodistribution and the dynamic γ-camera imaging studies in normal and PC-3 tumor-bearing SCID mice have shown significant tumor uptake, combined with fast blood clearance, through the urinary pathway.The addn. of the charged aa spacer in the BN structure was advantageous for biodistribution, pharmacokinetics and tumor targeting ability, because it reduced the upper abdominal radioactivity levels and increased tumor/normal tissue contrast ratios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0bZwfN573mbVg90H21EOLACvtfcHk0lg7QutVSmtFTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFWqsbc%253D&md5=b3e112a75bdb54a8cf2ac820e9a103f2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.02.049%26sid%3Dliteratum%253Aachs%26aulast%3DLiolios%26aufirst%3DC.%2BC.%26aulast%3DFragogeorgi%26aufirst%3DE.%2BA.%26aulast%3DZikos%26aufirst%3DC.%26aulast%3DLoudos%26aufirst%3DG.%26aulast%3DXanthopoulos%26aufirst%3DS.%26aulast%3DBouziotis%26aufirst%3DP.%26aulast%3DParavatou-Petsotas%26aufirst%3DM.%26aulast%3DLivaniou%26aufirst%3DE.%26aulast%3DVarvarigou%26aufirst%3DA.%2BD.%26aulast%3DSivolapenko%26aufirst%3DG.%2BB.%26atitle%3DStructural%2520Modifications%2520of%252099mTc-Labelled%2520Bombesin-like%2520Peptides%2520for%2520Optimizing%2520Pharmacokinetics%2520in%2520Prostate%2520Tumor%2520Targeting%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D430%26spage%3D1%26epage%3D2%26doi%3D10.1016%2Fj.ijpharm.2012.02.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zöller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzku, S.</span></span> <span> </span><span class="NLM_article-title">Establishment and Characterization of Monoclonal Antibodies against an Octahedral Gallium Chelate Suitable for Immunoscintigraphy with PET</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1366</span>– <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1992&pages=1366-1372&issue=7&author=M.+Zollerauthor=J.+Schuhmacherauthor=J.+Reedauthor=W.+Maier-Borstauthor=S.+Matzkuauthor=M.+Z%C3%B6llerauthor=J.+Schuhmacherauthor=J.+Reedauthor=W.+Maier-Borstauthor=S.+Matzku&title=Establishment+and+Characterization+of+Monoclonal+Antibodies+against+an+Octahedral+Gallium+Chelate+Suitable+for+Immunoscintigraphy+with+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZoller%26aufirst%3DM.%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DMaier-Borst%26aufirst%3DW.%26aulast%3DMatzku%26aufirst%3DS.%26aulast%3DZ%25C3%25B6ller%26aufirst%3DM.%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DMaier-Borst%26aufirst%3DW.%26aulast%3DMatzku%26aufirst%3DS.%26atitle%3DEstablishment%2520and%2520Characterization%2520of%2520Monoclonal%2520Antibodies%2520against%2520an%2520Octahedral%2520Gallium%2520Chelate%2520Suitable%2520for%2520Immunoscintigraphy%2520with%2520PET%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1992%26volume%3D33%26issue%3D7%26spage%3D1366%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span> <span> </span><span class="NLM_article-title">A New <sup>68</sup>Ge/<sup>68</sup>Ga Radioisotope Generator System for Production of <sup>68</sup>Ga in Dilute HCl</span>. <i>Int. J. Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/0020-708X(81)90174-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2F0020-708X%2881%2990174-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADyaL3MXntleitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1981&pages=31-36&issue=1&author=J.+Schuhmacherauthor=W.+Maier-Borst&title=A+New+68Ge%2F68Ga+Radioisotope+Generator+System+for+Production+of+68Ga+in+Dilute+HCl&doi=10.1016%2F0020-708X%2881%2990174-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new germanium-68/gallium-68 radioisotope generator system for production of gallium-68 in dilute hydrochloric acid</span></div><div class="casAuthors">Schuhmacher, J.; Maier-Borst, W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-6</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">The synthesis of an ion-exchanger resin produced from pyrogallol and formaldehyde and characterized by a highly efficient adsorption for 68Ge/68Ga radioisotope generator prepd. from this resin and operated with 10 mL of 4.5 N HCl as eluant constantly showed a high yield of 68Ga during a time period of more than 200 days with a contamination of <1 ppm 68Ge.  A small column, filled with com. available anion-exchanger resin and coupled in series with the generator, reduces the vol. and HCl concn. of the generator eluate in such a way that 80% of the available 68Ga appears in 4 mL 0.5 N HCl.  The eluate is free of radiolytic products and suitable for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRhjxbEUU3YbVg90H21EOLACvtfcHk0lg7QutVSmtFTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXntleitA%253D%253D&md5=856d9f944e43949f3a2f51a0f18ce5a8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2881%2990174-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252881%252990174-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DMaier-Borst%26aufirst%3DW.%26atitle%3DA%2520New%252068Ge%252F68Ga%2520Radioisotope%2520Generator%2520System%2520for%2520Production%2520of%252068Ga%2520in%2520Dilute%2520HCl%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1981%26volume%3D32%26issue%3D1%26spage%3D31%26epage%3D36%26doi%3D10.1016%2F0020-708X%2881%2990174-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder-Wüst, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hull, W.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wängler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span> <span> </span><span class="NLM_article-title"><sup>68</sup>Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1021/bc200279b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200279b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=688-697&issue=4&author=M.+Ederauthor=M.+Sch%C3%A4ferauthor=U.+Bauder-W%C3%BCstauthor=W.-E.+Hullauthor=C.+W%C3%A4nglerauthor=W.+Mierauthor=U.+Haberkornauthor=M.+Eisenhut&title=68Ga-Complex+Lipophilicity+and+the+Targeting+Property+of+a+Urea-Based+PSMA+Inhibitor+for+PET+Imaging&doi=10.1021%2Fbc200279b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span></div><div class="casAuthors">Eder, Matthias; Schaefer, Martin; Bauder-Wuest, Ulrike; Hull, William-Edmund; Waengler, Carmen; Mier, Walter; Haberkorn, Uwe; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">688-697</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors of the prostate-specific membrane antigen (PSMA) represent low-mol.-wt. pepidomimetics showing the ability to image PSMA-expressing prostate tumors.  The highly efficient, acyclic Ga(III) chelator N,N'-bis [2-hydroxy-5-(carboxyethyl)benzyl] ethylenediamine-N,N'- diacetic acid (HBED-CC) was introduced as a lipophilic side chain into the hydrophilic pharmacophore Glu-NH-CO-NH-Lys which was found favorable to interact with the PSMA "active binding site".  This report describes the syntheses, in vitro binding analyses, and biodistribution data of the radiogallium labeled PSMA inhibitor Glu-NH-CO-NH-Lys(Ahx)-HBED-CC in comparison to the corresponding DOTA conjugate.  The binding properties were analyzed using competitive cell binding and enzyme-based assays followed by internalization expts.  Compared to the DOTA-conjugate, the HBED-CC deriv. showed reduced unspecific binding and considerable higher specific internalization in LNCaP cells.  The 68Ga complex of the HBED-CC ligand exhibited higher specificity for PSMA expressing tumor cells resulting in improved in vivo properties. 68Ga labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC showed fast blood and organ clearances, low liver accumulation, and high specific uptake in PSMA expressing organs and tumor.  It could be demonstrated that the PET-imaging property of a urea-based PSMA inhibitor could significantly be improved with HBED-CC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XoCnl_RguLVg90H21EOLACvtfcHk0lh9mqluI5tVIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D&md5=4bb4cbba9f510ed2561b87a44bafa00a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbc200279b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200279b%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DBauder-W%25C3%25BCst%26aufirst%3DU.%26aulast%3DHull%26aufirst%3DW.-E.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3D68Ga-Complex%2520Lipophilicity%2520and%2520the%2520Targeting%2520Property%2520of%2520a%2520Urea-Based%2520PSMA%2520Inhibitor%2520for%2520PET%2520Imaging%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26issue%3D4%26spage%3D688%26epage%3D697%26doi%3D10.1021%2Fbc200279b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Paweł Kręcisz, Kamila Czarnecka, Leszek Królicki, Elżbieta Mikiciuk-Olasik, <span class="NLM_string-name hlFld-ContribAuthor">Paweł Szymański</span>. </span><span class="cited-content_cbyCitation_article-title">Radiolabeled Peptides and Antibodies in Medicine. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (1)
                                     , 25-42. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00617" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00617%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DRadiolabeled%252BPeptides%252Band%252BAntibodies%252Bin%252BMedicine%26aulast%3DKr%25C4%2599cisz%26aufirst%3DPawe%25C5%2582%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11112020%26date%3D02122020%26date%3D16122020%26volume%3D32%26issue%3D1%26spage%3D25%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Stefanie Dobitz, Patrick Wilhelm, Nina Romantini, Martina De Foresta, Cornelia Walther, Andreas Ritler, Roger Schibli, Philipp Berger, Xavier Deupi, Martin Béhé, <span class="NLM_string-name hlFld-ContribAuthor">Helma Wennemers</span>. </span><span class="cited-content_cbyCitation_article-title">Distance-Dependent Cellular Uptake of Oligoproline-Based Homobivalent Ligands Targeting GPCRs—An Experimental and Computational Analysis. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2020,</strong> <em>31 </em>
                                    (10)
                                     , 2431-2438. <a href="https://doi.org/10.1021/acs.bioconjchem.0c00484" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.0c00484</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.0c00484&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.0c00484%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DDistance-Dependent%252BCellular%252BUptake%252Bof%252BOligoproline-Based%252BHomobivalent%252BLigands%252BTargeting%252BGPCRs%2525E2%252580%252594An%252BExperimental%252Band%252BComputational%252BAnalysis%26aulast%3DDobitz%26aufirst%3DStefanie%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D28082020%26date%3D22092020%26date%3D13102020%26volume%3D31%26issue%3D10%26spage%3D2431%26epage%3D2438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc  Pretze</span>, <span class="hlFld-ContribAuthor ">Laura  Reffert</span>, <span class="hlFld-ContribAuthor ">Steffen  Diehl</span>, <span class="hlFld-ContribAuthor ">Stefan O.  Schönberg</span>, <span class="hlFld-ContribAuthor ">Carmen  Wängler</span>, <span class="hlFld-ContribAuthor ">Peter  Hohenberger</span>, <span class="hlFld-ContribAuthor ">Björn  Wängler</span>. </span><span class="cited-content_cbyCitation_article-title">GMP-compliant production of [68Ga]Ga-NeoB for positron emission tomography imaging of patients with gastrointestinal stromal tumor. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-021-00137-w" title="DOI URL">https://doi.org/10.1186/s41181-021-00137-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-021-00137-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-021-00137-w%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DGMP-compliant%252Bproduction%252Bof%252B%25255B68Ga%25255DGa-NeoB%252Bfor%252Bpositron%252Bemission%252Btomography%252Bimaging%252Bof%252Bpatients%252Bwith%252Bgastrointestinal%252Bstromal%252Btumor%26aulast%3DPretze%26aufirst%3DMarc%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karel D.  Klika</span>, <span class="hlFld-ContribAuthor ">Chiara  Da Pieve</span>, <span class="hlFld-ContribAuthor ">Klaus  Kopka</span>, <span class="hlFld-ContribAuthor ">Graham  Smith</span>, <span class="hlFld-ContribAuthor ">Ata  Makarem</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and application of a thiol-reactive HBED-type chelator for development of easy-to-produce Ga-radiopharmaceutical kits and imaging probes. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2021,</strong> <em>19 </em>
                                    (8)
                                     , 1722-1726. <a href="https://doi.org/10.1039/D0OB02513E" title="DOI URL">https://doi.org/10.1039/D0OB02513E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0OB02513E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0OB02513E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSynthesis%252Band%252Bapplication%252Bof%252Ba%252Bthiol-reactive%252BHBED-type%252Bchelator%252Bfor%252Bdevelopment%252Bof%252Beasy-to-produce%252BGa-radiopharmaceutical%252Bkits%252Band%252Bimaging%252Bprobes%26aulast%3DKlika%26aufirst%3DKarel%2BD.%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D8%26spage%3D1722%26epage%3D1726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos  Liolios</span>, <span class="hlFld-ContribAuthor ">Christos  Sachpekidis</span>, <span class="hlFld-ContribAuthor ">Antonios  Kolocouris</span>, <span class="hlFld-ContribAuthor ">Antonia  Dimitrakopoulou-Strauss</span>, <span class="hlFld-ContribAuthor ">Penelope  Bouziotis</span>. </span><span class="cited-content_cbyCitation_article-title">PET Diagnostic Molecules Utilizing Multimeric Cyclic RGD Peptide Analogs for Imaging Integrin αvβ3 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (6)
                                     , 1792. <a href="https://doi.org/10.3390/molecules26061792" title="DOI URL">https://doi.org/10.3390/molecules26061792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26061792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26061792%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPET%252BDiagnostic%252BMolecules%252BUtilizing%252BMultimeric%252BCyclic%252BRGD%252BPeptide%252BAnalogs%252Bfor%252BImaging%252BIntegrin%252B%2525CE%2525B1v%2525CE%2525B23%252BReceptors%26aulast%3DLiolios%26aufirst%3DChristos%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D6%26spage%3D1792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hang  Xu</span>, <span class="hlFld-ContribAuthor ">Gang  Sheng</span>, <span class="hlFld-ContribAuthor ">Lu  Lu</span>, <span class="hlFld-ContribAuthor ">Cuirong  Wang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Lili  Feng</span>, <span class="hlFld-ContribAuthor ">Lingtong  Meng</span>, <span class="hlFld-ContribAuthor ">Pengxiang  Min</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yijun  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Han</span>. </span><span class="cited-content_cbyCitation_article-title">GRPr-mediated photothermal and thermodynamic dual-therapy for prostate cancer with synergistic anti-apoptosis mechanism. </span><span class="cited-content_cbyCitation_journal-name">Nanoscale</span><span> <strong>2021,</strong> <em>13 </em>
                                    (7)
                                     , 4249-4261. <a href="https://doi.org/10.1039/D0NR07196J" title="DOI URL">https://doi.org/10.1039/D0NR07196J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0NR07196J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0NR07196J%26sid%3Dliteratum%253Aachs%26jtitle%3DNanoscale%26atitle%3DGRPr-mediated%252Bphotothermal%252Band%252Bthermodynamic%252Bdual-therapy%252Bfor%252Bprostate%252Bcancer%252Bwith%252Bsynergistic%252Banti-apoptosis%252Bmechanism%26aulast%3DXu%26aufirst%3DHang%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D7%26spage%3D4249%26epage%3D4261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Li</span>, <span class="hlFld-ContribAuthor ">Huawei  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaoai  Wu</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Haoxing  Wu</span>, <span class="hlFld-ContribAuthor ">Rong  Tian</span>. </span><span class="cited-content_cbyCitation_article-title">New Frontiers in Molecular Imaging Using Peptide-Based Radiopharmaceuticals for Prostate Cancer. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.583309" title="DOI URL">https://doi.org/10.3389/fchem.2020.583309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.583309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.583309%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DNew%252BFrontiers%252Bin%252BMolecular%252BImaging%252BUsing%252BPeptide-Based%252BRadiopharmaceuticals%252Bfor%252BProstate%252BCancer%26aulast%3DLi%26aufirst%3DXin%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Ferguson</span>, <span class="hlFld-ContribAuthor ">Melinda  Wuest</span>, <span class="hlFld-ContribAuthor ">Susan  Richter</span>, <span class="hlFld-ContribAuthor ">Cody  Bergman</span>, <span class="hlFld-ContribAuthor ">Jennifer  Dufour</span>, <span class="hlFld-ContribAuthor ">Daniel  Krys</span>, <span class="hlFld-ContribAuthor ">Jennifer  Simone</span>, <span class="hlFld-ContribAuthor ">Hans-Sonke  Jans</span>, <span class="hlFld-ContribAuthor ">Terence  Riauka</span>, <span class="hlFld-ContribAuthor ">Frank  Wuest</span>. </span><span class="cited-content_cbyCitation_article-title">A comparative PET imaging study of 44gSc- and 68Ga-labeled bombesin antagonist BBN2 derivatives in breast and prostate cancer models. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2020,</strong> <em>90-91 </em>, 74-83. <a href="https://doi.org/10.1016/j.nucmedbio.2020.10.005" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DA%252Bcomparative%252BPET%252Bimaging%252Bstudy%252Bof%252B44gSc-%252Band%252B68Ga-labeled%252Bbombesin%252Bantagonist%252BBBN2%252Bderivatives%252Bin%252Bbreast%252Band%252Bprostate%252Bcancer%252Bmodels%26aulast%3DFerguson%26aufirst%3DSimon%26date%3D2020%26volume%3D90-91%26spage%3D74%26epage%3D83" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benedikt  Judmann</span>, <span class="hlFld-ContribAuthor ">Diana  Braun</span>, <span class="hlFld-ContribAuthor ">Björn  Wängler</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Gert  Fricker</span>, <span class="hlFld-ContribAuthor ">Carmen  Wängler</span>. </span><span class="cited-content_cbyCitation_article-title">Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (8)
                                     , 173. <a href="https://doi.org/10.3390/ph13080173" title="DOI URL">https://doi.org/10.3390/ph13080173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13080173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13080173%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DCurrent%252BState%252Bof%252BRadiolabeled%252BHeterobivalent%252BPeptidic%252BLigands%252Bin%252BTumor%252BImaging%252Band%252BTherapy%26aulast%3DJudmann%26aufirst%3DBenedikt%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D8%26spage%3D173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos  Liolios</span>, <span class="hlFld-ContribAuthor ">Antonio  Shegani</span>, <span class="hlFld-ContribAuthor ">Ioanna  Roupa</span>, <span class="hlFld-ContribAuthor ">Christos  Kiritsis</span>, <span class="hlFld-ContribAuthor ">Ata  Makarem</span>, <span class="hlFld-ContribAuthor ">Maria  Paravatou-Petsotas</span>, <span class="hlFld-ContribAuthor ">Maria  Pelecanou</span>, <span class="hlFld-ContribAuthor ">Penelope  Bouziotis</span>, <span class="hlFld-ContribAuthor ">Minas  Papadopoulos</span>, <span class="hlFld-ContribAuthor ">Klaus  Kopka</span>, <span class="hlFld-ContribAuthor ">Ioannis  Pirmettis</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, characterization and evaluation of 68Ga labelled monomeric and dimeric quinazoline derivatives of the HBED-CC chelator targeting the epidermal growth factor receptor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>100 </em>, 103855. <a href="https://doi.org/10.1016/j.bioorg.2020.103855" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103855</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103855%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bcharacterization%252Band%252Bevaluation%252Bof%252B68Ga%252Blabelled%252Bmonomeric%252Band%252Bdimeric%252Bquinazoline%252Bderivatives%252Bof%252Bthe%252BHBED-CC%252Bchelator%252Btargeting%252Bthe%252Bepidermal%252Bgrowth%252Bfactor%252Breceptor%26aulast%3DLiolios%26aufirst%3DChristos%26date%3D2020%26volume%3D100%26spage%3D103855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Drishty  Satpati</span>, <span class="hlFld-ContribAuthor ">Kusum  Vats</span>, <span class="hlFld-ContribAuthor ">Rohit  Sharma</span>, <span class="hlFld-ContribAuthor ">Mythili  Kameswaran</span>, <span class="hlFld-ContribAuthor ">Haladhar Dev  Sarma</span>, <span class="hlFld-ContribAuthor ">Ashutosh  Dash</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, radiolabeling, and evaluation of gastrin releasing peptide receptor antagonist
              68
              Ga-HBED-CC-RM26. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 843-849. <a href="https://doi.org/10.1002/jlcr.3795" title="DOI URL">https://doi.org/10.1002/jlcr.3795</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3795&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3795%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DSynthesis%25252C%252Bradiolabeling%25252C%252Band%252Bevaluation%252Bof%252Bgastrin%252Breleasing%252Bpeptide%252Breceptor%252Bantagonist%252B68%252BGa-HBED-CC-RM26%26aulast%3DSatpati%26aufirst%3DDrishty%26date%3D2019%26date%3D2019%26volume%3D62%26issue%3D12%26spage%3D843%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christos  Liolios</span>, <span class="hlFld-ContribAuthor ">Christos  Sachpekidis</span>, <span class="hlFld-ContribAuthor ">Martin  Schäfer</span>, <span class="hlFld-ContribAuthor ">Klaus  Kopka</span>. </span><span class="cited-content_cbyCitation_article-title">Bispecific radioligands targeting prostate-specific membrane antigen and gastrin-releasing peptide receptors on the surface of prostate cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 510-522. <a href="https://doi.org/10.1002/jlcr.3749" title="DOI URL">https://doi.org/10.1002/jlcr.3749</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3749%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DBispecific%252Bradioligands%252Btargeting%252Bprostate-specific%252Bmembrane%252Bantigen%252Band%252Bgastrin-releasing%252Bpeptide%252Breceptors%252Bon%252Bthe%252Bsurface%252Bof%252Bprostate%252Bcancer%252Bcells%26aulast%3DLiolios%26aufirst%3DChristos%26date%3D2019%26date%3D2019%26volume%3D62%26issue%3D8%26spage%3D510%26epage%3D522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Fernández-Barahona</span>, <span class="hlFld-ContribAuthor ">María  Muñoz-Hernando</span>, <span class="hlFld-ContribAuthor ">Juan  Pellico</span>, <span class="hlFld-ContribAuthor ">Jesús  Ruiz-Cabello</span>, <span class="hlFld-ContribAuthor ">Fernando  Herranz</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging with 68Ga Radio-Nanomaterials: Shedding Light on Nanoparticles. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2018,</strong> <em>8 </em>
                                    (7)
                                     , 1098. <a href="https://doi.org/10.3390/app8071098" title="DOI URL">https://doi.org/10.3390/app8071098</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app8071098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp8071098%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DMolecular%252BImaging%252Bwith%252B68Ga%252BRadio-Nanomaterials%25253A%252BShedding%252BLight%252Bon%252BNanoparticles%26aulast%3DFern%25C3%25A1ndez-Barahona%26aufirst%3DIrene%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D7%26spage%3D1098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0008.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of GRPr Agonists and Antagonists Coupled with the Chelator HBED-CC<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) FeCl<sub>3</sub>, 1.2 equiv, 5% DIPEA, MeOH/H<sub>2</sub>O 1/1, v/v; (b) TFP (2,3,5,6-tetrafluorophenol), 10 equiv, 0.19 mmol, 311 mg, DIC, 4 equiv, 0.08 mmol, 118 μL, in DMF (1.0 mL), rt, 1 day; (c) pharmacophore (i–iii) 1.2 equiv 6.6 μmol, (i) 10.7 mg, (ii) 8.5 mg, and (iii) 8.3 mg; (d) pharmacophore (iv), 4 equiv, 13.0 mg, 8.5 μmol, excess DIPEA, in DMF (1.0 mL), rt, 1 day; where (i) H<sub>2</sub>N-BN(2–14); (ii) H<sub>2</sub>N-PEG<sub>2</sub>-[<span class="smallcaps smallerCapital">d</span>-Tyr<sup>6</sup>,β-Ala<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BN(6–14); (iii) H<sub>2</sub>N–Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14); (iv) H<sub>2</sub>N-PEG<sub>2</sub>-Y-[<span class="smallcaps smallerCapital">d</span>-Phe<sup>6</sup>,Sta<sup>13</sup>,Leu<sup>14</sup>]-BN(6–14) and Y = 4-amino-1-carboxymethylpiperidine; (e) [<sup>68</sup>Ga]GaCl<sub>3</sub>, 40 μL (80–100 MBq), <b>1–4</b> (0.3–1.0 nmol) in 0.1 M HEPES buffer (pH = 7.5, 100 μL), 10 μL of HEPES solution (2.1 M). pH 4.2, 98 °C, 10 min.</p></p></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. The γ-trace of the comparative RP-radio-HPLC analysis after labeling with <sup>68</sup>Ga is presented with the <i>t</i><sub>R</sub> (min) noted at the top of each peak. Radiochemical purity was above 98% in all cases. RP-HPLC analysis was performed on a Chromolith RP-18e (100 mm × 4.6 mm; Merck, Darmstadt, Germany), using a linear A–B gradient (0% B to 100% B in 5 min), flow of 4 mL/min, A consisting of 0.1% aqueous TFA, and B consisting of 0.1% TFA in CH<sub>3</sub>CN.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0001.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Surface, internalized, and total cell bound ligands [<sup>68</sup>Ga]<b>1</b>, [<sup>68</sup>Ga]<b>2</b>, [<sup>68</sup>Ga]<b>3</b>, and [<sup>68</sup>Ga]<b>4</b> expressed as cpm at 37 °C (45 min incubation time) in PC-3 (a) and T47D (b) cells. The values at the top of the bars represent the percentage of the total cell related activity that was surface bound or internalized. Statistical results are expressed as asterisks at the top of the bars (one way nonparametric ANOVA, <i>P</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Total cell related [<sup>68</sup>Ga]<b>i</b> agonists (<b>i</b> = <b>1</b>, <b>2</b>) and antagonists and (<b>i</b> = <b>3</b>, <b>4</b>) in PC-3 (a) and T47D (b) cells. The results are presented as specifically bound radioactivity (cpm) of <sup>68</sup>Ga-labeled compounds (30 nM in 2 × 10<sup>5</sup> PC-3 or T47D cells/well seeded 24 h before the experiment). As reference [<sup>68</sup>Ga]RM2 was included in the assay. Asterisks at the top of the bars represent the statistically significant differences against [<sup>68</sup>Ga]RM2 (ANOVA, one way nonparametric, <i>P</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Total cell-bound radioactivity over time of (a) [<sup>68</sup>Ga]<b>4</b> (antagonist) in PC-3 and PC-3 blocked, [<sup>68</sup>Ga]<b>3</b> (antagonist) in PC-3 and PC-3 blocked, T47D, LNCaP, and MDA-MB-231 cells and (b) [<sup>68</sup>Ga]<b>1</b> in PC-3, PC-3 blocked and [<sup>68</sup>Ga]<b>2</b> (agonists) in PC-3, PC-3 blocked and LNCaP cells. Results are expressed as % of the total activity added in 10<sup>5</sup> cells. The GRPr positive cell lines (PC-3, T47D) are presented with solid lines, while the GRPr negative cell lines (LNCaP and MBA-MB-231) and blocking experiments are presented with dashed lines. Blocking experiments were conducted with an addition of 1000-fold excess of the corresponding bombesin pharmacophore.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Comparative biodistribution studies of [<sup>68</sup>Ga]<b>i</b> (<b>i</b> =<b>1</b>−<b>4</b>) and [<sup>68</sup>Ga]RM2 (control) at 30 min (top) and 60 min (bottom) p.i. in Balb nu/nu male mice bearing PC-3 tumors. The results are expressed as percentage of the injected dose per g for each organ or tissue (mean %ID/g ± SD, <i>n</i> = 3−4). Asterisk represent statistically significant differences against [<sup>68</sup>Ga]RM2 (ANOVA, one way nonparametric, <i>P</i> < 0.05). (b) Tumor to normal tissue ratios (mean value ± SD) for the two antagonists under study, [<sup>68</sup>Ga]<b>3</b> and [<sup>68</sup>Ga]<b>4</b>, and the reference compound [<sup>68</sup>Ga]RM2 at 30 min (top) and 60 min p.i.(bottom).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Whole-body μPET images of athymic male nu/nu mice bearing PC-3 tumor xenografts (from left to right, MIP 20–40 min, MIP 120–140 min, and MIP 120–140 min blocked) after iv administration of (a) [<sup>68</sup>Ga]<b>3</b> (100 pmol, 35–45 MBq) and (b) [<sup>68</sup>Ga]<b>4</b> (100 pmol, 35–45 MBq), where T = tumor; K = kidneys, B = bladder, as indicated with arrows.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/medium/jm-2017-018569_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Time–activity curves expressed as SUVs around the tumor (<b>■</b>), muscle (●), heart (▲), liver (▼) for (a) [<sup>68</sup>Ga]<b>3</b> (100 pmol, 35–45 MBq) and (b) [<sup>68</sup>Ga]<b>4</b> (100 pmol, 35–45 MBq) at 0–60 min p.i. (c) Area under the curve (AUC<sub>0–57min</sub>) for [<sup>68</sup>Ga]<b>3</b> (left) and [<sup>68</sup>Ga]<b>4</b> (right) for selected organs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-5/acs.jmedchem.7b01856/20180302/images/large/jm-2017-018569_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b01856&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i28">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73856" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73856" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 39 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sancho, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Florio, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, R. T.</span></span> <span> </span><span class="NLM_article-title">Bombesin Receptor-Mediated Imaging and Cytotoxicity: Review and Current Status</span>. <i>Curr. Drug Delivery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">134</span>, <span class="refDoi"> DOI: 10.2174/156720111793663624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2174%2F156720111793663624" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=79-134&issue=1&author=V.+Sanchoauthor=A.+Di+Florioauthor=T.+W.+Moodyauthor=R.+T.+Jensen&title=Bombesin+Receptor-Mediated+Imaging+and+Cytotoxicity%3A+Review+and+Current+Status&doi=10.2174%2F156720111793663624"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F156720111793663624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720111793663624%26sid%3Dliteratum%253Aachs%26aulast%3DSancho%26aufirst%3DV.%26aulast%3DDi%2BFlorio%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DT.%2BW.%26aulast%3DJensen%26aufirst%3DR.%2BT.%26atitle%3DBombesin%2520Receptor-Mediated%2520Imaging%2520and%2520Cytotoxicity%253A%2520Review%2520and%2520Current%2520Status%26jtitle%3DCurr.%2520Drug%2520Delivery%26date%3D2011%26volume%3D8%26issue%3D1%26spage%3D79%26epage%3D134%26doi%3D10.2174%2F156720111793663624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parry, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rogers, B. E.</span></span> <span> </span><span class="NLM_article-title">MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-Releasing Peptide Receptor</span>. <i>Breast Cancer Res. Treat.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>101</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">183</span>, <span class="refDoi"> DOI: 10.1007/s10549-006-9287-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs10549-006-9287-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=16838112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD2sXkslegtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2007&pages=175-183&issue=2&author=J.+J.+Parryauthor=R.+Andrewsauthor=B.+E.+Rogers&title=MicroPET+Imaging+of+Breast+Cancer+Using+Radiolabeled+Bombesin+Analogs+Targeting+the+Gastrin-Releasing+Peptide+Receptor&doi=10.1007%2Fs10549-006-9287-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">MicroPET Imaging of Breast Cancer Using Radiolabeled Bombesin Analogs Targeting the Gastrin-releasing Peptide Receptor</span></div><div class="casAuthors">Parry, Jesse J.; Andrews, Rebecca; Rogers, Buck E.</div><div class="citationInfo"><span class="NLM_cas:title">Breast Cancer Research and Treatment</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">175-183</span>CODEN:
                <span class="NLM_cas:coden">BCTRD6</span>;
        ISSN:<span class="NLM_cas:issn">0167-6806</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mammog. is a well-established method for detecting primary breast cancer; however, it has some limitations that may be overcome using nuclear imaging methods.  Current radiopharmaceuticals have limited sensitivity for detecting small primary lesions and it has been suggested that novel radiopharmaceuticals are necessary for detection of primary breast cancer, as well as for detecting metastases and recurrence, or for monitoring therapy.  The gastrin-releasing peptide receptor (GRPR) is a seven-transmembrane G-protein coupled receptor that is overexpressed on primary breast cancer and lymph node metastases.  Bombesin (BN) is a tetradecapeptide that binds with high affinity to GRPR and can be radiolabeled with the positron-emitter, copper-64 (64Cu) for imaging with positron-emission tomog. (PET).  The goal of this study was to evaluate BN analogs that could be radiolabeled with 64Cu for PET imaging of breast cancer.  A series of BN analogs contg. 4, 5, 6, 8, and 12- carbon linkers were evaluated with regard to their binding and internalization into T-47D human breast cancer cells.  The 64Cu-labeled analogs were then evaluated in mice bearing T-47D xenografts by tissue biodistribution and microPET imaging.  These studies showed that all of the analogs had IC50 values <100 nM and were all internalized into T-47D cells.  Biodistribution studies showed that the BN analog with the 8-carbon linker not only had the highest tumor uptake but also had high normal tissue uptake in the liver.  The analogs contg. the 6- or 8-carbon linkers demonstrated good tumor uptake as detd. by microPET imaging.  Overall, this study shows the feasibility of using positron-labeled BN analogs for PET detection of GRPR-expressing breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq--Ps-3rD4l7Vg90H21EOLACvtfcHk0lhgTp0lKOeVVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXkslegtA%253D%253D&md5=95574f8ac5e6fabb8757c152ee70ccd4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1007%2Fs10549-006-9287-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10549-006-9287-8%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DJ.%2BJ.%26aulast%3DAndrews%26aufirst%3DR.%26aulast%3DRogers%26aufirst%3DB.%2BE.%26atitle%3DMicroPET%2520Imaging%2520of%2520Breast%2520Cancer%2520Using%2520Radiolabeled%2520Bombesin%2520Analogs%2520Targeting%2520the%2520Gastrin-Releasing%2520Peptide%2520Receptor%26jtitle%3DBreast%2520Cancer%2520Res.%2520Treat.%26date%3D2007%26volume%3D101%26issue%3D2%26spage%3D175%26epage%3D183%26doi%3D10.1007%2Fs10549-006-9287-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rybalov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ananias, H. J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoving, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Poel, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, I. J.</span></span> <span> </span><span class="NLM_article-title">PSMA, EpCAM, VEGF and GRPR as Imaging Targets in Locally Recurrent Prostate Cancer after Radiotherapy</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>15</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">6046</span>– <span class="NLM_lpage">6061</span>, <span class="refDoi"> DOI: 10.3390/ijms15046046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.3390%2Fijms15046046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=24727373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlWlur%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=6046-6061&issue=4&author=M.+Rybalovauthor=H.+J.+K.+Ananiasauthor=H.+D.+Hovingauthor=H.+G.+van+der+Poelauthor=S.+Rosatiauthor=I.+J.+de+Jong&title=PSMA%2C+EpCAM%2C+VEGF+and+GRPR+as+Imaging+Targets+in+Locally+Recurrent+Prostate+Cancer+after+Radiotherapy&doi=10.3390%2Fijms15046046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">PSMA, EpCAM, VEGF and GRPR as Imaging targets in locally recurrent prostate cancer after radiotherapy</span></div><div class="casAuthors">Rybalov, Maxim; Ananias, Hildo J. K.; Hoving, Hilde D.; van der Poel, Henk G.; Rosati, Stefano; de Jong, Igle J.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">6046-6061, 16</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">In this retrospective pilot study, the expression of the prostate-specific membrane antigen (PSMA), the epithelial cell adhesion mol. (EpCAM), the vascular endothelial growth factor (VEGF) and the gastrin-releasing peptide receptor (GRPR) in locally recurrent prostate cancer after brachytherapy or external beam radiotherapy (EBRT) was investigated, and their adequacy for targeted imaging was analyzed.  Prostate cancer specimens were collected of 17 patients who underwent salvage prostatectomy because of locally recurrent prostate cancer after brachytherapy or EBRT.  Immunohistochem. was performed.  A pathologist scored the immunoreactivity in prostate cancer and stroma.  Staining for PSMA was seen in 100% (17/17), EpCAM in 82.3% (14/17), VEGF in 82.3% (14/17) and GRPR in 100% (17/17) of prostate cancer specimens.  Staining for PSMA, EpCAM and VEGF was seen in 0% (0/17) and for GRPR in 100% (17/17) of the specimens' stromal compartments.  In 11.8% (2/17) of cases, the GRPR staining intensity of prostate cancer was higher than stroma, while in 88.2% (15/17), the staining was equal.  Based on the absence of stromal staining, PSMA, EpCAM and VEGF show high tumor distinctiveness.  Therefore, PSMA, EpCAM and VEGF can be used as targets for the bioimaging of recurrent prostate cancer after EBRT to exclude metastatic disease and/or to plan local salvage therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjXoO5EfXntrVg90H21EOLACvtfcHk0li--7t6OASh6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlWlur%252FP&md5=7dd698c124474848d71c2466ad65d4f0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.3390%2Fijms15046046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms15046046%26sid%3Dliteratum%253Aachs%26aulast%3DRybalov%26aufirst%3DM.%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%2BK.%26aulast%3DHoving%26aufirst%3DH.%2BD.%26aulast%3Dvan%2Bder%2BPoel%26aufirst%3DH.%2BG.%26aulast%3DRosati%26aufirst%3DS.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26atitle%3DPSMA%252C%2520EpCAM%252C%2520VEGF%2520and%2520GRPR%2520as%2520Imaging%2520Targets%2520in%2520Locally%2520Recurrent%2520Prostate%2520Cancer%2520after%2520Radiotherapy%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2014%26volume%3D15%26issue%3D4%26spage%3D6046%26epage%3D6061%26doi%3D10.3390%2Fijms15046046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wieser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosu, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultze-Seemann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumont-Walter, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, W. A.</span></span> <span> </span><span class="NLM_article-title">Positron Emission Tomography (PET) Imaging of Prostate Cancer with a Gastrin Releasing Peptide Receptor Antagonist - from Mice to Men</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">412</span>– <span class="NLM_lpage">419</span>, <span class="refDoi"> DOI: 10.7150/thno.7324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.7150%2Fthno.7324" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=412-419&issue=4&author=G.+Wieserauthor=R.+Mansiauthor=A.+L.+Grosuauthor=W.+Schultze-Seemannauthor=R.+A.+Dumont-Walterauthor=P.+T.+Meyerauthor=H.+R.+Maeckeauthor=J.+C.+Reubiauthor=W.+A.+Weber&title=Positron+Emission+Tomography+%28PET%29+Imaging+of+Prostate+Cancer+with+a+Gastrin+Releasing+Peptide+Receptor+Antagonist+-+from+Mice+to+Men&doi=10.7150%2Fthno.7324"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.7150%2Fthno.7324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.7324%26sid%3Dliteratum%253Aachs%26aulast%3DWieser%26aufirst%3DG.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DGrosu%26aufirst%3DA.%2BL.%26aulast%3DSchultze-Seemann%26aufirst%3DW.%26aulast%3DDumont-Walter%26aufirst%3DR.%2BA.%26aulast%3DMeyer%26aufirst%3DP.%2BT.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26atitle%3DPositron%2520Emission%2520Tomography%2520%2528PET%2529%2520Imaging%2520of%2520Prostate%2520Cancer%2520with%2520a%2520Gastrin%2520Releasing%2520Peptide%2520Receptor%2520Antagonist%2520-%2520from%2520Mice%2520to%2520Men%26jtitle%3DTheranostics%26date%3D2014%26volume%3D4%26issue%3D4%26spage%3D412%26epage%3D419%26doi%3D10.7150%2Fthno.7324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rehmann, R.</span></span> <span> </span><span class="NLM_article-title">Concomitant Vascular GRP-Receptor and VEGF-Receptor Expression in Human Tumors: Molecular Basis for Dual Targeting of Tumoral Vasculature</span>. <i>Peptides</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1457</span>– <span class="NLM_lpage">1462</span>, <span class="refDoi"> DOI: 10.1016/j.peptides.2011.05.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.peptides.2011.05.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=21605611" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3MXptVylt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=1457-1462&issue=7&author=J.+C.+Reubiauthor=A.+Fleischmannauthor=B.+Waserauthor=R.+Rehmann&title=Concomitant+Vascular+GRP-Receptor+and+VEGF-Receptor+Expression+in+Human+Tumors%3A+Molecular+Basis+for+Dual+Targeting+of+Tumoral+Vasculature&doi=10.1016%2Fj.peptides.2011.05.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Concomitant vascular GRP-receptor and VEGF-receptor expression in human tumors: Molecular basis for dual targeting of tumoral vasculature</span></div><div class="casAuthors">Reubi, Jean Claude; Fleischmann, Achim; Waser, Beatrice; Rehmann, Ruth</div><div class="citationInfo"><span class="NLM_cas:title">Peptides (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1457-1462</span>CODEN:
                <span class="NLM_cas:coden">PPTDD5</span>;
        ISSN:<span class="NLM_cas:issn">0196-9781</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Gastrin-releasing peptide (GRP) and GRP receptors (GRPR) play a role in tumor angiogenesis.  Recently, GRPR were found to be frequently expressed in the vasculature of a large variety of human cancers.  Here, we characterize these GRPR by comparing the vascular GRPR expression and localization in a selection of human cancers with that of an established biol. marker of neoangiogenesis, the vascular endothelial growth factor (VEGF) receptor.  In vitro quant. receptor autoradiog. was performed in parallel for GRPR and VEGF receptors (VEGFR) in 32 human tumors of various origins, using 125I-Tyr-bombesin and 125I-VEGF165 as radioligands, resp.  Moreover, VEGFR-2 was evaluated immunohistochem.  All tumors expressed GRPR and VEGFR in their vascular system.  VEGFR were expressed in the endothelium in the majority of the vessels.  GRPR were expressed in a subpopulation of vessels, preferably in their muscular coat.  The vessels expressing GRPR were all VEGFR-pos. whereas the VEGFR-expressing vessels were not all GRPR-pos.  GRPR expressing vessels were found immunohistochem. to co-express VEGFR-2.  Remarkably, the d. of vascular GRPR was much higher than that of VEGFR.  The concomitant expression of GRPR with VEGFR appears to be a frequent phenomenon in many human cancers.  The GRPR, localized and expressed in extremely high d. in a subgroup of vessels, may function as target for antiangiogenic tumor therapy or angiodestructive targeted radiotherapy with radiolabeled bombesin analogs alone, or preferably together with VEGFR targeted therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMo62E40UigbVg90H21EOLACvtfcHk0lhQktLqSFAYzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXptVylt7s%253D&md5=aebb3cb1530f6d7a68a3ea3ee9833241</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.peptides.2011.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.peptides.2011.05.007%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DFleischmann%26aufirst%3DA.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DRehmann%26aufirst%3DR.%26atitle%3DConcomitant%2520Vascular%2520GRP-Receptor%2520and%2520VEGF-Receptor%2520Expression%2520in%2520Human%2520Tumors%253A%2520Molecular%2520Basis%2520for%2520Dual%2520Targeting%2520of%2520Tumoral%2520Vasculature%26jtitle%3DPeptides%26date%3D2011%26volume%3D32%26issue%3D7%26spage%3D1457%26epage%3D1462%26doi%3D10.1016%2Fj.peptides.2011.05.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Peptide-Based Probes for Cancer Imaging</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>49</i></span> (<span class="NLM_issue">11</span>),  <span class="NLM_fpage">1735</span>– <span class="NLM_lpage">1738</span>, <span class="refDoi"> DOI: 10.2967/jnumed.108.053041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.108.053041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=18927341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVOhtLbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=1735-1738&issue=11&author=J.+C.+Reubiauthor=H.+R.+Maecke&title=Peptide-Based+Probes+for+Cancer+Imaging&doi=10.2967%2Fjnumed.108.053041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide-based probes for cancer imaging</span></div><div class="casAuthors">Reubi, Jean Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1735-1738</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">A review.  Receptors for regulatory peptides are overexpressed in a variety of human cancers.  They represent the mol. basis for in vivo imaging with radiolabeled peptide probes.  Somatostatin-derived tracers, designed to image the sst2-overexpressing neuroendocrine tumors, have enjoyed almost 2 decades of successful development and extensive clin. applications.  More recent developments include second- and third-generation somatostatin analogs, with a broader receptor subtype profile or with antagonistic properties.  Emerging tracers for other peptide receptors, including cholecystokinin/gastrin and GLP-1 analogs for neuroendocrine tumors, bombesin and neuropeptide-Y analogs for prostate or breast cancers, or Arg-Gly-Asp peptides for neoangiogenesis labeling, are also in current development.  Application fields include both SPECT/CT and PET/CT.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQl8P0WKboULVg90H21EOLACvtfcHk0lhQktLqSFAYzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVOhtLbP&md5=fac1bacd57f62609b1ad2dfee963952f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.108.053041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.108.053041%26sid%3Dliteratum%253Aachs%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DPeptide-Based%2520Probes%2520for%2520Cancer%2520Imaging%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26issue%3D11%26spage%3D1735%26epage%3D1738%26doi%3D10.2967%2Fjnumed.108.053041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalm, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martens, J. W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieuwerts, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Deurzen, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelewijn, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Blois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maina, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nock, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehrentz, J.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melis, M.</span></span> <span> </span><span class="NLM_article-title"><i>In Vitro</i> and <i>In Vivo</i> Application of Radiolabeled Gastrin-Releasing Peptide Receptor Ligands in Breast Cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">752</span>– <span class="NLM_lpage">757</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.153023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.114.153023" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=752-757&issue=5&author=S.+U.+Dalmauthor=J.+W.+M.+Martensauthor=A.+M.+Sieuwertsauthor=C.+H.+M.+van+Deurzenauthor=S.+J.+Koelewijnauthor=E.+de+Bloisauthor=T.+Mainaauthor=B.+A.+Nockauthor=L.+Brunelauthor=J.-A.+Fehrentzauthor=J.+Martinezauthor=M.+de+Jongauthor=M.+Melis&title=In+Vitro+and+In+Vivo+Application+of+Radiolabeled+Gastrin-Releasing+Peptide+Receptor+Ligands+in+Breast+Cancer&doi=10.2967%2Fjnumed.114.153023"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.153023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.153023%26sid%3Dliteratum%253Aachs%26aulast%3DDalm%26aufirst%3DS.%2BU.%26aulast%3DMartens%26aufirst%3DJ.%2BW.%2BM.%26aulast%3DSieuwerts%26aufirst%3DA.%2BM.%26aulast%3Dvan%2BDeurzen%26aufirst%3DC.%2BH.%2BM.%26aulast%3DKoelewijn%26aufirst%3DS.%2BJ.%26aulast%3Dde%2BBlois%26aufirst%3DE.%26aulast%3DMaina%26aufirst%3DT.%26aulast%3DNock%26aufirst%3DB.%2BA.%26aulast%3DBrunel%26aufirst%3DL.%26aulast%3DFehrentz%26aufirst%3DJ.-A.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3Dde%2BJong%26aufirst%3DM.%26aulast%3DMelis%26aufirst%3DM.%26atitle%3DIn%2520Vitro%2520and%2520In%2520Vivo%2520Application%2520of%2520Radiolabeled%2520Gastrin-Releasing%2520Peptide%2520Receptor%2520Ligands%2520in%2520Breast%2520Cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2015%26volume%3D56%26issue%3D5%26spage%3D752%26epage%3D757%26doi%3D10.2967%2Fjnumed.114.153023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasanphanich, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retzloff, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanda, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieckman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rold, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sublett, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. J.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Vivo Analysis of [<sup>64</sup>Cu-NO2A-8-Aoc-BBN(7–14)NH<sub>2</sub>]: A Site-Directed Radiopharmaceutical for Positron-Emission Tomography Imaging of T47D Human Breast Cancer Tumors</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">171</span>– <span class="NLM_lpage">181</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2008.11.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.nucmedbio.2008.11.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=19217529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitVyhtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2009&pages=171-181&issue=2&author=A.+F.+Prasanphanichauthor=L.+Retzloffauthor=S.+R.+Laneauthor=P.+K.+Nandaauthor=G.+L.+Sieckmanauthor=T.+L.+Roldauthor=L.+Maauthor=S.+D.+Figueroaauthor=S.+V.+Sublettauthor=T.+J.+Hoffmanauthor=C.+J.+Smith&title=In+Vitro+and+in+Vivo+Analysis+of+%5B64Cu-NO2A-8-Aoc-BBN%287%E2%80%9314%29NH2%5D%3A+A+Site-Directed+Radiopharmaceutical+for+Positron-Emission+Tomography+Imaging+of+T47D+Human+Breast+Cancer+Tumors&doi=10.1016%2Fj.nucmedbio.2008.11.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo analysis of [64Cu-NO2A-8-Aoc-BBN(7-14)NH2]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors</span></div><div class="casAuthors">Prasanphanich, Adam F.; Retzloff, Lauren; Lane, Stephanie R.; Nanda, Prasant K.; Sieckman, Gary L.; Rold, Tammy L.; Ma, Lixin; Figueroa, Said D.; Sublett, Samantha V.; Hoffman, Timothy J.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">171-181</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Introduction: Human breast cancer, from which the T-47D cell line was derived, is known to overexpress the gastrin-releasing peptide receptor (GRPR) in some cases.  Bombesin (BBN), an agonist for the GRPR, has been appended with a radionuclide capable of positron-emission tomog. (PET) imaging and therapy.  64Cu-NO2A-8-Aoc-BBN(7-14)NH2 (NO2A=1,4,7-triazacyclononane-1,4-diacetate) has produced high-quality microPET images of GRPR-pos. breast cancer xenografted tumors in mice.  Methods: The imaging probe was synthesized by solid-phase peptide synthesis followed by manual conjugation of the 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) bifunctional chelator and radiolabeling in aq. soln.  The radiolabeled conjugate was subjected to in vitro and in vivo studies to det. its specificity for the GRPR and its pharmacokinetic profile.  A T-47D tumor-bearing mouse was imaged with microPET/CT and microMRI imaging.  Results: The 64Cu-NO2A-8-Aoc-BBN(7-14)NH2 targeting vector was detd. to specifically localize in GRPR-pos. tissue.  Accumulation was obsd. in the tumor in sufficient quantities to allow for identification of tumors in microPET imaging procedures.  For example, uptake and retention in T-47D xenografts at 1, 4 and 24 h were detd. to be 2.27±0.08, 1.35±0.14 and 0.28±0.07 % ID/g, resp.  Conclusions: The 64Cu-NO2A-8-Aoc-BBN(7-14)NH2 produced high-quality microPET images.  The pharmacokinetic profile justifies investigation of this bioconjugate as a potentially useful diagnostic/therapeutic agent.  Addnl., the bioconjugate would serve as a good starting point for modification and optimization of similar agents to maximize tumor uptake and minimize nontarget accumulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpIBaUUwx6qabVg90H21EOLACvtfcHk0ljAOWB8XrlHag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitVyhtbk%253D&md5=c5e91e70a7ff3caf8156ff3c1b454487</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.11.005%26sid%3Dliteratum%253Aachs%26aulast%3DPrasanphanich%26aufirst%3DA.%2BF.%26aulast%3DRetzloff%26aufirst%3DL.%26aulast%3DLane%26aufirst%3DS.%2BR.%26aulast%3DNanda%26aufirst%3DP.%2BK.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DRold%26aufirst%3DT.%2BL.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DFigueroa%26aufirst%3DS.%2BD.%26aulast%3DSublett%26aufirst%3DS.%2BV.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Analysis%2520of%2520%255B64Cu-NO2A-8-Aoc-BBN%25287%25E2%2580%259314%2529NH2%255D%253A%2520A%2520Site-Directed%2520Radiopharmaceutical%2520for%2520Positron-Emission%2520Tomography%2520Imaging%2520of%2520T47D%2520Human%2520Breast%2520Cancer%2520Tumors%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2009%26volume%3D36%26issue%3D2%26spage%3D171%26epage%3D181%26doi%3D10.1016%2Fj.nucmedbio.2008.11.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stoykow, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erbes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bartholomä, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drendel, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronsert, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Werner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gitsch, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P. T.</span></span> <span> </span><span class="NLM_article-title">Gastrin-Releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist <sup>68</sup>Ga-RM2 And PET</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1641</span>– <span class="NLM_lpage">1650</span>, <span class="refDoi"> DOI: 10.7150/thno.14958</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.7150%2Fthno.14958" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=1641-1650&issue=10&author=C.+Stoykowauthor=T.+Erbesauthor=H.+R.+Maeckeauthor=S.+Bullaauthor=M.+Bartholom%C3%A4author=S.+Mayerauthor=V.+Drendelauthor=P.+Bronsertauthor=M.+Wernerauthor=G.+Gitschauthor=W.+A.+Weberauthor=E.+Stickelerauthor=P.+T.+Meyer&title=Gastrin-Releasing+Peptide+Receptor+Imaging+in+Breast+Cancer+Using+the+Receptor+Antagonist+68Ga-RM2+And+PET&doi=10.7150%2Fthno.14958"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.7150%2Fthno.14958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.14958%26sid%3Dliteratum%253Aachs%26aulast%3DStoykow%26aufirst%3DC.%26aulast%3DErbes%26aufirst%3DT.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DBulla%26aufirst%3DS.%26aulast%3DBartholom%25C3%25A4%26aufirst%3DM.%26aulast%3DMayer%26aufirst%3DS.%26aulast%3DDrendel%26aufirst%3DV.%26aulast%3DBronsert%26aufirst%3DP.%26aulast%3DWerner%26aufirst%3DM.%26aulast%3DGitsch%26aufirst%3DG.%26aulast%3DWeber%26aufirst%3DW.%2BA.%26aulast%3DStickeler%26aufirst%3DE.%26aulast%3DMeyer%26aufirst%3DP.%2BT.%26atitle%3DGastrin-Releasing%2520Peptide%2520Receptor%2520Imaging%2520in%2520Breast%2520Cancer%2520Using%2520the%2520Receptor%2520Antagonist%252068Ga-RM2%2520And%2520PET%26jtitle%3DTheranostics%26date%3D2016%26volume%3D6%26issue%3D10%26spage%3D1641%26epage%3D1650%26doi%3D10.7150%2Fthno.14958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erspamer, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bucci, M.</span></span> <span> </span><span class="NLM_article-title">Isolation and Amino Acid Sequences of Alytesin and Bombesin, Two Analogous Active Tetradecapeptides from the Skin of European Discoglossid Frogs</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>148</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.1016/0003-9861(72)90162-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2F0003-9861%2872%2990162-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1972&pages=443-446&issue=2&author=A.+Anastasiauthor=V.+Erspamerauthor=M.+Bucci&title=Isolation+and+Amino+Acid+Sequences+of+Alytesin+and+Bombesin%2C+Two+Analogous+Active+Tetradecapeptides+from+the+Skin+of+European+Discoglossid+Frogs&doi=10.1016%2F0003-9861%2872%2990162-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2F0003-9861%2872%2990162-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-9861%252872%252990162-2%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasi%26aufirst%3DA.%26aulast%3DErspamer%26aufirst%3DV.%26aulast%3DBucci%26aufirst%3DM.%26atitle%3DIsolation%2520and%2520Amino%2520Acid%2520Sequences%2520of%2520Alytesin%2520and%2520Bombesin%252C%2520Two%2520Analogous%2520Active%2520Tetradecapeptides%2520from%2520the%2520Skin%2520of%2520European%2520Discoglossid%2520Frogs%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1972%26volume%3D148%26issue%3D2%26spage%3D443%26epage%3D446%26doi%3D10.1016%2F0003-9861%2872%2990162-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cornelio, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesler, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartsmann, G.</span></span> <span> </span><span class="NLM_article-title">Gastrin-Releasing Peptide Receptor as a Molecular Target in Experimental Anticancer Therapy</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1457</span>– <span class="NLM_lpage">1466</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdm058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1093%2Fannonc%2Fmdm058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=17351255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BD2srgvFenuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=1457-1466&issue=9&author=D.+B.+Cornelioauthor=R.+Roeslerauthor=G.+Schwartsmann&title=Gastrin-Releasing+Peptide+Receptor+as+a+Molecular+Target+in+Experimental+Anticancer+Therapy&doi=10.1093%2Fannonc%2Fmdm058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy</span></div><div class="casAuthors">Cornelio D B; Roesler R; Schwartsmann G</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1457-66</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">Over the last two decades, several lines of experimental evidence have suggested that the gastrin-releasing peptide (GRP) may act as a growth factor in many types of cancer.  For that reason, gastrin-releasing peptide receptor (GRPR) antagonists have been developed as anticancer candidate compounds, exhibiting impressive antitumoral activity both in vitro and in vivo in various murine and human tumors.  In this article, the GRPR cell surface expression profile in human malignancies is reviewed aiming at the identification of potential tumor types for future clinical trials with GRP analogues and antagonists.  In this review, we summarize the current literature regarding the GRPR status in human malignancies.  Source data were obtained by searching all published material available through Medline, PubMed and relevant articles from 1971 to 2006.  The data available demonstrated a high expression of GRPRs in a large spectrum of human cancers, demonstrating the potential relevance of this intracellular signaling pathway in various human tumor models.  The GRPR may be an interesting target for therapeutic intervention in human malignancies, as carriers for cytotoxins, immunotoxins or radioactive compounds, being also a potential tool for tumor detection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVtrv8gW96B0h5eUSa2oe_fW6udTcc2eZfNLOiopIW2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2srgvFenuw%253D%253D&md5=01da9a7a9dc23455e2ca1020c7b8b0aa</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdm058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdm058%26sid%3Dliteratum%253Aachs%26aulast%3DCornelio%26aufirst%3DD.%2BB.%26aulast%3DRoesler%26aufirst%3DR.%26aulast%3DSchwartsmann%26aufirst%3DG.%26atitle%3DGastrin-Releasing%2520Peptide%2520Receptor%2520as%2520a%2520Molecular%2520Target%2520in%2520Experimental%2520Anticancer%2520Therapy%26jtitle%3DAnn.%2520Oncol.%26date%3D2007%26volume%3D18%26issue%3D9%26spage%3D1457%26epage%3D1466%26doi%3D10.1093%2Fannonc%2Fmdm058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okarvi, S. M.</span></span> <span> </span><span class="NLM_article-title">Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.7150/thno.4024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.7150%2Fthno.4024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=481-501&issue=5&author=M.+Faniauthor=H.+R.+Maeckeauthor=S.+M.+Okarvi&title=Radiolabeled+Peptides%3A+Valuable+Tools+for+the+Detection+and+Treatment+of+Cancer&doi=10.7150%2Fthno.4024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.7150%2Fthno.4024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.4024%26sid%3Dliteratum%253Aachs%26aulast%3DFani%26aufirst%3DM.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26aulast%3DOkarvi%26aufirst%3DS.%2BM.%26atitle%3DRadiolabeled%2520Peptides%253A%2520Valuable%2520Tools%2520for%2520the%2520Detection%2520and%2520Treatment%2520of%2520Cancer%26jtitle%3DTheranostics%26date%3D2012%26volume%3D2%26issue%3D5%26spage%3D481%26epage%3D501%26doi%3D10.7150%2Fthno.4024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Price, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orvig, C.</span></span> <span> </span><span class="NLM_article-title">Matching Chelators to Radiometals for Radiopharmaceuticals</span>. <i>Chem. Soc. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>43</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">260</span>– <span class="NLM_lpage">290</span>, <span class="refDoi"> DOI: 10.1039/C3CS60304K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1039%2FC3CS60304K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=24173525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVGktLzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=260-290&issue=1&author=E.+W.+Priceauthor=C.+Orvig&title=Matching+Chelators+to+Radiometals+for+Radiopharmaceuticals&doi=10.1039%2FC3CS60304K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Matching chelators to radiometals for radiopharmaceuticals</span></div><div class="casAuthors">Price, Eric W.; Orvig, Chris</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">260-290</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  Radiometals comprise many useful radioactive isotopes of various metallic elements.  When properly harnessed, these have valuable emission properties that can be used for diagnostic imaging techniques, such as single photon emission computed tomog. (SPECT, e.g.67Ga, 99mTc, 111In, 177Lu) and positron emission tomog. (PET, e.g.68Ga, 64Cu, 44Sc, 86Y, 89Zr), as well as therapeutic applications (e.g.47Sc, 114mIn, 177Lu, 90Y, 212/213Bi, 212Pb, 225Ac, 186/188Re).  A fundamental crit. component of a radiometal-based radiopharmaceutical is the chelator, the ligand system that binds the radiometal ion in a tight stable coordination complex so that it can be properly directed to a desirable mol. target in vivo.  This article is a guide for selecting the optimal match between chelator and radiometal for use in these systems.  The article briefly introduces a selection of relevant and high impact radiometals, and their potential utility to the fields of radiochem., nuclear medicine, and mol. imaging.  A description of radiometal-based radiopharmaceuticals is provided, and several key design considerations are discussed.  The exptl. methods by which chelators are assessed for their suitability with a variety of radiometal ions is explained, and a large selection of the most common and most promising chelators are evaluated and discussed for their potential use with a variety of radiometals.  Comprehensive tables have been assembled to provide a convenient and accessible overview of the field of radiometal chelating agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGxFFPqxTSFrVg90H21EOLACvtfcHk0lhUtiD0n27VzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVGktLzP&md5=30a847faed78cba5123ffca47bde5aa3</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC3CS60304K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60304K%26sid%3Dliteratum%253Aachs%26aulast%3DPrice%26aufirst%3DE.%2BW.%26aulast%3DOrvig%26aufirst%3DC.%26atitle%3DMatching%2520Chelators%2520to%2520Radiometals%2520for%2520Radiopharmaceuticals%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26issue%3D1%26spage%3D260%26epage%3D290%26doi%3D10.1039%2FC3CS60304K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wängler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knackmuss, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeGall, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Little, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span> <span> </span><span class="NLM_article-title">Tetrafluorophenolate of HBED-CC: A Versatile Conjugation Agent for <sup>68</sup>Ga-Labeled Small Recombinant Antibodies</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>35</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">1878</span>– <span class="NLM_lpage">1886</span>, <span class="refDoi"> DOI: 10.1007/s00259-008-0816-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-008-0816-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=18509635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=1878-1886&issue=10&author=M.+Ederauthor=B.+W%C3%A4nglerauthor=S.+Knackmussauthor=F.+LeGallauthor=M.+Littleauthor=U.+Haberkornauthor=W.+Mierauthor=M.+Eisenhut&title=Tetrafluorophenolate+of+HBED-CC%3A+A+Versatile+Conjugation+Agent+for+68Ga-Labeled+Small+Recombinant+Antibodies&doi=10.1007%2Fs00259-008-0816-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrafluorophenolate of HBED-CC: a versatile conjugation agent for 68Ga-labeled small recombinant antibodies</span></div><div class="casAuthors">Eder, Matthias; Waengler, Bjoern; Knackmuss, Stefan; LeGall, Fabrice; Little, Melvyn; Haberkorn, Uwe; Mier, Walter; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1878-1886</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">The success of 68Ga-labeled peptides for positron emission tomog. of neuroendocrine tumors is mainly depending on the complex chem. of this radioisotope. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), the chelator of choice has however limitations if its application is expanded to heat-sensitive proteins.  Recombinant antibodies like single chain Fv or diabodies belong to this class of proteins.  They are suited to provide imaging contrast despite the short-lived 68Ga because of their rapid blood clearances and nanomolar affinities.  The heterobifunctional agent N,N'-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N'-diacetic acid (HBED-CC) was chosen as an alternative ligand because this agent is complexing [68Ga]Ga3+ much faster than DOTA at ambient temps.  A versatile technol. for HBED-CC conjugation of proteins and 68Ga-labeling has been developed.  This included HBED-CC-tetrafluorophenol (TFP) ester synthesis, coupling to the antibody at various pH and complexation reactions performed in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer under different conditions.  The synthesis of the monoreactive 2,3,5,6-tetrafluorophenolate of HBED-CC at a carboxyl group not participating in complex formation used [Fe(HBED-CC)]- for ester formation.  The removal of Fe3+ from purified (HBED-CC)TFP ester was achieved with RP18 cartridge technol.  The conjugation chem. was performed with mAb425 which binds to the epidermal growth factor receptor (EGFR).  This protein was used for optimizing purposes only.  The influence of complexation parameters like temp., pH, reaction time, and HBED-CC/antibody ratio on the biol. activity of this model antibody was investigated.  Furthermore, the outcome of this labeling procedure on the biol. activity of a recombinant diabody (50 kDa) was studied.  It is known that small HBED-CC/antibody ratios are prerequisites for minimal interference of labels with antigen-binding domains.  Here, the coupling of about one HBED-CC per antibody proved to be sufficient for efficient 68Ga labeling, pointing to the successful application of 68Ga for mol. imaging with small recombinant proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaFp4SmuGX2LVg90H21EOLACvtfcHk0lg4BfTYAYl1FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFCjtbzK&md5=db2386f042dd670f321bb7020ea7074c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2Fs00259-008-0816-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-008-0816-z%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DKnackmuss%26aufirst%3DS.%26aulast%3DLeGall%26aufirst%3DF.%26aulast%3DLittle%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3DTetrafluorophenolate%2520of%2520HBED-CC%253A%2520A%2520Versatile%2520Conjugation%2520Agent%2520for%252068Ga-Labeled%2520Small%2520Recombinant%2520Antibodies%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2008%26volume%3D35%26issue%3D10%26spage%3D1878%26epage%3D1886%26doi%3D10.1007%2Fs00259-008-0816-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liolios, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopka, K.</span></span> <span> </span><span class="NLM_article-title">Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">751</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.5b00687</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.5b00687" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVejuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=737-751&issue=3&author=C.+Lioliosauthor=M.+Sch%C3%A4ferauthor=U.+Haberkornauthor=M.+Ederauthor=K.+Kopka&title=Novel+Bispecific+PSMA%2FGRPr+Targeting+Radioligands+with+Optimized+Pharmacokinetics+for+Improved+PET+Imaging+of+Prostate+Cancer&doi=10.1021%2Facs.bioconjchem.5b00687"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Bispecific PSMA/GRPr Targeting Radioligands with Optimized Pharmacokinetics for Improved PET Imaging of Prostate Cancer</span></div><div class="casAuthors">Liolios, C.; Schaefer, M.; Haberkorn, U.; Eder, M.; Kopka, K.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">737-751</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of bispecific radioligands (BRLs) targeting prostate-specific membrane antigen (PSMA) and gastrin releasing peptide receptor (GRPr), both expressed on prostate cancer cells, was developed.  Their design was based on the bombesin (BN) analog, H2N-PEG2-[D-Tyr6,β-Ala11,Thi13,Nle14]BN(6-14), which binds to GRPr with high affinity and specificity, and the peptidomimetic urea-based pseudoirreversible inhibitor of PSMA, Glu-ureido-Lys.  The two pharmacophores were coupled through copper(I)-catalyzed azide-alkyne cycloaddn. to the bis(tetrafluorophenyl) ester of the chelating agent HBED-CC via amino acid linkers made of pos. charged His (H) and neg. charged Glu (E): -(HE)n- (n = 0-3).  The BRLs were labeled with 68Ga, and their preliminary pharmacol. properties were evaluated in vitro (competitive and time kinetic binding assays) on prostate cancer (PC-3, LNCaP) and rat pancreatic (AR42J) cell lines and in vivo by biodistribution and small animal PET imaging studies in both normal and tumor-bearing mice.  The IC50/Ki values detd. for all BRLs essentially matched those of the resp. monomers.  The maximal cellular uptake of the BLRs was obsd. between 20 and 30 min.  The BRLs showed a synergistic ability in vivo by targeting both PSMA (LNCaP) and GRPr (PC-3) pos. tumors, whereas the charged -(HE)n- (n = 1-3) linkers significantly reduced the kidney and spleen uptake.  The bispecific (PSMA and GRPr) targeting ability and optimized pharmacokinetics of the compds. developed in this study could lead to their future application in clin. practice as more sensitive radiotracers for noninvasive imaging of prostate cancer (PCa) by PET/CT and PET/MRI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdb-s9rymAp7Vg90H21EOLACvtfcHk0lg4BfTYAYl1FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVejuw%253D%253D&md5=f6e7805810a50bd7ee9c955ac3df8056</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.5b00687&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.5b00687%26sid%3Dliteratum%253Aachs%26aulast%3DLiolios%26aufirst%3DC.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEder%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DNovel%2520Bispecific%2520PSMA%252FGRPr%2520Targeting%2520Radioligands%2520with%2520Optimized%2520Pharmacokinetics%2520for%2520Improved%2520PET%2520Imaging%2520of%2520Prostate%2520Cancer%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26issue%3D3%26spage%3D737%26epage%3D751%26doi%3D10.1021%2Facs.bioconjchem.5b00687" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder-Wüst, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kopka, K.</span></span> <span> </span><span class="NLM_article-title">Preclinical Evaluation of a Bispecific Low-Molecular Heterodimer Targeting Both PSMA and GRPR for Improved PET Imaging and Therapy of Prostate Cancer</span>. <i>Prostate</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>74</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">668</span>, <span class="refDoi"> DOI: 10.1002/pros.22784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1002%2Fpros.22784" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2014&pages=659-668&issue=6&author=M.+Ederauthor=M.+Sch%C3%A4ferauthor=U.+Bauder-W%C3%BCstauthor=U.+Haberkornauthor=M.+Eisenhutauthor=K.+Kopka&title=Preclinical+Evaluation+of+a+Bispecific+Low-Molecular+Heterodimer+Targeting+Both+PSMA+and+GRPR+for+Improved+PET+Imaging+and+Therapy+of+Prostate+Cancer&doi=10.1002%2Fpros.22784"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fpros.22784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpros.22784%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DBauder-W%25C3%25BCst%26aufirst%3DU.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DKopka%26aufirst%3DK.%26atitle%3DPreclinical%2520Evaluation%2520of%2520a%2520Bispecific%2520Low-Molecular%2520Heterodimer%2520Targeting%2520Both%2520PSMA%2520and%2520GRPR%2520for%2520Improved%2520PET%2520Imaging%2520and%2520Therapy%2520of%2520Prostate%2520Cancer%26jtitle%3DProstate%26date%3D2014%26volume%3D74%26issue%3D6%26spage%3D659%26epage%3D668%26doi%3D10.1002%2Fpros.22784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Handl, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mash, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruby, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillies, R. J.</span></span> <span> </span><span class="NLM_article-title">Hitting Multiple Targets with Multimeric Ligands</span>. <i>Expert Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">565</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1517/14728222.8.6.565</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1517%2F14728222.8.6.565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=15584863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmt1eisg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2004&pages=565-586&issue=6&author=H.+L.+Handlauthor=J.+Vagnerauthor=H.+Hanauthor=E.+Mashauthor=V.+J.+Hrubyauthor=R.+J.+Gillies&title=Hitting+Multiple+Targets+with+Multimeric+Ligands&doi=10.1517%2F14728222.8.6.565"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Hitting multiple targets with multimeric ligands</span></div><div class="casAuthors">Handl, Heather L.; Vagner, Josef; Han, Haiyong; Mash, Eugene; Hruby, Victor J.; Gillies, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-586</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Multimeric ligands consist of multiple monomeric ligands attached to a single backbone mol., creating a multimer that can bind to multiple receptors or targets simultaneously.  Numerous examples of multimeric binding exist within nature.  Due to the multiple and simultaneous binding events, multimeric ligands bind with an increased affinity compared to their corresponding monomers.  Multimeric ligands may provide opportunities in the field of drug discovery by providing enhanced selectivity and affinity of binding interactions, thus providing mol.-based targeted therapies.  However, gaps in our knowledge currently exist regarding the quant. measures for important design characteristics, such as flexibility, length and orientation of the inter-ligand linkers, receptor d. and ligand sequence.  In this review, multimeric ligand binding in two sep. phases is examd.  The prerecruitment phase describes the binding of one ligand of a multimer to its corresponding receptor, an event similar to monomeric ligand binding.  This results in transient increases in the local concn. of the other ligands, leading to apparent cooperativity.  The postrecruitment phase only occurs once all receptors have been aligned and bound by their corresponding ligand.  This phase is analogous to DNA-DNA interactions in that the stability of the complex is derived from phys. orientation.  Multiple factors influence the kinetics and thermodn. of multimeric binding, and these are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7NOkX9Q-NcLVg90H21EOLACvtfcHk0ljBRftCGQc02w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmt1eisg%253D%253D&md5=8aad8ea5debf2373eb5d59f5bab63dc5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F14728222.8.6.565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.8.6.565%26sid%3Dliteratum%253Aachs%26aulast%3DHandl%26aufirst%3DH.%2BL.%26aulast%3DVagner%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DH.%26aulast%3DMash%26aufirst%3DE.%26aulast%3DHruby%26aufirst%3DV.%2BJ.%26aulast%3DGillies%26aufirst%3DR.%2BJ.%26atitle%3DHitting%2520Multiple%2520Targets%2520with%2520Multimeric%2520Ligands%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2004%26volume%3D8%26issue%3D6%26spage%3D565%26epage%3D586%26doi%3D10.1517%2F14728222.8.6.565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carrithers, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, M. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Characterization of Bivalent Peptide Ligands Targeted to G-Protein-Coupled Receptors</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">542</span>, <span class="refDoi"> DOI: 10.1016/S1074-5521(96)90144-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2FS1074-5521%2896%2990144-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=8807885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADyaK28XkvFWgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1996&pages=537-542&issue=7&author=M.+D.+Carrithersauthor=M.+R.+Lerner&title=Synthesis+and+Characterization+of+Bivalent+Peptide+Ligands+Targeted+to+G-Protein-Coupled+Receptors&doi=10.1016%2FS1074-5521%2896%2990144-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and characterization of bivalent peptide ligands targeted to G-protein-coupled receptors</span></div><div class="casAuthors">Carrithers, Michael D.; Lerner, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">537-542</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">Through the effects of avidity, multivalency can increase the apparent affinity of a ligand for its binding site.  Low mol. wt., high affinity, multivalent ligands theor. could be used to deliver a variety of agents to specific cell subtypes.  In order to target specific G-protein-coupled receptors, a series of monospecific peptide dimers were synthesized that are designed to bind to two adjacent receptor sites.  These dimers, consisting of a ligand region, a short, flexible, uncharged spacer, a longer, polylysine spacer and a single cysteine residue to permit dimerization, and the corresponding monomers were synthesized by solid-phase peptide synthesis.  The ligand domain was either α-MSH an α-MSH receptor antagonist (α-MSH-ANT), or bombesin.  These ligands were characterized in a functional melanocyte dispersion assay.  In wild-type melanophores, the α-MSH dimer stimulated dispersion with an EC50 approx. seven-fold lower than that of the corresponding monomer.  Similarly, in cells transfected with bombesin receptor cDNA, the bombesin dimer was approx. five-fold more potent than the monomer.  The α-MSH-ANT monomer specifically inhibited α-MSH-mediated dispersion with no significant agonist activity, but the dimer acted predominantly as an agonist.  Peptide dimers can be synthesized easily and have enhanced functional activity; monospecific dimers have greater avidity and bispecific dimers are likely to have greater selectivity.  They may therefore have practical potential as specific well-targeting agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1F2Cst_puibVg90H21EOLACvtfcHk0ljBRftCGQc02w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFWgur0%253D&md5=596dd6900a21e7c91d509448f71001c3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2896%2990144-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252896%252990144-1%26sid%3Dliteratum%253Aachs%26aulast%3DCarrithers%26aufirst%3DM.%2BD.%26aulast%3DLerner%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%2520and%2520Characterization%2520of%2520Bivalent%2520Peptide%2520Ligands%2520Targeted%2520to%2520G-Protein-Coupled%2520Receptors%26jtitle%3DChem.%2520Biol.%26date%3D1996%26volume%3D3%26issue%3D7%26spage%3D537%26epage%3D542%26doi%3D10.1016%2FS1074-5521%2896%2990144-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaccard, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kretzschmar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Novel DOTA-Based Prochelator for Divalent Peptide Vectorization: Synthesis of Dimeric Bombesin Analogues for Multimodality Tumor Imaging and Therapy</span>. <i>Chem. Commun. (Cambridge, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">3248</span>– <span class="NLM_lpage">3250</span>, <span class="refDoi"> DOI: 10.1039/b805281f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1039%2Fb805281f" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=18622433" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=3248-3250&author=K.+Abirajauthor=H.+Jaccardauthor=M.+Kretzschmarauthor=L.+Helmauthor=H.+R.+Maecke&title=Novel+DOTA-Based+Prochelator+for+Divalent+Peptide+Vectorization%3A+Synthesis+of+Dimeric+Bombesin+Analogues+for+Multimodality+Tumor+Imaging+and+Therapy&doi=10.1039%2Fb805281f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1039%2Fb805281f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb805281f%26sid%3Dliteratum%253Aachs%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DJaccard%26aufirst%3DH.%26aulast%3DKretzschmar%26aufirst%3DM.%26aulast%3DHelm%26aufirst%3DL.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DNovel%2520DOTA-Based%2520Prochelator%2520for%2520Divalent%2520Peptide%2520Vectorization%253A%2520Synthesis%2520of%2520Dimeric%2520Bombesin%2520Analogues%2520for%2520Multimodality%2520Tumor%2520Imaging%2520and%2520Therapy%26jtitle%3DChem.%2520Commun.%2520%2528Cambridge%252C%2520U.%2520K.%2529%26date%3D2008%26volume%3D28%26spage%3D3248%26epage%3D3250%26doi%3D10.1039%2Fb805281f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gawlak, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiener, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braslawsky, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenfield, R. S.</span></span> <span> </span><span class="NLM_article-title">Homodimeric Forms of Bombesin Act as Potent Antagonists of Bombesin on Swiss 3T3 Cells</span>. <i>Growth Factors</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>5</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.3109/08977199109000280</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.3109%2F08977199109000280" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1991&pages=159-170&issue=2&author=S.+L.+Gawlakauthor=P.+A.+Kienerauthor=G.+R.+Braslawskyauthor=R.+S.+Greenfield&title=Homodimeric+Forms+of+Bombesin+Act+as+Potent+Antagonists+of+Bombesin+on+Swiss+3T3+Cells&doi=10.3109%2F08977199109000280"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3109%2F08977199109000280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F08977199109000280%26sid%3Dliteratum%253Aachs%26aulast%3DGawlak%26aufirst%3DS.%2BL.%26aulast%3DKiener%26aufirst%3DP.%2BA.%26aulast%3DBraslawsky%26aufirst%3DG.%2BR.%26aulast%3DGreenfield%26aufirst%3DR.%2BS.%26atitle%3DHomodimeric%2520Forms%2520of%2520Bombesin%2520Act%2520as%2520Potent%2520Antagonists%2520of%2520Bombesin%2520on%2520Swiss%25203T3%2520Cells%26jtitle%3DGrowth%2520Factors%26date%3D1991%26volume%3D5%26issue%3D2%26spage%3D159%26epage%3D170%26doi%3D10.3109%2F08977199109000280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumulon-Perreault, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ait-Mohand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bénard, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lecomte, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guérin, B.</span></span> <span> </span><span class="NLM_article-title">Comparative Study of <sup>64</sup>Cu/NOTA-[D-Tyr<sup>6</sup>,βAla<sup>11</sup>,Thi<sup>13</sup>,Nle<sup>14</sup>]BBN(6–14) Monomer and Dimers for Prostate Cancer PET Imaging</span>. <i>EJNMMI Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">8</span>, <span class="refDoi"> DOI: 10.1186/2191-219X-2-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1186%2F2191-219X-2-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=22333272" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaksL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2012&pages=8&issue=1&author=P.+Fournierauthor=V.+Dumulon-Perreaultauthor=S.+Ait-Mohandauthor=R.+Langloisauthor=F.+B%C3%A9nardauthor=R.+Lecomteauthor=B.+Gu%C3%A9rin&title=Comparative+Study+of+64Cu%2FNOTA-%5BD-Tyr6%2C%CE%B2Ala11%2CThi13%2CNle14%5DBBN%286%E2%80%9314%29+Monomer+and+Dimers+for+Prostate+Cancer+PET+Imaging&doi=10.1186%2F2191-219X-2-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative study of 64Cu/NOTA-[-Tyr6,βAla11, Thi13, Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging</span></div><div class="casAuthors">Fournier, Patrick; Dumulon-Perreault, Veronique; Ait-Mohand, Samia; Langlois, Rejean; Benard, Francois; Lecomte, Roger; Guerin, Brigitte</div><div class="citationInfo"><span class="NLM_cas:title">EJNMMI Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">ERJEAI</span>;
        ISSN:<span class="NLM_cas:issn">2191-219X</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Background: Gastrin-releasing peptide receptors [GRPR] are highly over-expressed in multiple cancers and have been studied as a diagnostic target.  Multimeric gastrin-releasing peptides are expected to have enhanced tumor uptake and affinity for GRPR.  In this study, a 64Cu-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid [NOTA]- monomer and two NOTA-dimers of [-Tyr6,βAla11, Thi13, Nle14]bombesin(6-14) ] [BBN(6-14)] were compared.  Methods: Monomeric and dimeric peptides were synthesized on solid phase support and radiolabeled with 64Cu.  NOTA-dimer 1 consists of asym. linked BBN(6-14), while NOTA-dimer 2 has similar spacer between the two BBN(6-14) ligands and the chelator.  In vitro GRPR-binding affinities were detd. with competitive binding assays on PC3 human prostate cancer cells.  In vivo stability and biodistribution of radiolabeled compds. were assessed in Balb/c mice.  Cellular uptake and efflux were measured with radiolabeled NOTA-monomer and NOTAdimer 2 on PC3 cells for up to 4 h.  In vivo biodistribution kinetics were measured in PC3 tumor-bearing Balb/c nude mice by μ-positron emission tomog. [μPET] imaging and confirmed by dissection and counting.  Results: NOTA-monomer, NOTA-dimers 1 and 2 were prepd. with purity of 99%.  The inhibition consts. of the three BBN peptides were comparable and in the low nanomolar range.  All 64Cu-labeled peptides were stable up to 24 h in mouse plasma and 1 h in vivo.  64Cu/NOTA-dimer 2 featuring a longer spacer between the two BBN(6-14) ligands is a more potent GRPR-targeting probe than 64Cu/NOTA-dimer 1.  PC3 tumor uptake profiles are slightly different for 64Cu/NOTA-monomer and 64Cu/NOTA-dimer 2; the monomeric BBN-peptide tracer exhibited higher tumor uptake during the first 0.5 h and a fast renal clearance resulting in higher tumor-to-muscle ratio when compared to 64Cu/NOTA-dimer 2.  The latter exhibited higher tumor-to-blood ratio and was retained longer at the tumor site when compared to 64Cu/NOTA-monomer.  Lower ratios of tumor-to-blood and tumor-to-muscle in blocking expts. showed GRPR-dependant tumor uptake for both tracers.  Conclusion: Both 64Cu/NOTA-monomer and 64Cu/NOTA-dimer 2 are suitable for detecting GRPR-pos. prostate cancer in vivo by PET.  Tumor retention was improved in vivo with 64Cu/NOTA-dimer 2 by applying polyvalency effect and/or statistical rebinding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpphGC1jlwklrVg90H21EOLACvtfcHk0ljLo3b_FcyFFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaksL%252FJ&md5=0773e92b6d6cfe89f71b2d2c0e3fc706</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1186%2F2191-219X-2-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2191-219X-2-8%26sid%3Dliteratum%253Aachs%26aulast%3DFournier%26aufirst%3DP.%26aulast%3DDumulon-Perreault%26aufirst%3DV.%26aulast%3DAit-Mohand%26aufirst%3DS.%26aulast%3DLanglois%26aufirst%3DR.%26aulast%3DB%25C3%25A9nard%26aufirst%3DF.%26aulast%3DLecomte%26aufirst%3DR.%26aulast%3DGu%25C3%25A9rin%26aufirst%3DB.%26atitle%3DComparative%2520Study%2520of%252064Cu%252FNOTA-%255BD-Tyr6%252C%25CE%25B2Ala11%252CThi13%252CNle14%255DBBN%25286%25E2%2580%259314%2529%2520Monomer%2520and%2520Dimers%2520for%2520Prostate%2520Cancer%2520PET%2520Imaging%26jtitle%3DEJNMMI%2520Res.%26date%3D2012%26volume%3D2%26issue%3D1%26spage%3D8%26doi%3D10.1186%2F2191-219X-2-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlucci, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ananias, H. J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dierckx, R. A. J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helfrich, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jong, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsinga, P. H.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a Technetium-99m Labeled Bombesin Homodimer for GRPR Imaging in Prostate Cancer</span>. <i>Amino Acids</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>44</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">543</span>– <span class="NLM_lpage">553</span>, <span class="refDoi"> DOI: 10.1007/s00726-012-1369-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00726-012-1369-9" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2013&pages=543-553&issue=2&author=Z.+Yuauthor=G.+Carlucciauthor=H.+J.+K.+Ananiasauthor=R.+A.+J.+O.+Dierckxauthor=S.+Liuauthor=W.+Helfrichauthor=F.+Wangauthor=I.+J.+de+Jongauthor=P.+H.+Elsinga&title=Evaluation+of+a+Technetium-99m+Labeled+Bombesin+Homodimer+for+GRPR+Imaging+in+Prostate+Cancer&doi=10.1007%2Fs00726-012-1369-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00726-012-1369-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00726-012-1369-9%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DZ.%26aulast%3DCarlucci%26aufirst%3DG.%26aulast%3DAnanias%26aufirst%3DH.%2BJ.%2BK.%26aulast%3DDierckx%26aufirst%3DR.%2BA.%2BJ.%2BO.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DHelfrich%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DF.%26aulast%3Dde%2BJong%26aufirst%3DI.%2BJ.%26aulast%3DElsinga%26aufirst%3DP.%2BH.%26atitle%3DEvaluation%2520of%2520a%2520Technetium-99m%2520Labeled%2520Bombesin%2520Homodimer%2520for%2520GRPR%2520Imaging%2520in%2520Prostate%2520Cancer%26jtitle%3DAmino%2520Acids%26date%3D2013%26volume%3D44%26issue%3D2%26spage%3D543%26epage%3D553%26doi%3D10.1007%2Fs00726-012-1369-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koczan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuettenberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmieder, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dimitrakopoulou-Strauss, A.</span></span> <span> </span><span class="NLM_article-title">Correlation of the Ga-68-Bombesin Analog Ga-68-BZH3 with Receptors Expression in Gliomas as Measured by Quantitative Dynamic Positron Emission Tomography (dPET) and Gene Arrays</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">376</span>– <span class="NLM_lpage">383</span>, <span class="refDoi"> DOI: 10.1007/s11307-011-0508-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs11307-011-0508-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=21744169" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BC38zkvVehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=376-383&issue=3&author=L.+G.+Straussauthor=D.+Koczanauthor=M.+Seizauthor=J.+Tuettenbergauthor=K.+Schmiederauthor=L.+Panauthor=C.+Chengauthor=A.+Dimitrakopoulou-Strauss&title=Correlation+of+the+Ga-68-Bombesin+Analog+Ga-68-BZH3+with+Receptors+Expression+in+Gliomas+as+Measured+by+Quantitative+Dynamic+Positron+Emission+Tomography+%28dPET%29+and+Gene+Arrays&doi=10.1007%2Fs11307-011-0508-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of the Ga-68-bombesin analog Ga-68-BZH3 with receptors expression in gliomas as measured by quantitative dynamic positron emission tomography (dPET) and gene arrays</span></div><div class="casAuthors">Strauss Ludwig G; Koczan Dirk; Seiz Marcel; Tuettenberg Jochen; Schmieder Kirsten; Pan Leyun; Cheng Caixia; Dimitrakopoulou-Strauss Antonia</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">376-83</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  The kinetics of Ga-68-BZH3, a Ga-68-bombesin analog, was compared to molecular biological data obtained from gene arrays in seven patients with a recurrent glioma.  The primary aim of this study was the correlation of receptor expression and tracer kinetics.  PROCEDURES:  Dynamic positron emission tomography studies were performed and the data were analyzed by a volume-of-interest technique using a two-tissue compartment model as well as a non-compartment model.  Gene array data were obtained from gene array analysis of tumor tissue samples.  RESULTS:  The correlation analysis revealed a significant nonlinear correlation of r = 0.89 (p < 0.03) for k1 and BB(2) (gastrin-releasing peptide receptor).  BB(1) and BB(3) were not significantly correlated with k1. vb and k3 were not significantly correlated with the expression data of the receptors on the p < 0.05 level.  CONCLUSIONS:  The parameter k1 is correlated with the expression of BB(2) based on gene array data.  The quantitative analysis of the Ga-68-BZH3 kinetics can be used to predict the receptor expression of BB(2) in gliomas based on k1 of the compartment analysis.  However, this study is limited to the expression data on the mRNA level and further studies are needed to assess the correlation of gene expression on the protein level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHdHQtkCqfRTC850By6mxpfW6udTcc2eY-uhBhXIRYtrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38zkvVehtw%253D%253D&md5=805fcded5cd13feba23a2021ddb57213</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1007%2Fs11307-011-0508-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-011-0508-0%26sid%3Dliteratum%253Aachs%26aulast%3DStrauss%26aufirst%3DL.%2BG.%26aulast%3DKoczan%26aufirst%3DD.%26aulast%3DSeiz%26aufirst%3DM.%26aulast%3DTuettenberg%26aufirst%3DJ.%26aulast%3DSchmieder%26aufirst%3DK.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DC.%26aulast%3DDimitrakopoulou-Strauss%26aufirst%3DA.%26atitle%3DCorrelation%2520of%2520the%2520Ga-68-Bombesin%2520Analog%2520Ga-68-BZH3%2520with%2520Receptors%2520Expression%2520in%2520Gliomas%2520as%2520Measured%2520by%2520Quantitative%2520Dynamic%2520Positron%2520Emission%2520Tomography%2520%2528dPET%2529%2520and%2520Gene%2520Arrays%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26issue%3D3%26spage%3D376%26epage%3D383%26doi%3D10.1007%2Fs11307-011-0508-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Minamimoto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, F. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamali, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loening, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasanawala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gambhir, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iagaru, A.</span></span> <span> </span><span class="NLM_article-title">Pilot Comparison of <sup>68</sup>Ga-RM2 PET and <sup>68</sup>Ga-PSMA-11 PET in Patients with Biochemically Recurrent Prostate Cancer</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">557</span>– <span class="NLM_lpage">562</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.168393</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.115.168393" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=557-562&issue=4&author=R.+Minamimotoauthor=S.+Hancockauthor=B.+Schneiderauthor=F.+T.+Chinauthor=M.+Jamaliauthor=A.+Loeningauthor=S.+Vasanawalaauthor=S.+S.+Gambhirauthor=A.+Iagaru&title=Pilot+Comparison+of+68Ga-RM2+PET+and+68Ga-PSMA-11+PET+in+Patients+with+Biochemically+Recurrent+Prostate+Cancer&doi=10.2967%2Fjnumed.115.168393"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.168393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.168393%26sid%3Dliteratum%253Aachs%26aulast%3DMinamimoto%26aufirst%3DR.%26aulast%3DHancock%26aufirst%3DS.%26aulast%3DSchneider%26aufirst%3DB.%26aulast%3DChin%26aufirst%3DF.%2BT.%26aulast%3DJamali%26aufirst%3DM.%26aulast%3DLoening%26aufirst%3DA.%26aulast%3DVasanawala%26aufirst%3DS.%26aulast%3DGambhir%26aufirst%3DS.%2BS.%26aulast%3DIagaru%26aufirst%3DA.%26atitle%3DPilot%2520Comparison%2520of%252068Ga-RM2%2520PET%2520and%252068Ga-PSMA-11%2520PET%2520in%2520Patients%2520with%2520Biochemically%2520Recurrent%2520Prostate%2520Cancer%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26issue%3D4%26spage%3D557%26epage%3D562%26doi%3D10.2967%2Fjnumed.115.168393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waser, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borkowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Development of a Potent DOTA-Conjugated Bombesin Antagonist for Targeting GRPr-Positive Tumours</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1007/s00259-010-1596-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-010-1596-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=20717822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2gtLvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=97-107&issue=1&author=R.+Mansiauthor=X.+Wangauthor=F.+Forrerauthor=B.+Waserauthor=R.+Cescatoauthor=K.+Grahamauthor=S.+Borkowskiauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Development+of+a+Potent+DOTA-Conjugated+Bombesin+Antagonist+for+Targeting+GRPr-Positive+Tumours&doi=10.1007%2Fs00259-010-1596-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a potent DOTA-conjugated bombesin antagonist for targeting GRPr-positive tumours</span></div><div class="casAuthors">Mansi, Rosalba; Wang, Xuejuan; Forrer, Flavio; Waser, Beatrice; Cescato, Renzo; Graham, Keith; Borkowski, Sandra; Reubi, Jean Claude; Maecke, Helmut R.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-107</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Radiolabeled somatostatin-based antagonists show a higher uptake in tumor-bearing mouse models than agonists of similar or even distinctly higher receptor affinity.  Very similar results were obtained with another family of G protein-coupled receptor ligands, the bombesin family.  We describe a new conjugate, RM2, with the chelator DOTA coupled to D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2 via the cationic spacer 4-amino-1-carboxymethyl-piperidine for labeling with radiometals such as 111In and 68Ga.  Methods: RM2 was synthesized on a solid support and evaluated in vitro in PC-3 cells.  IC50 and Kd values were detd.  The antagonist potency was evaluated by immunofluorescence-based internalization and Ca2+ mobilization assays.  Biodistribution studies were performed in PC-3 and LNCaP tumor-bearing mice with 111In-RM2 and 68Ga-RM2, resp.  PET/CT studies were performed on PC-3 and LNCaP tumor-bearing nude mice with 68Ga-RM2.  Results: RM2 and 111In-RM2 are high-affinity and selective ligands for the GRP receptor (7.7±3.3 nmol/l for RM2; 9.3±3.3 nmol/l for natIn-RM2).  The potent antagonistic properties were confirmed by an immunofluorescence-based internalization and Ca2+ mobilization assays. 68Ga- and 111In-RM2 showed high and specific uptake in both the tumor and the pancreas.  Uptake in the tumor remained high (15.2±4.8%IA/g at 1 h; 11.7±2.4%IA/g at 4 h), whereas a relatively fast washout from the pancreas and the other abdominal organs was obsd.  Uptake in the pancreas decreased rapidly from 22.6±4.7%IA/g at 1 h to 1.5±0.5%IA/g at 4 h.  Conclusion: RM2 was shown to be a potent GRPr antagonist.  Pharmacokinetics and imaging studies indicate that 111In-RM2 and 68Ga-RM2 are ideal candidates for clin. SPECT and PET studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiAsvAlokOzLVg90H21EOLACvtfcHk0ljqvZTtRPtK1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2gtLvJ&md5=f3b9a6bfaf46bd8cbf0bfc7db8c2d764</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00259-010-1596-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-010-1596-9%26sid%3Dliteratum%253Aachs%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DForrer%26aufirst%3DF.%26aulast%3DWaser%26aufirst%3DB.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DBorkowski%26aufirst%3DS.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DDevelopment%2520of%2520a%2520Potent%2520DOTA-Conjugated%2520Bombesin%2520Antagonist%2520for%2520Targeting%2520GRPr-Positive%2520Tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2011%26volume%3D38%26issue%3D1%26spage%3D97%26epage%3D107%26doi%3D10.1007%2Fs00259-010-1596-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zaknun, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Brand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavel, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baum, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hörsch, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dorisio, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Dorisiol, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cremonesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwekkeboom, D. J.</span></span> <span> </span><span class="NLM_article-title">The Joint IAEA, EANM, and SNMMI Practical Guidance on Peptide Receptor Radionuclide Therapy (PRRNT) in Neuroendocrine Tumours</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">816</span>, <span class="refDoi"> DOI: 10.1007/s00259-012-2330-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-012-2330-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=23389427" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmt1OgsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=800-816&issue=5&author=J.+J.+Zaknunauthor=L.+Bodeiauthor=J.+Mueller-Brandauthor=M.+E.+Pavelauthor=R.+P.+Baumauthor=D.+H%C3%B6rschauthor=M.+S.+O%E2%80%99Dorisioauthor=T.+M.+O%E2%80%99Dorisiolauthor=J.+R.+Howeauthor=M.+Cremonesiauthor=D.+J.+Kwekkeboom&title=The+Joint+IAEA%2C+EANM%2C+and+SNMMI+Practical+Guidance+on+Peptide+Receptor+Radionuclide+Therapy+%28PRRNT%29+in+Neuroendocrine+Tumours&doi=10.1007%2Fs00259-012-2330-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours</span></div><div class="casAuthors">Zaknun, John J.; Bodei, L.; Mueller-Brand, J.; Pavel, M. E.; Baum, R. P.; Hoersch, D.; O'Dorisio, M. S.; O'Dorisiol, T. M.; Howe, J. R.; Cremonesi, M.; Kwekkeboom, D. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">800-816</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Peptide receptor radionuclide therapy (PRRNT) is a molecularly targeted radiation therapy involving the systemic administration of a radiolabeled peptide designed to target with high affinity and specificity receptors overexpressed on tumors.  PRRNT employing the radiotagged somatostatin receptor agonists 90Y-DOTATOC ([90Y-DOTA0,Tyr3]-octreotide) or 177Lu-DOTATATE ([177Lu-DOTA0,Tyr3,Thr8]-octreotide or [177Lu-DOTA0,Tyr3]-octreotate) have been successfully used for the past 15 years to target metastatic or inoperable neuroendocrine tumors expressing the somatostatin receptor subtype 2.  Accumulated evidence from clin. experience indicates that these tumors can be subjected to a high absorbed dose which leads to partial or complete objective responses in up to 30 % of treated patients.  Survival analyses indicate that patients presenting with high tumor receptor expression at study entry and receiving 177Lu-DOTATATE or 90Y-DOTATOC treatment show significantly higher objective responses, leading to longer survival and improved quality of life.  Side effects of PRRNT are typically seen in the kidneys and bone marrow.  These, however, are usually mild provided adequate protective measures are undertaken.  Despite the large body of evidence regarding efficacy and clin. safety, PRRNT is still considered an investigational treatment and its implementation must comply with national legislation, and ethical guidelines concerning human therapeutic investigations.  This guidance was formulated based on recent literature and leading experts' opinions.  It covers the rationale, indications and contraindications for PRRNT, assessment of treatment response and patient follow-up.  This document is aimed at guiding nuclear medicine specialists in selecting likely candidates to receive PRRNT and to deliver the treatment in a safe and effective manner.  This document is largely based on the book published through a joint international effort under the auspices of the Nuclear Medicine Section of the International Atomic Energy Agency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0CTc3ejXDIrVg90H21EOLACvtfcHk0ljqvZTtRPtK1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmt1OgsrY%253D&md5=49fb597ad447cbb1c9a3f12d5e5644be</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2330-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2330-6%26sid%3Dliteratum%253Aachs%26aulast%3DZaknun%26aufirst%3DJ.%2BJ.%26aulast%3DBodei%26aufirst%3DL.%26aulast%3DMueller-Brand%26aufirst%3DJ.%26aulast%3DPavel%26aufirst%3DM.%2BE.%26aulast%3DBaum%26aufirst%3DR.%2BP.%26aulast%3DH%25C3%25B6rsch%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Dorisio%26aufirst%3DM.%2BS.%26aulast%3DO%25E2%2580%2599Dorisiol%26aufirst%3DT.%2BM.%26aulast%3DHowe%26aufirst%3DJ.%2BR.%26aulast%3DCremonesi%26aufirst%3DM.%26aulast%3DKwekkeboom%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Joint%2520IAEA%252C%2520EANM%252C%2520and%2520SNMMI%2520Practical%2520Guidance%2520on%2520Peptide%2520Receptor%2520Radionuclide%2520Therapy%2520%2528PRRNT%2529%2520in%2520Neuroendocrine%2520Tumours%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26issue%3D5%26spage%3D800%26epage%3D816%26doi%3D10.1007%2Fs00259-012-2330-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babich, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span> <span> </span><span class="NLM_article-title">PSMA as a Target for Radiolabelled Small Molecules</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">819</span>– <span class="NLM_lpage">823</span>, <span class="refDoi"> DOI: 10.1007/s00259-013-2374-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-013-2374-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=23463331" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BC3svjsFSjsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=819-823&issue=6&author=M.+Ederauthor=M.+Eisenhutauthor=J.+Babichauthor=U.+Haberkorn&title=PSMA+as+a+Target+for+Radiolabelled+Small+Molecules&doi=10.1007%2Fs00259-013-2374-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">PSMA as a target for radiolabelled small molecules</span></div><div class="casAuthors">Eder Matthias; Eisenhut Michael; Babich John; Haberkorn Uwe</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">819-23</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQWV4uZ6DElrHO4gDb7JggCfW6udTcc2ebmxGUYOqt4MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svjsFSjsQ%253D%253D&md5=2e1b63f6f70015f72227b98c04a955a4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2374-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2374-2%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DEisenhut%26aufirst%3DM.%26aulast%3DBabich%26aufirst%3DJ.%26aulast%3DHaberkorn%26aufirst%3DU.%26atitle%3DPSMA%2520as%2520a%2520Target%2520for%2520Radiolabelled%2520Small%2520Molecules%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26issue%3D6%26spage%3D819%26epage%3D823%26doi%3D10.1007%2Fs00259-013-2374-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Nahhas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Win, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szyszko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubello, D.</span></span> <span> </span><span class="NLM_article-title">What Can Gallium-68 PET Add to Receptor and Molecular Imaging?</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1897</span>– <span class="NLM_lpage">1901</span>, <span class="refDoi"> DOI: 10.1007/s00259-007-0568-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1007%2Fs00259-007-0568-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=17713764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A280%3ADC%252BD2sjhsFymsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=1897-1901&issue=12&author=A.+Al-Nahhasauthor=Z.+Winauthor=T.+Szyszkoauthor=A.+Singhauthor=S.+Khanauthor=D.+Rubello&title=What+Can+Gallium-68+PET+Add+to+Receptor+and+Molecular+Imaging%3F&doi=10.1007%2Fs00259-007-0568-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">What can gallium-68 PET add to receptor and molecular imaging?</span></div><div class="casAuthors">Al-Nahhas Adil; Win Zarni; Szyszko Teresa; Singh Aviral; Khan Sameer; Rubello Domenico</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1897-901</span>
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQNwYR8FsSp6-9TkgmBqTqfW6udTcc2ebmxGUYOqt4MLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sjhsFymsg%253D%253D&md5=bb9c22a2e455cae4f80fd000b0ed16f1</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1007%2Fs00259-007-0568-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-007-0568-1%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Nahhas%26aufirst%3DA.%26aulast%3DWin%26aufirst%3DZ.%26aulast%3DSzyszko%26aufirst%3DT.%26aulast%3DSingh%26aufirst%3DA.%26aulast%3DKhan%26aufirst%3DS.%26aulast%3DRubello%26aufirst%3DD.%26atitle%3DWhat%2520Can%2520Gallium-68%2520PET%2520Add%2520to%2520Receptor%2520and%2520Molecular%2520Imaging%253F%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2007%26volume%3D34%26issue%3D12%26spage%3D1897%26epage%3D1901%26doi%3D10.1007%2Fs00259-007-0568-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abiraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamma, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cescato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reubi, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maecke, H. R.</span></span> <span> </span><span class="NLM_article-title">Bombesin Antagonist-Based Radioligands for Translational Nuclear Imaging of Gastrin-Releasing Peptide Receptor-Positive Tumors</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1970</span>– <span class="NLM_lpage">1978</span>, <span class="refDoi"> DOI: 10.2967/jnumed.111.094375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.111.094375" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1970-1978&issue=12&author=K.+Abirajauthor=R.+Mansiauthor=M.-L.+Tammaauthor=M.+Faniauthor=F.+Forrerauthor=G.+Nicolasauthor=R.+Cescatoauthor=J.+C.+Reubiauthor=H.+R.+Maecke&title=Bombesin+Antagonist-Based+Radioligands+for+Translational+Nuclear+Imaging+of+Gastrin-Releasing+Peptide+Receptor-Positive+Tumors&doi=10.2967%2Fjnumed.111.094375"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.111.094375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.111.094375%26sid%3Dliteratum%253Aachs%26aulast%3DAbiraj%26aufirst%3DK.%26aulast%3DMansi%26aufirst%3DR.%26aulast%3DTamma%26aufirst%3DM.-L.%26aulast%3DFani%26aufirst%3DM.%26aulast%3DForrer%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DG.%26aulast%3DCescato%26aufirst%3DR.%26aulast%3DReubi%26aufirst%3DJ.%2BC.%26aulast%3DMaecke%26aufirst%3DH.%2BR.%26atitle%3DBombesin%2520Antagonist-Based%2520Radioligands%2520for%2520Translational%2520Nuclear%2520Imaging%2520of%2520Gastrin-Releasing%2520Peptide%2520Receptor-Positive%2520Tumors%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26issue%3D12%26spage%3D1970%26epage%3D1978%26doi%3D10.2967%2Fjnumed.111.094375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halmos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schally, A. V.</span></span> <span> </span><span class="NLM_article-title">Reduction in Receptors for Bombesin and Epidermal Growth Factor in Xenografts of Human Small-Cell Lung Cancer after Treatment with Bombesin Antagonist RC-3095</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>94</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">956</span>– <span class="NLM_lpage">960</span>, <span class="refDoi"> DOI: 10.1073/pnas.94.3.956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1073%2Fpnas.94.3.956" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=956-960&issue=3&author=G.+Halmosauthor=A.+V.+Schally&title=Reduction+in+Receptors+for+Bombesin+and+Epidermal+Growth+Factor+in+Xenografts+of+Human+Small-Cell+Lung+Cancer+after+Treatment+with+Bombesin+Antagonist+RC-3095&doi=10.1073%2Fpnas.94.3.956"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.3.956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.3.956%26sid%3Dliteratum%253Aachs%26aulast%3DHalmos%26aufirst%3DG.%26aulast%3DSchally%26aufirst%3DA.%2BV.%26atitle%3DReduction%2520in%2520Receptors%2520for%2520Bombesin%2520and%2520Epidermal%2520Growth%2520Factor%2520in%2520Xenografts%2520of%2520Human%2520Small-Cell%2520Lung%2520Cancer%2520after%2520Treatment%2520with%2520Bombesin%2520Antagonist%2520RC-3095%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D3%26spage%3D956%26epage%3D960%26doi%3D10.1073%2Fpnas.94.3.956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varasteh, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitran, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenström, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velikyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosestedt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindeberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sörensen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlova, A.</span></span> <span> </span><span class="NLM_article-title">The Effect of Macrocyclic Chelators on the Targeting Properties of the <sup>68</sup>Ga-Labeled Gastrin Releasing Peptide Receptor Antagonist PEG<sub>2</sub>-RM26</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">446</span>– <span class="NLM_lpage">454</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.nucmedbio.2014.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=25684649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC2MXivVSjtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=446-454&issue=5&author=Z.+Varastehauthor=B.+Mitranauthor=U.+Rosenstr%C3%B6mauthor=I.+Velikyanauthor=M.+Rosestedtauthor=G.+Lindebergauthor=J.+S%C3%B6rensenauthor=M.+Larhedauthor=V.+Tolmachevauthor=A.+Orlova&title=The+Effect+of+Macrocyclic+Chelators+on+the+Targeting+Properties+of+the+68Ga-Labeled+Gastrin+Releasing+Peptide+Receptor+Antagonist+PEG2-RM26&doi=10.1016%2Fj.nucmedbio.2014.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26</span></div><div class="casAuthors">Varasteh, Zohreh; Mitran, Bogdan; Rosenstroem, Ulrika; Velikyan, Irina; Rosestedt, Maria; Lindeberg, Gunnar; Soerensen, Jens; Larhed, Mats; Tolmachev, Vladimir; Orlova, Anna</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-454</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Overexpression of gastrin-releasing peptide receptors (GRPR) has been reported in several cancers.  Bombesin (BN) analogs are short peptides with a high affinity for GRPR.  Different BN analogs were evaluated for radionuclide imaging and therapy of GRPR-expressing tumors.  We have previously investigated an antagonistic analog of BN (D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2, RM26) conjugated to NOTA via a PEG2 spacer (NOTA-PEG2-RM26) labeled with 68Ga, 111In and Al18F. 68Ga-labeled NOTA-PEG2-RM26 showed high tumor-to-organ ratios.  The influence of different macrocyclic chelators (NOTA, NODAGA, DOTA and DOTAGA) on the targeting properties of 68Ga-labeled PEG2-RM26 was studied in vitro and in vivo.  All conjugates were labeled with generator-produced 68Ga with high yields and demonstrated high stability and specific binding to GRPR.  The IC50 values of natGa-X-PEG2-RM26 (X = NOTA, DOTA, NODAGA, DOTAGA) were 2.3 ± 0.2, 3.0 ± 0.3, 2.9 ± 0.3 and 10.0 ± 0.6 nM, resp.  The internalization of the conjugates by PC-3 cells was low.  However, the DOTA-conjugated analog demonstrated a higher internalization rate compared to other analogs.  GRPR-specific uptake was found in receptor-pos. normal tissues and PC-3 xenografts for all conjugates.  The biodistribution of the conjugates was influenced by the choice of the chelator moiety.  Although all radiotracers cleared rapidly from the blood, [68Ga]Ga-NOTA-PEG2-RM26 showed significantly lower uptake in lung, muscle and bone compared to the other analogs.  The uptake in tumors (5.40 ± 1.04 %ID/g at 2 h p.i.) and the tumor-to-organ ratios (25 ± 3, 157 ± 23 and 39 ± 4 for blood, muscle and bone, resp.) were significantly higher for the NOTA-conjugate than the other analogs.  Chelators had a clear influence on the biodistribution and targeting properties of 68Ga-labeled antagonistic BN analogs.  Pos. charged [68Ga]Ga-NOTA-PEG2-RM26 provided a low kidney radioactivity uptake, high affinity, high tumor uptake and high image contrast.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq8-ZMoClJ4j7Vg90H21EOLACvtfcHk0ljFRhRjJrMQKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXivVSjtLw%253D&md5=ce275834a01ad4241f3402e64ce68ccb</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DVarasteh%26aufirst%3DZ.%26aulast%3DMitran%26aufirst%3DB.%26aulast%3DRosenstr%25C3%25B6m%26aufirst%3DU.%26aulast%3DVelikyan%26aufirst%3DI.%26aulast%3DRosestedt%26aufirst%3DM.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DJ.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DThe%2520Effect%2520of%2520Macrocyclic%2520Chelators%2520on%2520the%2520Targeting%2520Properties%2520of%2520the%252068Ga-Labeled%2520Gastrin%2520Releasing%2520Peptide%2520Receptor%2520Antagonist%2520PEG2-RM26%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2015%26volume%3D42%26issue%3D5%26spage%3D446%26epage%3D454%26doi%3D10.1016%2Fj.nucmedbio.2014.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Varasteh, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberg, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velikyan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindeberg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sörensen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larhed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orlova, A.</span></span> <span> </span><span class="NLM_article-title">In Vitro and in Vivo Evaluation of a <sup>18</sup>F-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">e81932</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0081932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1371%2Fjournal.pone.0081932" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=e81932&issue=12&author=Z.+Varastehauthor=O.+Abergauthor=I.+Velikyanauthor=G.+Lindebergauthor=J.+S%C3%B6rensenauthor=M.+Larhedauthor=G.+Antoniauthor=M.+Sandstr%C3%B6mauthor=V.+Tolmachevauthor=A.+Orlova&title=In+Vitro+and+in+Vivo+Evaluation+of+a+18F-Labeled+High+Affinity+NOTA+Conjugated+Bombesin+Antagonist+as+a+PET+Ligand+for+GRPR-Targeted+Tumor+Imaging&doi=10.1371%2Fjournal.pone.0081932"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0081932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0081932%26sid%3Dliteratum%253Aachs%26aulast%3DVarasteh%26aufirst%3DZ.%26aulast%3DAberg%26aufirst%3DO.%26aulast%3DVelikyan%26aufirst%3DI.%26aulast%3DLindeberg%26aufirst%3DG.%26aulast%3DS%25C3%25B6rensen%26aufirst%3DJ.%26aulast%3DLarhed%26aufirst%3DM.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DSandstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTolmachev%26aufirst%3DV.%26aulast%3DOrlova%26aufirst%3DA.%26atitle%3DIn%2520Vitro%2520and%2520in%2520Vivo%2520Evaluation%2520of%2520a%252018F-Labeled%2520High%2520Affinity%2520NOTA%2520Conjugated%2520Bombesin%2520Antagonist%2520as%2520a%2520PET%2520Ligand%2520for%2520GRPR-Targeted%2520Tumor%2520Imaging%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D12%26spage%3De81932%26doi%3D10.1371%2Fjournal.pone.0081932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maddalena, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cagnolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linder, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweedle, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunn, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lantry, L. E.</span></span> <span> </span><span class="NLM_article-title"><sup>177</sup>Lu-AMBA Biodistribution, Radiotherapeutic Efficacy, Imaging, and Autoradiography in Prostate Cancer Models with Low GRP-R Expression</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">2017</span>– <span class="NLM_lpage">2024</span>, <span class="refDoi"> DOI: 10.2967/jnumed.109.064444</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.2967%2Fjnumed.109.064444" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=2017-2024&issue=12&author=M.+E.+Maddalenaauthor=J.+Foxauthor=J.+Chenauthor=W.+Fengauthor=A.+Cagnoliniauthor=K.+E.+Linderauthor=M.+F.+Tweedleauthor=A.+D.+Nunnauthor=L.+E.+Lantry&title=177Lu-AMBA+Biodistribution%2C+Radiotherapeutic+Efficacy%2C+Imaging%2C+and+Autoradiography+in+Prostate+Cancer+Models+with+Low+GRP-R+Expression&doi=10.2967%2Fjnumed.109.064444"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.109.064444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.109.064444%26sid%3Dliteratum%253Aachs%26aulast%3DMaddalena%26aufirst%3DM.%2BE.%26aulast%3DFox%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DW.%26aulast%3DCagnolini%26aufirst%3DA.%26aulast%3DLinder%26aufirst%3DK.%2BE.%26aulast%3DTweedle%26aufirst%3DM.%2BF.%26aulast%3DNunn%26aufirst%3DA.%2BD.%26aulast%3DLantry%26aufirst%3DL.%2BE.%26atitle%3D177Lu-AMBA%2520Biodistribution%252C%2520Radiotherapeutic%2520Efficacy%252C%2520Imaging%252C%2520and%2520Autoradiography%2520in%2520Prostate%2520Cancer%2520Models%2520with%2520Low%2520GRP-R%2520Expression%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26issue%3D12%26spage%3D2017%26epage%3D2024%26doi%3D10.2967%2Fjnumed.109.064444" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Retzloff, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzke, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figureoa, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sublett, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sieckman, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rold, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of [<sup>99m</sup>Tc-(CO)<sub>3</sub>-X-Y-bombesin(7-14)NH<sub>2</sub>] Conjugates for Targeting Gastrin-Releasing Peptide Receptors Overexpressed on Breast Carcinoma</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">19</span>– <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=20150613" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVymtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=19-30&issue=1&author=L.+B.+Retzloffauthor=L.+Heinzkeauthor=S.+D.+Figureoaauthor=S.+V.+Sublettauthor=L.+Maauthor=G.+L.+Sieckmanauthor=T.+L.+Roldauthor=I.+Santosauthor=T.+J.+Hoffmanauthor=C.+J.+Smith&title=Evaluation+of+%5B99mTc-%28CO%293-X-Y-bombesin%287-14%29NH2%5D+Conjugates+for+Targeting+Gastrin-Releasing+Peptide+Receptors+Overexpressed+on+Breast+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of [99mTc-(CO)3-X-Y-bombesin(7-14)NH2] conjugates for targeting gastrin-releasing peptide receptors overexpressed on breast carcinoma</span></div><div class="casAuthors">Retzloff, Lauren B.; Heinzke, Laura; Figureoa, Said D.; Sublett, Samantha V.; Ma, Lixin; Sieckman, Gary L.; Rold, Tammy L.; Santos, Isabel; Hoffman, Timothy J.; Smith, Charles J.</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-30</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">Background: Gastrin-releasing peptide (GRP) receptors are overexpressed on a variety of human carcinomas, including those of the breast.  These receptors may be targeted with bombesin (BBN), which binds to GRP receptors with high affinity and specificity.  The aim of this study was to develop a 99mTc(I)-BBN analog with favorable pharmacokinetic properties in order to improve the visualization of breast cancer tissue.  Materials and Methods: Solid-phase peptide synthesis was used to produce a series of X-Y-BBN-NH2 conjugates, where X is pyrazolyl (PZ1) or 2,3-diaminopropionic acid (DPR) and Y is a spacer sequence.  Their metalated counterparts were prepd. by reacting [99mTc-(H2O)3(CO)3]+ with the corresponding ligand.  Results: While the PZ1 conjugates exhibited higher GRP receptor binding affinities in vitro, the DPR analogs demonstrated superior target tissue accumulation and pharmacokinetic properties in vivo.  Conclusion: These results demonstrate the ability of the DPR derivs. (Y=glycylserylglycine, triserine) to clearly identify the T47-D tumor tissue in xenografted SCID mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ04fN5ANys7Vg90H21EOLACvtfcHk0lg71d3ntW_Mkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVymtb8%253D&md5=5bc920cde43e8b31afe1e730e402c3f0</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRetzloff%26aufirst%3DL.%2BB.%26aulast%3DHeinzke%26aufirst%3DL.%26aulast%3DFigureoa%26aufirst%3DS.%2BD.%26aulast%3DSublett%26aufirst%3DS.%2BV.%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSieckman%26aufirst%3DG.%2BL.%26aulast%3DRold%26aufirst%3DT.%2BL.%26aulast%3DSantos%26aufirst%3DI.%26aulast%3DHoffman%26aufirst%3DT.%2BJ.%26aulast%3DSmith%26aufirst%3DC.%2BJ.%26atitle%3DEvaluation%2520of%2520%255B99mTc-%2528CO%25293-X-Y-bombesin%25287-14%2529NH2%255D%2520Conjugates%2520for%2520Targeting%2520Gastrin-Releasing%2520Peptide%2520Receptors%2520Overexpressed%2520on%2520Breast%2520Carcinoma%26jtitle%3DAnticancer%2520Res.%26date%3D2010%26volume%3D30%26issue%3D1%26spage%3D19%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giacchetti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauvillé, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Crémoux, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abita, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuttitta, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo, F.</span></span> <span> </span><span class="NLM_article-title">Characterization, in Some Human Breast Cancer Cell Lines, of Gastrin-Releasing Peptide-like Receptors Which Are Absent in Normal Breast Epithelial Cells</span>. <i>Int. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>46</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">298</span>, <span class="refDoi"> DOI: 10.1002/ijc.2910460226</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1002%2Fijc.2910460226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=2166713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADyaK3MXhtF2ntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1990&pages=293-298&issue=2&author=S.+Giacchettiauthor=C.+Gauvill%C3%A9author=P.+de+Cr%C3%A9mouxauthor=L.+Bertinauthor=P.+Berthonauthor=J.+P.+Abitaauthor=F.+Cuttittaauthor=F.+Calvo&title=Characterization%2C+in+Some+Human+Breast+Cancer+Cell+Lines%2C+of+Gastrin-Releasing+Peptide-like+Receptors+Which+Are+Absent+in+Normal+Breast+Epithelial+Cells&doi=10.1002%2Fijc.2910460226"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization, in some human breast cancer cell lines, of gastrin-releasing peptide-like receptors which are absent in normal breast epithelial cells</span></div><div class="casAuthors">Giacchetti, Sylvie; Gauville, Christiane; De Cremoux, Patricia; Bertin, Laurent; Berthon, Philippe; Abita, Jean Pierre; Cuttitta, Franck; Calvo, Fabien</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Cancer</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">293-8</span>CODEN:
                <span class="NLM_cas:coden">IJCNAW</span>;
        ISSN:<span class="NLM_cas:issn">0020-7136</span>.
    </div><div class="casAbstract">The binding of 125I-Tyr4 bombesin was investigated on plasma membranes of 8 human breast cancer cell lines and 2 long-term cultures of normal human breast epithelial cells.  Scatchard plots were compatible with high-affinity, single-site class of receptors in 3 cell lines (KD of 0.75 × 10-9 and 10-9M, Bmax of 0.75 × 10-13 and 9.7 × 10-13M/mg protein in MDA-MB231 and in T47D cells, resp.) while no binding was obsd. in 5 other cell lines and normal epithelial cells.  The neuropeptide and its structural analogs (natural or synthetic) inhibited the binding of 125I-Tyr4 bombesin in the following order of potency: gastrin-releasing peptide (GRP, EC50 = 1.7 × 10-10M) > BIM 26159 > bombesin, Tyr4 bombesin > BIM 26147 > litorin > neuromedin C.  In contrast, 125I-Tyr4 bombesin binding was not displaced by neuromedin B, somatostatin, bradykinin and insulin.  In agreement with the binding data, SDS-PAGE of the complex 125I-Tyr4 bombesin-receptor covalently linked by ethylene glycol-bissuccinimidyl succinate (EGS) identified after autoradiog. a single band with a mol. wt. of 75,000, which disappeared in the presence of bombesin in excess.  No transcription of either GRP or neuromedin B mRNA could be shown in tumor or normal cells.  Exogenous gastrin-releasing peptide had no effect on growth of the cell lines when a serum-free medium was used, implicating that in breast cancer cell lines this receptor does not mediate growth but has a functional role.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXyOvTjAow8bVg90H21EOLACvtfcHk0lgdAA-p2YL8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXhtF2ntLk%253D&md5=e08a59fc54abedd6f0d054f50a1a6134</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fijc.2910460226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fijc.2910460226%26sid%3Dliteratum%253Aachs%26aulast%3DGiacchetti%26aufirst%3DS.%26aulast%3DGauvill%25C3%25A9%26aufirst%3DC.%26aulast%3Dde%2BCr%25C3%25A9moux%26aufirst%3DP.%26aulast%3DBertin%26aufirst%3DL.%26aulast%3DBerthon%26aufirst%3DP.%26aulast%3DAbita%26aufirst%3DJ.%2BP.%26aulast%3DCuttitta%26aufirst%3DF.%26aulast%3DCalvo%26aufirst%3DF.%26atitle%3DCharacterization%252C%2520in%2520Some%2520Human%2520Breast%2520Cancer%2520Cell%2520Lines%252C%2520of%2520Gastrin-Releasing%2520Peptide-like%2520Receptors%2520Which%2520Are%2520Absent%2520in%2520Normal%2520Breast%2520Epithelial%2520Cells%26jtitle%3DInt.%2520J.%2520Cancer%26date%3D1990%26volume%3D46%26issue%3D2%26spage%3D293%26epage%3D298%26doi%3D10.1002%2Fijc.2910460226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liolios, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fragogeorgi, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zikos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loudos, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xanthopoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouziotis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paravatou-Petsotas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Livaniou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varvarigou, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivolapenko, G. B.</span></span> <span> </span><span class="NLM_article-title">Structural Modifications of <sup>99m</sup>Tc-Labelled Bombesin-like Peptides for Optimizing Pharmacokinetics in Prostate Tumor Targeting</span>. <i>Int. J. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>430</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">2</span>, <span class="refDoi"> DOI: 10.1016/j.ijpharm.2012.02.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2Fj.ijpharm.2012.02.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=22459664" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFWqsbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=430&publication_year=2012&pages=1-2&author=C.+C.+Lioliosauthor=E.+A.+Fragogeorgiauthor=C.+Zikosauthor=G.+Loudosauthor=S.+Xanthopoulosauthor=P.+Bouziotisauthor=M.+Paravatou-Petsotasauthor=E.+Livaniouauthor=A.+D.+Varvarigouauthor=G.+B.+Sivolapenko&title=Structural+Modifications+of+99mTc-Labelled+Bombesin-like+Peptides+for+Optimizing+Pharmacokinetics+in+Prostate+Tumor+Targeting&doi=10.1016%2Fj.ijpharm.2012.02.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural modifications of 99mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting</span></div><div class="casAuthors">Liolios, Christos C.; Fragogeorgi, Eirini A.; Zikos, Christos; Loudos, George; Xanthopoulos, Stavros; Bouziotis, Penelope; Paravatou-Petsotas, Maria; Livaniou, Evangelia; Varvarigou, Alexandra D.; Sivolapenko, Gregory B.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Pharmaceutics (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">430</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-17</span>CODEN:
                <span class="NLM_cas:coden">IJPHDE</span>;
        ISSN:<span class="NLM_cas:issn">0378-5173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The main goal of the present study was to investigate the importance of the addn. of a pos. charged aa in the naturally occurring Bombesin (BN) peptide for its utilization as radiodiagnostic agent, taking into consideration the biodistribution profile, the pharmacokinetic characteristics and the tumor targeting ability.  Two BN-derivs. of the general structure [M-chelator]-(spacer)-BN(2-14)-NH2, where M: 99mTc or 185/187Re, chelator: Gly-Gly-Cys-, spacer: -(arginine)3-, M-BN-A; spacer: -(ornithine)3-, M-BN-O; have been prepd. and evaluated as tumor imaging agents.  The peptides under study presented high radiolabelling efficiency (>98%), significant stability in human plasma (>60% intact radiolabeled peptide after 1 h incubation) and comparable receptor binding affinity with the std. [125I-Tyr4]-BN.  Their internalization rates in the prostate cancer PC-3 cells differed, although the amt. of internalized peptide was the same.  The biodistribution and the dynamic γ-camera imaging studies in normal and PC-3 tumor-bearing SCID mice have shown significant tumor uptake, combined with fast blood clearance, through the urinary pathway.The addn. of the charged aa spacer in the BN structure was advantageous for biodistribution, pharmacokinetics and tumor targeting ability, because it reduced the upper abdominal radioactivity levels and increased tumor/normal tissue contrast ratios.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0bZwfN573mbVg90H21EOLACvtfcHk0lgdAA-p2YL8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFWqsbc%253D&md5=b3e112a75bdb54a8cf2ac820e9a103f2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.ijpharm.2012.02.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijpharm.2012.02.049%26sid%3Dliteratum%253Aachs%26aulast%3DLiolios%26aufirst%3DC.%2BC.%26aulast%3DFragogeorgi%26aufirst%3DE.%2BA.%26aulast%3DZikos%26aufirst%3DC.%26aulast%3DLoudos%26aufirst%3DG.%26aulast%3DXanthopoulos%26aufirst%3DS.%26aulast%3DBouziotis%26aufirst%3DP.%26aulast%3DParavatou-Petsotas%26aufirst%3DM.%26aulast%3DLivaniou%26aufirst%3DE.%26aulast%3DVarvarigou%26aufirst%3DA.%2BD.%26aulast%3DSivolapenko%26aufirst%3DG.%2BB.%26atitle%3DStructural%2520Modifications%2520of%252099mTc-Labelled%2520Bombesin-like%2520Peptides%2520for%2520Optimizing%2520Pharmacokinetics%2520in%2520Prostate%2520Tumor%2520Targeting%26jtitle%3DInt.%2520J.%2520Pharm.%26date%3D2012%26volume%3D430%26spage%3D1%26epage%3D2%26doi%3D10.1016%2Fj.ijpharm.2012.02.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zoller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zöller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzku, S.</span></span> <span> </span><span class="NLM_article-title">Establishment and Characterization of Monoclonal Antibodies against an Octahedral Gallium Chelate Suitable for Immunoscintigraphy with PET</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>33</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1366</span>– <span class="NLM_lpage">1372</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1992&pages=1366-1372&issue=7&author=M.+Zollerauthor=J.+Schuhmacherauthor=J.+Reedauthor=W.+Maier-Borstauthor=S.+Matzkuauthor=M.+Z%C3%B6llerauthor=J.+Schuhmacherauthor=J.+Reedauthor=W.+Maier-Borstauthor=S.+Matzku&title=Establishment+and+Characterization+of+Monoclonal+Antibodies+against+an+Octahedral+Gallium+Chelate+Suitable+for+Immunoscintigraphy+with+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZoller%26aufirst%3DM.%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DMaier-Borst%26aufirst%3DW.%26aulast%3DMatzku%26aufirst%3DS.%26aulast%3DZ%25C3%25B6ller%26aufirst%3DM.%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DReed%26aufirst%3DJ.%26aulast%3DMaier-Borst%26aufirst%3DW.%26aulast%3DMatzku%26aufirst%3DS.%26atitle%3DEstablishment%2520and%2520Characterization%2520of%2520Monoclonal%2520Antibodies%2520against%2520an%2520Octahedral%2520Gallium%2520Chelate%2520Suitable%2520for%2520Immunoscintigraphy%2520with%2520PET%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1992%26volume%3D33%26issue%3D7%26spage%3D1366%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schuhmacher, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maier-Borst, W.</span></span> <span> </span><span class="NLM_article-title">A New <sup>68</sup>Ge/<sup>68</sup>Ga Radioisotope Generator System for Production of <sup>68</sup>Ga in Dilute HCl</span>. <i>Int. J. Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>32</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/0020-708X(81)90174-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=10.1016%2F0020-708X%2881%2990174-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADyaL3MXntleitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1981&pages=31-36&issue=1&author=J.+Schuhmacherauthor=W.+Maier-Borst&title=A+New+68Ge%2F68Ga+Radioisotope+Generator+System+for+Production+of+68Ga+in+Dilute+HCl&doi=10.1016%2F0020-708X%2881%2990174-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">A new germanium-68/gallium-68 radioisotope generator system for production of gallium-68 in dilute hydrochloric acid</span></div><div class="casAuthors">Schuhmacher, J.; Maier-Borst, W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-6</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">The synthesis of an ion-exchanger resin produced from pyrogallol and formaldehyde and characterized by a highly efficient adsorption for 68Ge/68Ga radioisotope generator prepd. from this resin and operated with 10 mL of 4.5 N HCl as eluant constantly showed a high yield of 68Ga during a time period of more than 200 days with a contamination of <1 ppm 68Ge.  A small column, filled with com. available anion-exchanger resin and coupled in series with the generator, reduces the vol. and HCl concn. of the generator eluate in such a way that 80% of the available 68Ga appears in 4 mL 0.5 N HCl.  The eluate is free of radiolytic products and suitable for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRhjxbEUU3YbVg90H21EOLACvtfcHk0lgdAA-p2YL8kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXntleitA%253D%253D&md5=856d9f944e43949f3a2f51a0f18ce5a8</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2881%2990174-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252881%252990174-5%26sid%3Dliteratum%253Aachs%26aulast%3DSchuhmacher%26aufirst%3DJ.%26aulast%3DMaier-Borst%26aufirst%3DW.%26atitle%3DA%2520New%252068Ge%252F68Ga%2520Radioisotope%2520Generator%2520System%2520for%2520Production%2520of%252068Ga%2520in%2520Dilute%2520HCl%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1981%26volume%3D32%26issue%3D1%26spage%3D31%26epage%3D36%26doi%3D10.1016%2F0020-708X%2881%2990174-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schäfer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauder-Wüst, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hull, W.-E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wängler, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberkorn, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenhut, M.</span></span> <span> </span><span class="NLM_article-title"><sup>68</sup>Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">697</span>, <span class="refDoi"> DOI: 10.1021/bc200279b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bc200279b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2012&pages=688-697&issue=4&author=M.+Ederauthor=M.+Sch%C3%A4ferauthor=U.+Bauder-W%C3%BCstauthor=W.-E.+Hullauthor=C.+W%C3%A4nglerauthor=W.+Mierauthor=U.+Haberkornauthor=M.+Eisenhut&title=68Ga-Complex+Lipophilicity+and+the+Targeting+Property+of+a+Urea-Based+PSMA+Inhibitor+for+PET+Imaging&doi=10.1021%2Fbc200279b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging</span></div><div class="casAuthors">Eder, Matthias; Schaefer, Martin; Bauder-Wuest, Ulrike; Hull, William-Edmund; Waengler, Carmen; Mier, Walter; Haberkorn, Uwe; Eisenhut, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">688-697</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Urea-based inhibitors of the prostate-specific membrane antigen (PSMA) represent low-mol.-wt. pepidomimetics showing the ability to image PSMA-expressing prostate tumors.  The highly efficient, acyclic Ga(III) chelator N,N'-bis [2-hydroxy-5-(carboxyethyl)benzyl] ethylenediamine-N,N'- diacetic acid (HBED-CC) was introduced as a lipophilic side chain into the hydrophilic pharmacophore Glu-NH-CO-NH-Lys which was found favorable to interact with the PSMA "active binding site".  This report describes the syntheses, in vitro binding analyses, and biodistribution data of the radiogallium labeled PSMA inhibitor Glu-NH-CO-NH-Lys(Ahx)-HBED-CC in comparison to the corresponding DOTA conjugate.  The binding properties were analyzed using competitive cell binding and enzyme-based assays followed by internalization expts.  Compared to the DOTA-conjugate, the HBED-CC deriv. showed reduced unspecific binding and considerable higher specific internalization in LNCaP cells.  The 68Ga complex of the HBED-CC ligand exhibited higher specificity for PSMA expressing tumor cells resulting in improved in vivo properties. 68Ga labeled Glu-NH-CO-NH-Lys(Ahx)-HBED-CC showed fast blood and organ clearances, low liver accumulation, and high specific uptake in PSMA expressing organs and tumor.  It could be demonstrated that the PET-imaging property of a urea-based PSMA inhibitor could significantly be improved with HBED-CC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9XoCnl_RguLVg90H21EOLACvtfcHk0lj7krb6yvljnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVCmtLo%253D&md5=4bb4cbba9f510ed2561b87a44bafa00a</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fbc200279b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc200279b%26sid%3Dliteratum%253Aachs%26aulast%3DEder%26aufirst%3DM.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DM.%26aulast%3DBauder-W%25C3%25BCst%26aufirst%3DU.%26aulast%3DHull%26aufirst%3DW.-E.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DC.%26aulast%3DMier%26aufirst%3DW.%26aulast%3DHaberkorn%26aufirst%3DU.%26aulast%3DEisenhut%26aufirst%3DM.%26atitle%3D68Ga-Complex%2520Lipophilicity%2520and%2520the%2520Targeting%2520Property%2520of%2520a%2520Urea-Based%2520PSMA%2520Inhibitor%2520for%2520PET%2520Imaging%26jtitle%3DBioconjugate%2520Chem.%26date%3D2012%26volume%3D23%26issue%3D4%26spage%3D688%26epage%3D697%26doi%3D10.1021%2Fbc200279b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i25"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01856">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_01205"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b01856">10.1021/acs.jmedchem.7b01856</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Ligands <b>1</b>−<b>4</b> IC<sub>50</sub> curves, [<sup>nat</sup>Ga]<b>1</b>−<b>4</b> RP-HPLC results, [<sup>68</sup>Ga]<b>1</b>−<b>4</b>, [<sup>nat</sup>Ga]RM2 biodistribution and tumor to normal tissue data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b01856/suppl_file/jm7b01856_si_001.pdf">jm7b01856_si_001.pdf (482.91 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b01856&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-5%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b01856" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b01856" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997d704d9f3dd7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
